{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "e2190872",
   "metadata": {},
   "source": [
    "# Part III. Data Model\n",
    "\n",
    "#### Creating Data Model and Storing in Neo4j Graph Database  \n",
    "- Company Nodes\n",
    "- *[link: period]*\n",
    "- Document Nodes \n",
    "- *[link: filter criteria]*\n",
    "- Sentence Nodes\n",
    "- *[link: order of appearance]*\n",
    "- Noun-Phrase Nodes\n",
    "- *[link: algorithm]*\n",
    "- Cluster Nodes\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "c324d6bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import json\n",
    "from bs4 import BeautifulSoup\n",
    "import re\n",
    "import time\n",
    "import os\n",
    "from ast import literal_eval # pandas store list as string; need to convert back\n",
    "from collections import Counter\n",
    "\n",
    "import spacy\n",
    "#!python -m spacy download en_core_web_lg\n",
    "# ERROR: en-core-web-lg 2.3.0 has requirement spacy<2.4.0,>=2.3.0, but you'll have spacy 3.2.1 which is incompatible.\n",
    "\n",
    "from wordcloud import WordCloud\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "pd.set_option('max_colwidth',None)\n",
    "pd.set_option('display.max_rows', None)\n",
    "pd.set_option('display.width', 0)\n",
    "\n",
    "import neo4j"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "fc612f67",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['count(n)'] [[10452]]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'CALL db.indices'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from neo4j import GraphDatabase\n",
    "driver = GraphDatabase.driver(uri=\"bolt://localhost\", auth=(\"neo4j\", \"password_neo4j\"),encrypted=False,max_connection_lifetime=200)\n",
    "\n",
    "# Initialization - Only run once to clean the database\n",
    "\n",
    "with driver.session() as session:\n",
    "#    session.run(\"MATCH (n) detach delete (n)\")\n",
    "    result = session.run(\"MATCH (n) RETURN count(n) \")\n",
    "\n",
    "print(result.keys(), result.values())\n",
    "\n",
    "    \n",
    "# Creating constraint will automatically create index\n",
    "\n",
    "\"CREATE INDEX ON :CausalSentence(text)\"\n",
    "\"CREATE INDEX ON :Noun(text)\"\n",
    "\"DROP INDEX ON :Noun(text)\"\n",
    "\"DROP INDEX ON :CausalSentence(text)\"\n",
    "\n",
    "\"CREATE CONSTRAINT ON (n:Noun) ASSERT (n.text) IS UNIQUE\"\n",
    "\"CREATE CONSTRAINT ON (n:CausalSentence) ASSERT (n.text) IS UNIQUE\"\n",
    "\n",
    "\"DROP CONSTRAINT ON (p:Person) ASSERT (p.name) IS UNIQUE\"\n",
    "\n",
    "# CREATE index : non-unique\n",
    "# CREATE constraint: unique\n",
    "\n",
    "\"CREATE CONSTRAINT ON (n:Company) ASSERT (n.ticker) IS UNIQUE\" \n",
    "#Unable to create CONSTRAINT ON ( company:Company ) ASSERT (company.ticker) IS UNIQUE: Both Node(20359) and Node(20482) have the label `Company` and property `ticker` = 'AMCR'\n",
    "\"CREATE CONSTRAINT ON (n:Document) ASSERT (n.file) IS UNIQUE\"\n",
    "#Unable to create CONSTRAINT ON ( document:Document ) ASSERT (document.file) IS UNIQUE: Both Node(21728) and Node(21948) have the label `Document` and property `file` = '0001652044-16-000012'\n",
    "\"CREATE INDEX ON :Company(ticker)\"\n",
    "\"CREATE INDEX ON :Document(file)\"\n",
    "\n",
    "\"CALL db.constraints\"\n",
    "\"CALL db.indices\" # including constraints\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "b1a8044a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['count(n)'] [[1423]]\n"
     ]
    }
   ],
   "source": [
    "with driver.session() as session:\n",
    "    session.run(\"MATCH (n:Noun) detach delete (n)\")\n",
    "    result = session.run(\"MATCH (n) RETURN count(n) \")\n",
    "\n",
    "print(result.keys(), result.values())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "57773aab",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "523\n",
      "10\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>cik</th>\n",
       "      <th>name</th>\n",
       "      <th>exchange</th>\n",
       "      <th>10K_files</th>\n",
       "      <th>10Q_files</th>\n",
       "      <th>k_count</th>\n",
       "      <th>q_count</th>\n",
       "      <th>total</th>\n",
       "      <th>GICS Sector</th>\n",
       "      <th>GICS Sub-Industry</th>\n",
       "      <th>Date first added</th>\n",
       "      <th>Founded</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>OGN</td>\n",
       "      <td>1821825.0</td>\n",
       "      <td>Organon &amp; Co.</td>\n",
       "      <td>NYSE</td>\n",
       "      <td>[]</td>\n",
       "      <td>['0001821825-21-000009', '0001821825-21-000005']</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Health Care</td>\n",
       "      <td>Pharmaceuticals</td>\n",
       "      <td>6/3/2021</td>\n",
       "      <td>2021.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NI</td>\n",
       "      <td>1111711.0</td>\n",
       "      <td>NISOURCE INC.</td>\n",
       "      <td>NYSE</td>\n",
       "      <td>['0001174947-21-000255', '0001111711-21-000010', '0001174947-20-000354', '0001111711-20-000013', '0001174947-19-000367', '0001111711-19-000008', '0001174947-18-000312', '0001111711-18-000008', '0001174947-17-000571', '0001111711-17-000011', '0001111711-16-000049', '0001111711-15-000008', '0001111711-13-000007', '0000950123-11-019598', '0000950123-10-017958', '0000950152-09-001944', '0000950137-08-003307', '0000950137-07-003072', '0000950134-06-004660', '0000950137-05-002819', '0000950137-04-001796', '0000893220-03-000230', '0000893220-02-000181']</td>\n",
       "      <td>['0001174947-21-001005', '0001111711-21-000036', '0001111711-21-000029', '0001174947-21-000750', '0001174947-21-000500', '0001111711-21-000018', '0001174947-20-001096', '0001111711-20-000047', '0001174947-20-000869', '0001111711-20-000036', '0001174947-20-000638', '0001111711-20-000022', '0001174947-19-001160', '0001111711-19-000041', '0001174947-19-000963', '0001111711-19-000034', '0001174947-19-000654', '0001111711-19-000022', '0001174947-18-001364', '0001111711-18-000049', '0001174947-18-001074', '0001111711-18-000034', '0001174947-18-000725', '0001111711-18-000021', '0001174947-17-001544', '0001111711-17-000060', '0001174947-17-001200', '0001111711-17-000052', '0001174947-17-000865', '0001111711-17-000032', '0001111711-16-000084', '0001111711-16-000078', '0001111711-16-000064', '0001111711-15-000037', '0001111711-15-000030', '0001111711-15-000022', '0001111711-14-000063', '0001111711-14-000052', '0001111711-14-000036', '0001111711-13-000050', '0001111711-13-000038', '0001111711-13-000021', '0001111711-12-000011', '0001193125-12-324979', '0001193125-12-199491', '0001193125-11-285590', '0000950123-11-071412', '0000950123-11-043546', '0000950123-10-097945', '0000950123-10-071671', '0000950123-10-043358', '0000950123-09-055295', '0000950123-09-029492', '0000950137-09-003509', '0000950137-08-013400', '0000950137-08-010113', '0000950137-08-006593', '0000950137-07-016481', '0000950134-07-016678', '0000950137-07-006784', '0000950137-06-011743', '0000950137-06-005428', '0000950134-05-020465', '0000950137-05-005438', '0000950137-04-009316', '0000950137-04-006309', '0000950137-04-003737', '0000950137-03-005772', '0000950137-03-004186', '0000950137-03-002776', '0000893220-02-001364', '0000893220-02-001000', '0000893220-02-000609', '0000893220-01-500838', '0000893220-01-500533', '0000893220-01-500163']</td>\n",
       "      <td>23</td>\n",
       "      <td>76</td>\n",
       "      <td>99.0</td>\n",
       "      <td>Utilities</td>\n",
       "      <td>Multi-Utilities</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1912.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>GIS</td>\n",
       "      <td>40704.0</td>\n",
       "      <td>GENERAL MILLS INC</td>\n",
       "      <td>NYSE</td>\n",
       "      <td>['0001193125-21-204830', '0001193125-20-186469', '0001193125-19-184675', '0001193125-18-209377', '0001193125-17-217396', '0001193125-16-638404', '0001193125-15-245476', '0001193125-14-260716', '0001193125-13-282371', '0001193125-12-293636', '0000950123-10-064517', '0000950123-09-021887', '0000950137-08-009268', '0000897101-07-001522', '0000897101-06-001513', '0000897101-05-001694', '0000897101-04-001455', '0000897101-03-000909', '0000897101-02-000567']</td>\n",
       "      <td>['0001193125-21-279392', '0001193125-21-092576', '0001193125-20-320164', '0001193125-20-252378', '0001193125-20-077160', '0001193125-19-317557', '0001193125-19-248132', '0001193125-19-080962', '0001193125-18-353281', '0001193125-18-276507', '0001193125-18-090832', '0001193125-17-374688', '0001193125-17-289410', '0001193125-17-090879', '0001193125-16-798939', '0001193125-16-716004', '0001193125-16-515116', '0001193125-15-406352', '0001193125-15-326176', '0001193125-15-096983', '0001193125-14-445397', '0001193125-14-345796', '0001193125-14-105810', '0001193125-13-477790', '0001193125-13-370415', '0001193125-13-117256', '0001193125-12-508388', '0001193125-12-396943', '0001193125-12-125489', '0001193125-11-347162', '0001193125-11-253354', '0000950123-11-028211', '0000950123-10-114560', '0000950123-10-088122', '0000950123-10-027743', '0000950123-09-071898', '0000950123-09-045366', '0000950137-09-002011', '0000950137-08-014460', '0000950137-08-011679', '0000897101-08-000662', '0000897101-07-002742', '0000897101-07-001957', '0000897101-07-000714', '0000897101-07-000053', '0000897101-06-001997', '0000897101-06-000713', '0000897101-06-000047', '0000897101-05-002102', '0000897101-05-000891', '0000897101-05-000060', '0000897101-04-002037', '0000897101-04-000682', '0000897101-04-000033', '0000897101-03-001221', '0000897101-03-000277', '0000897101-03-000006', '0000897101-02-000687', '0000897101-02-000250', '0000897101-02-000005', '0000897101-01-500645', '0000897101-01-500115']</td>\n",
       "      <td>19</td>\n",
       "      <td>62</td>\n",
       "      <td>81.0</td>\n",
       "      <td>Consumer Staples</td>\n",
       "      <td>Packaged Foods &amp; Meats</td>\n",
       "      <td>3/31/1969</td>\n",
       "      <td>1856.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>D</td>\n",
       "      <td>715957.0</td>\n",
       "      <td>DOMINION ENERGY, INC</td>\n",
       "      <td>NYSE</td>\n",
       "      <td>['0001104659-21-042324', '0000929638-21-000493', '0000929638-21-000489', '0000929638-21-000485', '0000929638-21-000497', '0001098151-21-000013', '0001564590-21-008442', '0000882184-20-000143', '0000929638-20-000453', '0000929638-20-000456', '0000929638-20-000460', '0000929638-20-000447', '0001104659-20-039424', '0001098151-20-000008', '0001193125-20-054469', '0000882184-19-000147', '0001144204-19-016159', '0000929638-19-000396', '0000929638-19-000393', '0000929638-19-000388', '0001098151-19-000009', '0001193125-19-057924', '0000882184-18-000120', '0000929638-18-000409', '0000929638-18-000401', '0001098151-18-000009', '0001193125-18-059578', '0000882184-17-000103', '0001104659-17-019967', '0000929638-17-000398']</td>\n",
       "      <td>['0001564590-21-054856', '0001213900-21-042535', '0001098151-21-000036', '0001564590-21-041966', '0000882184-21-000152', '0001213900-21-028791', '0001098151-21-000024', '0001564590-21-023081', '0000882184-21-000126', '0000882184-21-000021', '0001564590-20-051677', '0001098151-20-000063', '0001098151-20-000049', '0001564590-20-036451', '0000882184-20-000112', '0001098151-20-000039', '0001564590-20-021084', '0000882184-20-000099', '0000882184-20-000017', '0001098151-19-000046', '0001564590-19-039434', '0001098151-19-000040', '0001564590-19-027723', '0000882184-19-000107', '0001098151-19-000029', '0001564590-19-015583', '0000882184-19-000096', '0000882184-19-000022', '0001098151-18-000042', '0001564590-18-026483', '0001098151-18-000033', '0001564590-18-018690', '0000882184-18-000083', '0001098151-18-000023', '0001564590-18-010863', '0000882184-18-000075', '0000882184-18-000019', '0001098151-17-000056', '0001564590-17-020637', '0001098151-17-000038', '0001564590-17-015133', '0000882184-17-000080', '0001098151-17-000027', '0001193125-17-157920', '0000882184-17-000073', '0000882184-17-000020', '0001193125-16-763981', '0001098151-16-000087', '0001193125-16-669379', '0001098151-16-000076', '0000882184-16-000178', '0001098151-16-000070', '0001193125-16-579092', '0000882184-16-000164', '0000882184-16-000122', '0001098151-15-000045', '0001193125-15-363617', '0001098151-15-000038', '0001193125-15-280118', '0000882184-15-000064', '0001098151-15-000029', '0001193125-15-170979', '0000882184-15-000051', '0000882184-15-000017', '0001098151-14-000051', '0001098151-14-000037', '0001193125-14-287078', '0000882184-14-000070', '0001098151-14-000024', '0001193125-14-171734', '0000882184-14-000057', '0000882184-14-000024', '0001098151-13-000011', '0001193125-13-427104', '0001562762-13-000244', '0001193125-13-321004', '0000882184-13-000053', '0001144204-13-028177', '0000215466-13-000076', '0001193125-13-172823', '0000882184-13-000012', '0001144204-12-060961', '0000215466-12-000044', '0001193125-12-435134', '0001144204-12-044315', '0000215466-12-000021', '0001193125-12-327880', '0000882184-12-000031', '0001144204-12-029649', '0000215466-12-000006', '0001193125-12-185437', '0001193125-12-175867', '0001193125-12-027358', '0001144204-11-069989', '0000950123-11-098408', '0001193125-11-298648', '0001193125-11-285781', '0001193125-11-242386', '0000950123-11-077516', '0001224952-11-000006']</td>\n",
       "      <td>30</td>\n",
       "      <td>100</td>\n",
       "      <td>130.0</td>\n",
       "      <td>Utilities</td>\n",
       "      <td>Electric Utilities</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1983.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>GL</td>\n",
       "      <td>320335.0</td>\n",
       "      <td>GLOBE LIFE INC.</td>\n",
       "      <td>NYSE</td>\n",
       "      <td>['0000320335-21-000010', '0000320335-20-000008', '0000320335-19-000006', '0000320335-18-000006', '0000320335-17-000010', '0000320335-16-000059', '0001193125-15-069449', '0001193125-14-076801', '0001193125-13-084290', '0001193125-12-085031', '0001193125-11-049737', '0001193125-10-042810', '0001193125-09-040782', '0001193125-08-043419', '0001193125-07-043904', '0001193125-06-046266', '0001193125-05-051197', '0001193125-04-042167', '0000931763-03-000621', '0000931763-02-000748']</td>\n",
       "      <td>['0000320335-21-000050', '0000320335-21-000040', '0000320335-21-000024', '0000320335-20-000055', '0000320335-20-000039', '0000320335-20-000031', '0001683168-20-000308', '0000320335-19-000041', '0000320335-19-000034', '0000320335-19-000015', '0000320335-18-000045', '0000320335-18-000033', '0000320335-18-000016', '0000320335-17-000044', '0000320335-17-000029', '0000320335-17-000018', '0000320335-16-000098', '0000320335-16-000092', '0000320335-16-000078', '0000320335-15-000045', '0000320335-15-000035', '0000320335-15-000013', '0001193125-14-402773', '0001193125-14-191468', '0001193125-13-434167', '0001193125-13-326079', '0001193125-13-210593', '0001193125-12-460061', '0001193125-12-342840', '0001193125-12-221919', '0001193125-11-301448', '0001193125-11-213567', '0001193125-11-131793', '0001193125-10-251848', '0001193125-10-181240', '0001193125-10-112180', '0001193125-09-227080', '0001193125-09-168413', '0001193125-09-105258', '0001193125-08-229885', '0001193125-08-171953', '0001193125-08-110923', '0001193125-07-239575', '0001193125-07-175075', '0001193125-07-107532', '0001193125-06-227873', '0001193125-06-165709', '0001193125-06-102126', '0001193125-05-219580', '0001193125-05-158726', '0001193125-05-100284', '0001193125-04-190456', '0001193125-04-134156', '0001193125-04-082033', '0001193125-03-078307', '0001193125-03-034329', '0000931763-03-001581', '0000931763-02-003414', '0000931763-02-002736', '0000931763-02-001770', '0000931763-01-502108', '0000931763-01-501466', '0000931763-01-500605']</td>\n",
       "      <td>20</td>\n",
       "      <td>63</td>\n",
       "      <td>83.0</td>\n",
       "      <td>Financials</td>\n",
       "      <td>Life &amp; Health Insurance</td>\n",
       "      <td>4/30/1989</td>\n",
       "      <td>1900.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  ticker        cik                  name exchange  \\\n",
       "0    OGN  1821825.0         Organon & Co.     NYSE   \n",
       "1     NI  1111711.0         NISOURCE INC.     NYSE   \n",
       "2    GIS    40704.0     GENERAL MILLS INC     NYSE   \n",
       "3      D   715957.0  DOMINION ENERGY, INC     NYSE   \n",
       "4     GL   320335.0       GLOBE LIFE INC.     NYSE   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          10K_files  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                []   \n",
       "1                                                                                                                                                                          ['0001174947-21-000255', '0001111711-21-000010', '0001174947-20-000354', '0001111711-20-000013', '0001174947-19-000367', '0001111711-19-000008', '0001174947-18-000312', '0001111711-18-000008', '0001174947-17-000571', '0001111711-17-000011', '0001111711-16-000049', '0001111711-15-000008', '0001111711-13-000007', '0000950123-11-019598', '0000950123-10-017958', '0000950152-09-001944', '0000950137-08-003307', '0000950137-07-003072', '0000950134-06-004660', '0000950137-05-002819', '0000950137-04-001796', '0000893220-03-000230', '0000893220-02-000181']   \n",
       "2                                                                                                                                                                                                                                                                          ['0001193125-21-204830', '0001193125-20-186469', '0001193125-19-184675', '0001193125-18-209377', '0001193125-17-217396', '0001193125-16-638404', '0001193125-15-245476', '0001193125-14-260716', '0001193125-13-282371', '0001193125-12-293636', '0000950123-10-064517', '0000950123-09-021887', '0000950137-08-009268', '0000897101-07-001522', '0000897101-06-001513', '0000897101-05-001694', '0000897101-04-001455', '0000897101-03-000909', '0000897101-02-000567']   \n",
       "3  ['0001104659-21-042324', '0000929638-21-000493', '0000929638-21-000489', '0000929638-21-000485', '0000929638-21-000497', '0001098151-21-000013', '0001564590-21-008442', '0000882184-20-000143', '0000929638-20-000453', '0000929638-20-000456', '0000929638-20-000460', '0000929638-20-000447', '0001104659-20-039424', '0001098151-20-000008', '0001193125-20-054469', '0000882184-19-000147', '0001144204-19-016159', '0000929638-19-000396', '0000929638-19-000393', '0000929638-19-000388', '0001098151-19-000009', '0001193125-19-057924', '0000882184-18-000120', '0000929638-18-000409', '0000929638-18-000401', '0001098151-18-000009', '0001193125-18-059578', '0000882184-17-000103', '0001104659-17-019967', '0000929638-17-000398']   \n",
       "4                                                                                                                                                                                                                                                  ['0000320335-21-000010', '0000320335-20-000008', '0000320335-19-000006', '0000320335-18-000006', '0000320335-17-000010', '0000320335-16-000059', '0001193125-15-069449', '0001193125-14-076801', '0001193125-13-084290', '0001193125-12-085031', '0001193125-11-049737', '0001193125-10-042810', '0001193125-09-040782', '0001193125-08-043419', '0001193125-07-043904', '0001193125-06-046266', '0001193125-05-051197', '0001193125-04-042167', '0000931763-03-000621', '0000931763-02-000748']   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          10Q_files  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ['0001821825-21-000009', '0001821825-21-000005']   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ['0001174947-21-001005', '0001111711-21-000036', '0001111711-21-000029', '0001174947-21-000750', '0001174947-21-000500', '0001111711-21-000018', '0001174947-20-001096', '0001111711-20-000047', '0001174947-20-000869', '0001111711-20-000036', '0001174947-20-000638', '0001111711-20-000022', '0001174947-19-001160', '0001111711-19-000041', '0001174947-19-000963', '0001111711-19-000034', '0001174947-19-000654', '0001111711-19-000022', '0001174947-18-001364', '0001111711-18-000049', '0001174947-18-001074', '0001111711-18-000034', '0001174947-18-000725', '0001111711-18-000021', '0001174947-17-001544', '0001111711-17-000060', '0001174947-17-001200', '0001111711-17-000052', '0001174947-17-000865', '0001111711-17-000032', '0001111711-16-000084', '0001111711-16-000078', '0001111711-16-000064', '0001111711-15-000037', '0001111711-15-000030', '0001111711-15-000022', '0001111711-14-000063', '0001111711-14-000052', '0001111711-14-000036', '0001111711-13-000050', '0001111711-13-000038', '0001111711-13-000021', '0001111711-12-000011', '0001193125-12-324979', '0001193125-12-199491', '0001193125-11-285590', '0000950123-11-071412', '0000950123-11-043546', '0000950123-10-097945', '0000950123-10-071671', '0000950123-10-043358', '0000950123-09-055295', '0000950123-09-029492', '0000950137-09-003509', '0000950137-08-013400', '0000950137-08-010113', '0000950137-08-006593', '0000950137-07-016481', '0000950134-07-016678', '0000950137-07-006784', '0000950137-06-011743', '0000950137-06-005428', '0000950134-05-020465', '0000950137-05-005438', '0000950137-04-009316', '0000950137-04-006309', '0000950137-04-003737', '0000950137-03-005772', '0000950137-03-004186', '0000950137-03-002776', '0000893220-02-001364', '0000893220-02-001000', '0000893220-02-000609', '0000893220-01-500838', '0000893220-01-500533', '0000893220-01-500163']   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ['0001193125-21-279392', '0001193125-21-092576', '0001193125-20-320164', '0001193125-20-252378', '0001193125-20-077160', '0001193125-19-317557', '0001193125-19-248132', '0001193125-19-080962', '0001193125-18-353281', '0001193125-18-276507', '0001193125-18-090832', '0001193125-17-374688', '0001193125-17-289410', '0001193125-17-090879', '0001193125-16-798939', '0001193125-16-716004', '0001193125-16-515116', '0001193125-15-406352', '0001193125-15-326176', '0001193125-15-096983', '0001193125-14-445397', '0001193125-14-345796', '0001193125-14-105810', '0001193125-13-477790', '0001193125-13-370415', '0001193125-13-117256', '0001193125-12-508388', '0001193125-12-396943', '0001193125-12-125489', '0001193125-11-347162', '0001193125-11-253354', '0000950123-11-028211', '0000950123-10-114560', '0000950123-10-088122', '0000950123-10-027743', '0000950123-09-071898', '0000950123-09-045366', '0000950137-09-002011', '0000950137-08-014460', '0000950137-08-011679', '0000897101-08-000662', '0000897101-07-002742', '0000897101-07-001957', '0000897101-07-000714', '0000897101-07-000053', '0000897101-06-001997', '0000897101-06-000713', '0000897101-06-000047', '0000897101-05-002102', '0000897101-05-000891', '0000897101-05-000060', '0000897101-04-002037', '0000897101-04-000682', '0000897101-04-000033', '0000897101-03-001221', '0000897101-03-000277', '0000897101-03-000006', '0000897101-02-000687', '0000897101-02-000250', '0000897101-02-000005', '0000897101-01-500645', '0000897101-01-500115']   \n",
       "3  ['0001564590-21-054856', '0001213900-21-042535', '0001098151-21-000036', '0001564590-21-041966', '0000882184-21-000152', '0001213900-21-028791', '0001098151-21-000024', '0001564590-21-023081', '0000882184-21-000126', '0000882184-21-000021', '0001564590-20-051677', '0001098151-20-000063', '0001098151-20-000049', '0001564590-20-036451', '0000882184-20-000112', '0001098151-20-000039', '0001564590-20-021084', '0000882184-20-000099', '0000882184-20-000017', '0001098151-19-000046', '0001564590-19-039434', '0001098151-19-000040', '0001564590-19-027723', '0000882184-19-000107', '0001098151-19-000029', '0001564590-19-015583', '0000882184-19-000096', '0000882184-19-000022', '0001098151-18-000042', '0001564590-18-026483', '0001098151-18-000033', '0001564590-18-018690', '0000882184-18-000083', '0001098151-18-000023', '0001564590-18-010863', '0000882184-18-000075', '0000882184-18-000019', '0001098151-17-000056', '0001564590-17-020637', '0001098151-17-000038', '0001564590-17-015133', '0000882184-17-000080', '0001098151-17-000027', '0001193125-17-157920', '0000882184-17-000073', '0000882184-17-000020', '0001193125-16-763981', '0001098151-16-000087', '0001193125-16-669379', '0001098151-16-000076', '0000882184-16-000178', '0001098151-16-000070', '0001193125-16-579092', '0000882184-16-000164', '0000882184-16-000122', '0001098151-15-000045', '0001193125-15-363617', '0001098151-15-000038', '0001193125-15-280118', '0000882184-15-000064', '0001098151-15-000029', '0001193125-15-170979', '0000882184-15-000051', '0000882184-15-000017', '0001098151-14-000051', '0001098151-14-000037', '0001193125-14-287078', '0000882184-14-000070', '0001098151-14-000024', '0001193125-14-171734', '0000882184-14-000057', '0000882184-14-000024', '0001098151-13-000011', '0001193125-13-427104', '0001562762-13-000244', '0001193125-13-321004', '0000882184-13-000053', '0001144204-13-028177', '0000215466-13-000076', '0001193125-13-172823', '0000882184-13-000012', '0001144204-12-060961', '0000215466-12-000044', '0001193125-12-435134', '0001144204-12-044315', '0000215466-12-000021', '0001193125-12-327880', '0000882184-12-000031', '0001144204-12-029649', '0000215466-12-000006', '0001193125-12-185437', '0001193125-12-175867', '0001193125-12-027358', '0001144204-11-069989', '0000950123-11-098408', '0001193125-11-298648', '0001193125-11-285781', '0001193125-11-242386', '0000950123-11-077516', '0001224952-11-000006']   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          ['0000320335-21-000050', '0000320335-21-000040', '0000320335-21-000024', '0000320335-20-000055', '0000320335-20-000039', '0000320335-20-000031', '0001683168-20-000308', '0000320335-19-000041', '0000320335-19-000034', '0000320335-19-000015', '0000320335-18-000045', '0000320335-18-000033', '0000320335-18-000016', '0000320335-17-000044', '0000320335-17-000029', '0000320335-17-000018', '0000320335-16-000098', '0000320335-16-000092', '0000320335-16-000078', '0000320335-15-000045', '0000320335-15-000035', '0000320335-15-000013', '0001193125-14-402773', '0001193125-14-191468', '0001193125-13-434167', '0001193125-13-326079', '0001193125-13-210593', '0001193125-12-460061', '0001193125-12-342840', '0001193125-12-221919', '0001193125-11-301448', '0001193125-11-213567', '0001193125-11-131793', '0001193125-10-251848', '0001193125-10-181240', '0001193125-10-112180', '0001193125-09-227080', '0001193125-09-168413', '0001193125-09-105258', '0001193125-08-229885', '0001193125-08-171953', '0001193125-08-110923', '0001193125-07-239575', '0001193125-07-175075', '0001193125-07-107532', '0001193125-06-227873', '0001193125-06-165709', '0001193125-06-102126', '0001193125-05-219580', '0001193125-05-158726', '0001193125-05-100284', '0001193125-04-190456', '0001193125-04-134156', '0001193125-04-082033', '0001193125-03-078307', '0001193125-03-034329', '0000931763-03-001581', '0000931763-02-003414', '0000931763-02-002736', '0000931763-02-001770', '0000931763-01-502108', '0000931763-01-501466', '0000931763-01-500605']   \n",
       "\n",
       "   k_count  q_count  total       GICS Sector        GICS Sub-Industry  \\\n",
       "0        0        2    2.0       Health Care          Pharmaceuticals   \n",
       "1       23       76   99.0         Utilities          Multi-Utilities   \n",
       "2       19       62   81.0  Consumer Staples   Packaged Foods & Meats   \n",
       "3       30      100  130.0         Utilities       Electric Utilities   \n",
       "4       20       63   83.0        Financials  Life & Health Insurance   \n",
       "\n",
       "  Date first added  Founded  \n",
       "0         6/3/2021   2021.0  \n",
       "1              NaN   1912.0  \n",
       "2        3/31/1969   1856.0  \n",
       "3              NaN   1983.0  \n",
       "4        4/30/1989   1900.0  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_root = \"C:/Users/clair/Desktop/Thesis/masterThesis2022/Data/\"\n",
    "\n",
    "df_stats = pd.read_csv(data_root+\"statistics_combined.csv\")\n",
    "print(len(df_stats))\n",
    "\n",
    "df_samples = pd.read_csv(data_root+\"statistics_samples2.csv\")\n",
    "print(len(df_samples))\n",
    "df_samples.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "29fda7fb",
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of company nodes created: ['count(c)'] [[523]]\n"
     ]
    }
   ],
   "source": [
    "# Create company nodes\n",
    "\n",
    "with driver.session() as session:\n",
    "    session.run(\"LOAD CSV WITH HEADERS FROM 'file:///statistics_combined.csv' AS row \"\n",
    "                \"CREATE (c:Company {ticker: row.ticker, name: row.name, exchange: row.exchange}) \"  \n",
    "               )\n",
    "    result = session.run(\"MATCH (c:Company) RETURN count(c) \")\n",
    "\n",
    "print('Number of company nodes created:', result.keys(), result.values())\n",
    "  \n",
    "\n",
    "# the below patch code is needed as previously missing {sector: row.`GICS Sector`, subsector: row.`GICS SubIndustry`}\n",
    "with driver.session() as session:\n",
    "    for index, row in df_stats.iterrows():\n",
    "        session.run(\"MATCH (c:Company {ticker:$ticker}) SET c.sector=$sector, c.subsector=$subsector \", \n",
    "                    ticker=row['ticker'],sector=row['GICS Sector'],subsector=row['GICS Sub-Industry'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e26d95ce",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# Process all documents - DO NOT RUN!!!\n",
    "\n",
    "### Transform df_company (each row represents a company) into df_doc (each row represents a document)\n",
    "### identify MD&A section and save as raw.txt in the same folder\n",
    "\n",
    "from util import process_doc\n",
    "\n",
    "path_save = \"D:/masterThesis2022/Data/\"\n",
    "\n",
    "df_doc = process_doc(df_company=df_stats, download_path= path_save, save_path=data_root)\n",
    "\n",
    "\n",
    "# test\n",
    "#df_ = process_doc(df_company=df_stats[2:3].copy(), download_path= data_root+\"Samples\\\\\", save_path=data_root+\"Samples\\\\\")\n",
    "#df_.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "cfe0f39d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>type</th>\n",
       "      <th>file</th>\n",
       "      <th>year</th>\n",
       "      <th>num</th>\n",
       "      <th>ix</th>\n",
       "      <th>start</th>\n",
       "      <th>end</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>OGN</td>\n",
       "      <td>10-Q</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>21</td>\n",
       "      <td>000009</td>\n",
       "      <td>1</td>\n",
       "      <td>132687</td>\n",
       "      <td>176620</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>OGN</td>\n",
       "      <td>10-Q</td>\n",
       "      <td>0001821825-21-000005</td>\n",
       "      <td>21</td>\n",
       "      <td>000005</td>\n",
       "      <td>1</td>\n",
       "      <td>95825</td>\n",
       "      <td>123717</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NI</td>\n",
       "      <td>10-K</td>\n",
       "      <td>0001174947-21-000255</td>\n",
       "      <td>21</td>\n",
       "      <td>000255</td>\n",
       "      <td>1</td>\n",
       "      <td>257209</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NI</td>\n",
       "      <td>10-K</td>\n",
       "      <td>0001111711-21-000010</td>\n",
       "      <td>21</td>\n",
       "      <td>000010</td>\n",
       "      <td>1</td>\n",
       "      <td>191157</td>\n",
       "      <td>259177</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NI</td>\n",
       "      <td>10-K</td>\n",
       "      <td>0001174947-20-000354</td>\n",
       "      <td>20</td>\n",
       "      <td>000354</td>\n",
       "      <td>0</td>\n",
       "      <td>155108</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  ticker  type                  file year     num  ix   start     end\n",
       "0    OGN  10-Q  0001821825-21-000009   21  000009   1  132687  176620\n",
       "1    OGN  10-Q  0001821825-21-000005   21  000005   1   95825  123717\n",
       "2     NI  10-K  0001174947-21-000255   21  000255   1  257209       0\n",
       "3     NI  10-K  0001111711-21-000010   21  000010   1  191157  259177\n",
       "4     NI  10-K  0001174947-20-000354   20  000354   0  155108       0"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# samples - already processed separately\n",
    "\n",
    "file_name = \"sample2_sentences.pkl\" #latest - last modified on 2021-11-29\n",
    "df_ = pd.read_pickle(data_root+file_name)\n",
    "df_['temp']= df_['file'].apply(lambda s: s.split('-'))\n",
    "df_['year'] = df_['temp'].apply(lambda s:s[1])\n",
    "df_['num'] = df_['temp'].apply(lambda s:s[2])\n",
    "\n",
    "df_samples = pd.DataFrame()\n",
    "for col in ['ticker', 'type', 'file', 'year', 'num', 'ix', 'start', 'end']:\n",
    "    df_samples[col] = df_[col]\n",
    "\n",
    "df_samples.to_pickle(data_root + 'df_sample.pkl')\n",
    "\n",
    "df_samples.head()\n",
    "\n",
    "# Attempt to order documents by 'yy-Q1','yy-Q2', etc. and make 10K as 'yy-Q4' but yy-1; TODO \n",
    "# ticker = 'NI'\n",
    "# df_samples[df_samples['type'] == '10-K'][df_samples['ticker'] == ticker]#[['year','num']]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "7a13631a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of document nodes created: ['count(d)'] [[738]]\n"
     ]
    }
   ],
   "source": [
    "# Create document nodes from samples (738 documents from 10 companies)\n",
    "\n",
    "with driver.session() as session:\n",
    "\n",
    "    for index, row in df_samples.iterrows():\n",
    "\n",
    "        session.run(\"MERGE (d:Document {id: $id, ticker: $ticker, type: $type, file:$file, ix:$ix, mda:$mda}) \"\n",
    "                    \"WITH d MATCH (c:Company {ticker: $ticker}), (d:Document {ticker: $ticker}) \"\n",
    "                    \"MERGE (c)-[r:HAS {year:$year,num:$num}]->(d) \", \n",
    "                    ticker=row['ticker'], type=row['type'],file=row['file'],ix=row['ix'],\n",
    "                    mda=[row['start'],row['end']], year=row['year'],num=row['num'],id=row['year']+'_'+row['type'])\n",
    "    \n",
    "    result = session.run(\"MATCH (d:Document) RETURN count(d) \")\n",
    "\n",
    "print('Number of document nodes created:', result.keys(), result.values())\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "0411d4ae",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ticker</th>\n",
       "      <th>type</th>\n",
       "      <th>file</th>\n",
       "      <th>year</th>\n",
       "      <th>num</th>\n",
       "      <th>ix</th>\n",
       "      <th>start</th>\n",
       "      <th>end</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>OGN</td>\n",
       "      <td>10-Q</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>21</td>\n",
       "      <td>000009</td>\n",
       "      <td>1</td>\n",
       "      <td>132687</td>\n",
       "      <td>176620</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>OGN</td>\n",
       "      <td>10-Q</td>\n",
       "      <td>0001821825-21-000005</td>\n",
       "      <td>21</td>\n",
       "      <td>000005</td>\n",
       "      <td>1</td>\n",
       "      <td>95825</td>\n",
       "      <td>123717</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  ticker  type                  file year     num  ix   start     end\n",
       "0    OGN  10-Q  0001821825-21-000009   21  000009   1  132687  176620\n",
       "1    OGN  10-Q  0001821825-21-000005   21  000005   1   95825  123717"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_root = \"C:/Users/clair/Desktop/Thesis/masterThesis2022/Data/\"\n",
    "\n",
    "df_samples = pd.read_pickle(data_root + 'df_sample.pkl')\n",
    "\n",
    "df_samples[0:2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "1f4906ab",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('OGN', '10-Q', '0001821825-21-000009') num of sentences: 214 -> 44\n",
      "('OGN', '10-Q', '0001821825-21-000005') num of sentences: 156 -> 31\n",
      "('NI', '10-K', '0001111711-21-000010') num of sentences: 460 -> 27\n",
      "('NI', '10-K', '0001111711-20-000013') num of sentences: 460 -> 22\n",
      "('NI', '10-K', '0001111711-19-000008') num of sentences: 401 -> 20\n",
      "('NI', '10-K', '0001111711-18-000008') num of sentences: 395 -> 21\n",
      "('NI', '10-K', '0001111711-17-000011') num of sentences: 392 -> 19\n",
      "('NI', '10-K', '0001111711-16-000049') num of sentences: 409 -> 29\n",
      "('NI', '10-K', '0001111711-15-000008') num of sentences: 727 -> 43\n",
      "('NI', '10-K', '0001111711-13-000007') num of sentences: 784 -> 64\n",
      "('NI', '10-K', '0000950123-11-019598') num of sentences: 603 -> 54\n",
      "('NI', '10-K', '0000950123-10-017958') num of sentences: 853 -> 59\n",
      "('NI', '10-K', '0000950152-09-001944') num of sentences: 923 -> 53\n",
      "('NI', '10-K', '0000950137-08-003307') num of sentences: 731 -> 53\n",
      "('NI', '10-K', '0000950137-07-003072') num of sentences: 626 -> 44\n",
      "('NI', '10-K', '0000950134-06-004660') num of sentences: 621 -> 36\n",
      "('NI', '10-K', '0000950137-05-002819') num of sentences: 604 -> 32\n",
      "('NI', '10-K', '0000950137-04-001796') num of sentences: 595 -> 29\n",
      "('NI', '10-K', '0000893220-03-000230') num of sentences: 569 -> 25\n",
      "('NI', '10-Q', '0001174947-21-001005') num of sentences: 54 -> 0\n",
      "('NI', '10-Q', '0001111711-21-000036') num of sentences: 355 -> 11\n",
      "('NI', '10-Q', '0001111711-21-000029') num of sentences: 299 -> 12\n",
      "('NI', '10-Q', '0001174947-21-000750') num of sentences: 478 -> 16\n",
      "('NI', '10-Q', '0001174947-21-000500') num of sentences: 475 -> 17\n",
      "('NI', '10-Q', '0001111711-21-000018') num of sentences: 282 -> 14\n",
      "('NI', '10-Q', '0001111711-20-000047') num of sentences: 364 -> 22\n",
      "('NI', '10-Q', '0001111711-20-000036') num of sentences: 409 -> 27\n",
      "('NI', '10-Q', '0001111711-20-000022') num of sentences: 320 -> 24\n",
      "('NI', '10-Q', '0001174947-19-001160') num of sentences: 497 -> 25\n",
      "('NI', '10-Q', '0001111711-19-000041') num of sentences: 278 -> 23\n",
      "('NI', '10-Q', '0001174947-19-000963') num of sentences: 490 -> 24\n",
      "('NI', '10-Q', '0001111711-19-000034') num of sentences: 281 -> 23\n",
      "('NI', '10-Q', '0001174947-19-000654') num of sentences: 408 -> 19\n",
      "('NI', '10-Q', '0001111711-19-000022') num of sentences: 228 -> 14\n",
      "('NI', '10-Q', '0001174947-18-001364') num of sentences: 459 -> 35\n",
      "('NI', '10-Q', '0001111711-18-000049') num of sentences: 319 -> 30\n",
      "('NI', '10-Q', '0001174947-18-001074') num of sentences: 411 -> 31\n",
      "('NI', '10-Q', '0001111711-18-000034') num of sentences: 288 -> 24\n",
      "('NI', '10-Q', '0001174947-18-000725') num of sentences: 352 -> 15\n",
      "('NI', '10-Q', '0001111711-18-000021') num of sentences: 248 -> 15\n",
      "('NI', '10-Q', '0001174947-17-001544') num of sentences: 429 -> 18\n",
      "('NI', '10-Q', '0001111711-17-000060') num of sentences: 290 -> 24\n",
      "('NI', '10-Q', '0001174947-17-001200') num of sentences: 450 -> 22\n",
      "('NI', '10-Q', '0001111711-17-000052') num of sentences: 283 -> 22\n",
      "('NI', '10-Q', '0001111711-17-000032') num of sentences: 239 -> 19\n",
      "('NI', '10-Q', '0001111711-16-000084') num of sentences: 274 -> 28\n",
      "('NI', '10-Q', '0001111711-16-000078') num of sentences: 271 -> 26\n",
      "('NI', '10-Q', '0001111711-16-000064') num of sentences: 260 -> 21\n",
      "('NI', '10-Q', '0001111711-15-000037') num of sentences: 308 -> 29\n",
      "('NI', '10-Q', '0001111711-15-000030') num of sentences: 492 -> 36\n",
      "('NI', '10-Q', '0001111711-15-000022') num of sentences: 425 -> 25\n",
      "('NI', '10-Q', '0001111711-14-000063') num of sentences: 550 -> 43\n",
      "('NI', '10-Q', '0000950123-10-043358') num of sentences: 265 -> 23\n",
      "('NI', '10-Q', '0000950123-09-055295') num of sentences: 211 -> 16\n",
      "('NI', '10-Q', '0000950123-09-029492') num of sentences: 276 -> 30\n",
      "('NI', '10-Q', '0000950137-09-003509') num of sentences: 231 -> 18\n",
      "('NI', '10-Q', '0000950137-08-013400') num of sentences: 265 -> 24\n",
      "('NI', '10-Q', '0000950137-08-010113') num of sentences: 238 -> 24\n",
      "('NI', '10-Q', '0000950137-08-006593') num of sentences: 228 -> 18\n",
      "('NI', '10-Q', '0000950137-07-016481') num of sentences: 456 -> 44\n",
      "('NI', '10-Q', '0000950134-07-016678') num of sentences: 390 -> 44\n",
      "('NI', '10-Q', '0000950137-07-006784') num of sentences: 337 -> 25\n",
      "('NI', '10-Q', '0000950137-06-011743') num of sentences: 473 -> 40\n",
      "('NI', '10-Q', '0000950137-06-005428') num of sentences: 334 -> 27\n",
      "('NI', '10-Q', '0000950134-05-020465') num of sentences: 408 -> 34\n",
      "('NI', '10-Q', '0000950137-05-005438') num of sentences: 298 -> 19\n",
      "('NI', '10-Q', '0000950137-04-009316') num of sentences: 357 -> 29\n",
      "('NI', '10-Q', '0000950137-04-006309') num of sentences: 327 -> 34\n",
      "('NI', '10-Q', '0000950137-04-003737') num of sentences: 252 -> 20\n",
      "('NI', '10-Q', '0000950137-03-005772') num of sentences: 333 -> 29\n",
      "('NI', '10-Q', '0000950137-03-004186') num of sentences: 271 -> 25\n",
      "('NI', '10-Q', '0000950137-03-002776') num of sentences: 224 -> 26\n",
      "('NI', '10-Q', '0000893220-02-001364') num of sentences: 310 -> 35\n",
      "('NI', '10-Q', '0000893220-02-001000') num of sentences: 285 -> 37\n",
      "('NI', '10-Q', '0000893220-02-000609') num of sentences: 224 -> 17\n",
      "('NI', '10-Q', '0000893220-01-500838') num of sentences: 259 -> 29\n",
      "('NI', '10-Q', '0000893220-01-500533') num of sentences: 226 -> 24\n",
      "('NI', '10-Q', '0000893220-01-500163') num of sentences: 168 -> 16\n",
      "('GIS', '10-K', '0001193125-21-204830') num of sentences: 449 -> 50\n",
      "('GIS', '10-K', '0001193125-20-186469') num of sentences: 890 -> 77\n",
      "('GIS', '10-K', '0001193125-19-184675') num of sentences: 393 -> 22\n",
      "('GIS', '10-K', '0001193125-18-209377') num of sentences: 482 -> 48\n",
      "('GIS', '10-K', '0001193125-17-217396') num of sentences: 513 -> 56\n",
      "('GIS', '10-K', '0001193125-16-638404') num of sentences: 473 -> 47\n",
      "('GIS', '10-K', '0001193125-15-245476') num of sentences: 463 -> 32\n",
      "('GIS', '10-K', '0001193125-14-260716') num of sentences: 458 -> 42\n",
      "('GIS', '10-K', '0001193125-13-282371') num of sentences: 579 -> 41\n",
      "('GIS', '10-K', '0001193125-12-293636') num of sentences: 586 -> 47\n",
      "('GIS', '10-K', '0000950123-10-064517') num of sentences: 418 -> 41\n",
      "('GIS', '10-K', '0000950123-09-021887') num of sentences: 481 -> 35\n",
      "('GIS', '10-K', '0000950137-08-009268') num of sentences: 378 -> 24\n",
      "('GIS', '10-K', '0000897101-07-001522') num of sentences: 602 -> 39\n",
      "('GIS', '10-K', '0000897101-06-001513') num of sentences: 343 -> 30\n",
      "('GIS', '10-K', '0000897101-05-001694') num of sentences: 327 -> 18\n",
      "('GIS', '10-Q', '0001193125-21-279392') num of sentences: 264 -> 34\n",
      "('GIS', '10-Q', '0001193125-21-092576') num of sentences: 318 -> 52\n",
      "('GIS', '10-Q', '0001193125-20-320164') num of sentences: 309 -> 50\n",
      "('GIS', '10-Q', '0001193125-20-252378') num of sentences: 271 -> 28\n",
      "('GIS', '10-Q', '0001193125-20-077160') num of sentences: 324 -> 41\n",
      "('GIS', '10-Q', '0001193125-19-317557') num of sentences: 300 -> 39\n",
      "('GIS', '10-Q', '0001193125-19-248132') num of sentences: 257 -> 25\n",
      "('GIS', '10-Q', '0001193125-19-080962') num of sentences: 327 -> 34\n",
      "('GIS', '10-Q', '0001193125-18-353281') num of sentences: 317 -> 39\n",
      "('GIS', '10-Q', '0001193125-18-276507') num of sentences: 253 -> 19\n",
      "('GIS', '10-Q', '0001193125-18-090832') num of sentences: 337 -> 39\n",
      "('GIS', '10-Q', '0001193125-17-374688') num of sentences: 319 -> 40\n",
      "('GIS', '10-Q', '0001193125-17-289410') num of sentences: 232 -> 25\n",
      "('GIS', '10-Q', '0001193125-17-090879') num of sentences: 307 -> 32\n",
      "('GIS', '10-Q', '0001193125-16-798939') num of sentences: 266 -> 24\n",
      "('GIS', '10-Q', '0001193125-16-716004') num of sentences: 207 -> 15\n",
      "('GIS', '10-Q', '0001193125-16-515116') num of sentences: 259 -> 17\n",
      "('GIS', '10-Q', '0001193125-15-406352') num of sentences: 242 -> 13\n",
      "('GIS', '10-Q', '0001193125-15-326176') num of sentences: 188 -> 11\n",
      "('GIS', '10-Q', '0001193125-15-096983') num of sentences: 255 -> 14\n",
      "('GIS', '10-Q', '0001193125-14-445397') num of sentences: 244 -> 14\n",
      "('GIS', '10-Q', '0001193125-14-345796') num of sentences: 191 -> 7\n",
      "('GIS', '10-Q', '0001193125-14-105810') num of sentences: 269 -> 23\n",
      "('GIS', '10-Q', '0001193125-13-477790') num of sentences: 242 -> 25\n",
      "('GIS', '10-Q', '0001193125-13-370415') num of sentences: 185 -> 9\n",
      "('GIS', '10-Q', '0001193125-13-117256') num of sentences: 292 -> 33\n",
      "('GIS', '10-Q', '0001193125-12-508388') num of sentences: 264 -> 28\n",
      "('GIS', '10-Q', '0001193125-12-396943') num of sentences: 214 -> 21\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('GIS', '10-Q', '0001193125-12-125489') num of sentences: 223 -> 20\n",
      "('GIS', '10-Q', '0001193125-11-347162') num of sentences: 218 -> 28\n",
      "('GIS', '10-Q', '0001193125-11-253354') num of sentences: 163 -> 15\n",
      "('GIS', '10-Q', '0000950123-11-028211') num of sentences: 227 -> 22\n",
      "('GIS', '10-Q', '0000950123-10-114560') num of sentences: 121 -> 13\n",
      "('GIS', '10-Q', '0000950123-10-088122') num of sentences: 82 -> 9\n",
      "('GIS', '10-Q', '0000950123-10-027743') num of sentences: 221 -> 18\n",
      "('GIS', '10-Q', '0000950123-09-071898') num of sentences: 125 -> 12\n",
      "('GIS', '10-Q', '0000950123-09-045366') num of sentences: 145 -> 9\n",
      "('GIS', '10-Q', '0000950137-09-002011') num of sentences: 175 -> 14\n",
      "('GIS', '10-Q', '0000950137-08-014460') num of sentences: 146 -> 18\n",
      "('GIS', '10-Q', '0000950137-08-011679') num of sentences: 154 -> 8\n",
      "('GIS', '10-Q', '0000897101-08-000662') num of sentences: 330 -> 21\n",
      "('GIS', '10-Q', '0000897101-07-002742') num of sentences: 277 -> 15\n",
      "('GIS', '10-Q', '0000897101-07-001957') num of sentences: 211 -> 12\n",
      "('GIS', '10-Q', '0000897101-07-000714') num of sentences: 257 -> 8\n",
      "('GIS', '10-Q', '0000897101-07-000053') num of sentences: 198 -> 11\n",
      "('GIS', '10-Q', '0000897101-06-001997') num of sentences: 139 -> 4\n",
      "('GIS', '10-Q', '0000897101-06-000713') num of sentences: 197 -> 19\n",
      "('GIS', '10-Q', '0000897101-06-000047') num of sentences: 189 -> 10\n",
      "('GIS', '10-Q', '0000897101-05-002102') num of sentences: 151 -> 2\n",
      "('GIS', '10-Q', '0000897101-05-000891') num of sentences: 185 -> 7\n",
      "('GIS', '10-Q', '0000897101-05-000060') num of sentences: 180 -> 6\n",
      "('GIS', '10-Q', '0000897101-04-002037') num of sentences: 136 -> 5\n",
      "('GIS', '10-Q', '0000897101-04-000682') num of sentences: 115 -> 8\n",
      "('GIS', '10-Q', '0000897101-04-000033') num of sentences: 86 -> 4\n",
      "('GIS', '10-Q', '0000897101-03-001221') num of sentences: 66 -> 5\n",
      "('GIS', '10-Q', '0000897101-03-000277') num of sentences: 110 -> 6\n",
      "('GIS', '10-Q', '0000897101-03-000006') num of sentences: 91 -> 3\n",
      "('GIS', '10-Q', '0000897101-02-000687') num of sentences: 48 -> 5\n",
      "('D', '10-K', '0001104659-21-042324') num of sentences: 4 -> 0\n",
      "('D', '10-K', '0000929638-21-000493') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-21-000489') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-21-000485') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-21-000497') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0001564590-21-008442') num of sentences: 418 -> 34\n",
      "('D', '10-K', '0000882184-20-000143') num of sentences: 525 -> 44\n",
      "('D', '10-K', '0000929638-20-000453') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-20-000456') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-20-000460') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-20-000447') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0001104659-20-039424') num of sentences: 4 -> 0\n",
      "('D', '10-K', '0001193125-20-054469') num of sentences: 460 -> 38\n",
      "('D', '10-K', '0000882184-19-000147') num of sentences: 499 -> 34\n",
      "('D', '10-K', '0001144204-19-016159') num of sentences: 4 -> 0\n",
      "('D', '10-K', '0000929638-19-000396') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-19-000393') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-19-000388') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0001193125-19-057924') num of sentences: 440 -> 43\n",
      "('D', '10-K', '0000882184-18-000120') num of sentences: 621 -> 49\n",
      "('D', '10-K', '0001193125-18-059578') num of sentences: 418 -> 39\n",
      "('D', '10-K', '0000882184-17-000103') num of sentences: 508 -> 41\n",
      "('D', '10-K', '0001104659-17-019967') num of sentences: 3 -> 0\n",
      "('D', '10-K', '0000929638-17-000398') num of sentences: 3 -> 0\n",
      "('D', '10-Q', '0001564590-21-054856') num of sentences: 161 -> 28\n",
      "('D', '10-Q', '0001213900-21-042535') num of sentences: 81 -> 2\n",
      "('D', '10-Q', '0001564590-21-041966') num of sentences: 160 -> 26\n",
      "('D', '10-Q', '0000882184-21-000152') num of sentences: 481 -> 29\n",
      "('D', '10-Q', '0001213900-21-028791') num of sentences: 75 -> 2\n",
      "('D', '10-Q', '0001098151-21-000024') num of sentences: 376 -> 14\n",
      "('D', '10-Q', '0001564590-21-023081') num of sentences: 124 -> 16\n",
      "('D', '10-Q', '0000882184-21-000126') num of sentences: 476 -> 31\n",
      "('D', '10-Q', '0000882184-21-000021') num of sentences: 432 -> 31\n",
      "('D', '10-Q', '0001564590-20-051677') num of sentences: 183 -> 17\n",
      "('D', '10-Q', '0001098151-20-000063') num of sentences: 398 -> 14\n",
      "('D', '10-Q', '0001098151-20-000049') num of sentences: 392 -> 14\n",
      "('D', '10-Q', '0001564590-20-036451') num of sentences: 202 -> 25\n",
      "('D', '10-Q', '0000882184-20-000112') num of sentences: 464 -> 30\n",
      "('D', '10-Q', '0001098151-20-000039') num of sentences: 87 -> 1\n",
      "('D', '10-Q', '0001564590-20-021084') num of sentences: 154 -> 17\n",
      "('D', '10-Q', '0000882184-20-000099') num of sentences: 456 -> 29\n",
      "('D', '10-Q', '0000882184-20-000017') num of sentences: 374 -> 22\n",
      "('D', '10-Q', '0001098151-19-000046') num of sentences: 92 -> 0\n",
      "('D', '10-Q', '0001564590-19-039434') num of sentences: 182 -> 31\n",
      "('D', '10-Q', '0001098151-19-000040') num of sentences: 91 -> 1\n",
      "('D', '10-Q', '0001564590-19-027723') num of sentences: 163 -> 33\n",
      "('D', '10-Q', '0000882184-19-000107') num of sentences: 418 -> 24\n",
      "('D', '10-Q', '0001098151-19-000029') num of sentences: 78 -> 1\n",
      "('D', '10-Q', '0001564590-19-015583') num of sentences: 123 -> 18\n",
      "('D', '10-Q', '0000882184-19-000096') num of sentences: 419 -> 22\n",
      "('D', '10-Q', '0000882184-19-000022') num of sentences: 376 -> 24\n",
      "('D', '10-Q', '0001098151-18-000042') num of sentences: 88 -> 2\n",
      "('D', '10-Q', '0001564590-18-026483') num of sentences: 170 -> 26\n",
      "('D', '10-Q', '0001098151-18-000033') num of sentences: 98 -> 0\n",
      "('D', '10-Q', '0001564590-18-018690') num of sentences: 143 -> 24\n",
      "('D', '10-Q', '0000882184-18-000083') num of sentences: 431 -> 27\n",
      "('D', '10-Q', '0001098151-18-000023') num of sentences: 116 -> 3\n",
      "('D', '10-Q', '0001564590-18-010863') num of sentences: 116 -> 19\n",
      "('D', '10-Q', '0000882184-18-000075') num of sentences: 410 -> 26\n",
      "('D', '10-Q', '0000882184-18-000019') num of sentences: 384 -> 27\n",
      "('D', '10-Q', '0001098151-17-000056') num of sentences: 120 -> 5\n",
      "('D', '10-Q', '0001564590-17-020637') num of sentences: 167 -> 25\n",
      "('D', '10-Q', '0001098151-17-000038') num of sentences: 104 -> 0\n",
      "('D', '10-Q', '0001564590-17-015133') num of sentences: 164 -> 30\n",
      "('D', '10-Q', '0000882184-17-000080') num of sentences: 348 -> 26\n",
      "('D', '10-Q', '0001098151-17-000027') num of sentences: 91 -> 0\n",
      "('D', '10-Q', '0001193125-17-157920') num of sentences: 125 -> 18\n",
      "('D', '10-Q', '0000882184-17-000073') num of sentences: 336 -> 24\n",
      "('D', '10-Q', '0000882184-17-000020') num of sentences: 300 -> 26\n",
      "('D', '10-Q', '0001193125-16-763981') num of sentences: 155 -> 27\n",
      "('D', '10-Q', '0001098151-16-000087') num of sentences: 93 -> 3\n",
      "('D', '10-Q', '0001193125-16-669379') num of sentences: 155 -> 24\n",
      "('D', '10-Q', '0001098151-16-000076') num of sentences: 96 -> 3\n",
      "('D', '10-Q', '0000882184-16-000178') num of sentences: 319 -> 17\n",
      "('D', '10-Q', '0001098151-16-000070') num of sentences: 80 -> 0\n",
      "('D', '10-Q', '0001193125-16-579092') num of sentences: 101 -> 15\n",
      "('D', '10-Q', '0000882184-16-000164') num of sentences: 315 -> 18\n",
      "('D', '10-Q', '0000882184-16-000122') num of sentences: 298 -> 18\n",
      "('D', '10-Q', '0001098151-15-000045') num of sentences: 113 -> 2\n",
      "('D', '10-Q', '0001193125-15-363617') num of sentences: 145 -> 28\n",
      "('D', '10-Q', '0001098151-15-000038') num of sentences: 112 -> 3\n",
      "('D', '10-Q', '0001193125-15-280118') num of sentences: 134 -> 22\n",
      "('D', '10-Q', '0000882184-15-000064') num of sentences: 362 -> 32\n",
      "('D', '10-Q', '0001098151-15-000029') num of sentences: 93 -> 3\n",
      "('D', '10-Q', '0001193125-15-170979') num of sentences: 95 -> 18\n",
      "('D', '10-Q', '0000882184-15-000051') num of sentences: 345 -> 34\n",
      "('D', '10-Q', '0000882184-15-000017') num of sentences: 310 -> 31\n",
      "('D', '10-Q', '0001098151-14-000051') num of sentences: 94 -> 0\n",
      "('D', '10-Q', '0001193125-14-287078') num of sentences: 180 -> 24\n",
      "('D', '10-Q', '0000882184-14-000070') num of sentences: 371 -> 32\n",
      "('D', '10-Q', '0001098151-14-000024') num of sentences: 86 -> 1\n",
      "('D', '10-Q', '0001193125-14-171734') num of sentences: 139 -> 17\n",
      "('D', '10-Q', '0000882184-14-000057') num of sentences: 349 -> 31\n",
      "('D', '10-Q', '0000882184-14-000024') num of sentences: 322 -> 32\n",
      "('D', '10-Q', '0001098151-13-000011') num of sentences: 75 -> 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('D', '10-Q', '0001193125-13-427104') num of sentences: 168 -> 20\n",
      "('D', '10-Q', '0001562762-13-000244') num of sentences: 72 -> 2\n",
      "('D', '10-Q', '0001193125-13-321004') num of sentences: 171 -> 17\n",
      "('D', '10-Q', '0000882184-13-000053') num of sentences: 358 -> 37\n",
      "('D', '10-Q', '0001144204-13-028177') num of sentences: 265 -> 10\n",
      "('D', '10-Q', '0000215466-13-000076') num of sentences: 281 -> 10\n",
      "('D', '10-Q', '0001193125-13-172823') num of sentences: 133 -> 10\n",
      "('D', '10-Q', '0000882184-13-000012') num of sentences: 321 -> 29\n",
      "('D', '10-Q', '0001144204-12-060961') num of sentences: 292 -> 17\n",
      "('D', '10-Q', '0000215466-12-000044') num of sentences: 307 -> 20\n",
      "('D', '10-Q', '0001193125-12-435134') num of sentences: 156 -> 16\n",
      "('D', '10-Q', '0001144204-12-044315') num of sentences: 307 -> 17\n",
      "('D', '10-Q', '0000215466-12-000021') num of sentences: 306 -> 22\n",
      "('D', '10-Q', '0001193125-12-327880') num of sentences: 153 -> 23\n",
      "('D', '10-Q', '0000882184-12-000031') num of sentences: 370 -> 33\n",
      "('D', '10-Q', '0001144204-12-029649') num of sentences: 276 -> 8\n",
      "('D', '10-Q', '0000215466-12-000006') num of sentences: 236 -> 14\n",
      "('D', '10-Q', '0001193125-12-185437') num of sentences: 112 -> 10\n",
      "('D', '10-Q', '0001193125-12-175867') num of sentences: 342 -> 29\n",
      "('D', '10-Q', '0001193125-12-027358') num of sentences: 295 -> 24\n",
      "('D', '10-Q', '0001144204-11-069989') num of sentences: 116 -> 10\n",
      "('D', '10-Q', '0001193125-11-298648') num of sentences: 337 -> 20\n",
      "('D', '10-Q', '0001193125-11-285781') num of sentences: 155 -> 19\n",
      "('D', '10-Q', '0001193125-11-242386') num of sentences: 111 -> 13\n",
      "('D', '10-Q', '0001224952-11-000006') num of sentences: 55 -> 5\n",
      "('GL', '10-K', '0000320335-21-000010') num of sentences: 607 -> 37\n",
      "('GL', '10-K', '0000320335-20-000008') num of sentences: 528 -> 27\n",
      "('GL', '10-K', '0000320335-19-000006') num of sentences: 528 -> 33\n",
      "('GL', '10-K', '0000320335-18-000006') num of sentences: 584 -> 42\n",
      "('GL', '10-K', '0000320335-17-000010') num of sentences: 605 -> 39\n",
      "('GL', '10-K', '0000320335-16-000059') num of sentences: 618 -> 40\n",
      "('GL', '10-K', '0001193125-15-069449') num of sentences: 717 -> 54\n",
      "('GL', '10-K', '0001193125-14-076801') num of sentences: 689 -> 43\n",
      "('GL', '10-K', '0001193125-13-084290') num of sentences: 648 -> 46\n",
      "('GL', '10-K', '0001193125-12-085031') num of sentences: 724 -> 49\n",
      "('GL', '10-K', '0001193125-11-049737') num of sentences: 740 -> 39\n",
      "('GL', '10-K', '0001193125-10-042810') num of sentences: 795 -> 43\n",
      "('GL', '10-K', '0001193125-09-040782') num of sentences: 775 -> 39\n",
      "('GL', '10-K', '0001193125-08-043419') num of sentences: 736 -> 42\n",
      "('GL', '10-K', '0001193125-07-043904') num of sentences: 708 -> 46\n",
      "('GL', '10-K', '0001193125-06-046266') num of sentences: 636 -> 43\n",
      "('GL', '10-K', '0001193125-05-051197') num of sentences: 622 -> 49\n",
      "('GL', '10-K', '0001193125-04-042167') num of sentences: 699 -> 47\n",
      "('GL', '10-K', '0000931763-03-000621') num of sentences: 664 -> 30\n",
      "('GL', '10-Q', '0000320335-21-000050') num of sentences: 465 -> 35\n",
      "('GL', '10-Q', '0000320335-21-000040') num of sentences: 434 -> 34\n",
      "('GL', '10-Q', '0000320335-21-000024') num of sentences: 426 -> 33\n",
      "('GL', '10-Q', '0000320335-20-000055') num of sentences: 478 -> 31\n",
      "('GL', '10-Q', '0000320335-20-000039') num of sentences: 492 -> 35\n",
      "('GL', '10-Q', '0000320335-20-000031') num of sentences: 483 -> 34\n",
      "('GL', '10-Q', '0001683168-20-000308') num of sentences: 146 -> 7\n",
      "('GL', '10-Q', '0000320335-19-000041') num of sentences: 418 -> 25\n",
      "('GL', '10-Q', '0000320335-19-000034') num of sentences: 406 -> 27\n",
      "('GL', '10-Q', '0000320335-19-000015') num of sentences: 360 -> 20\n",
      "('GL', '10-Q', '0000320335-18-000045') num of sentences: 377 -> 22\n",
      "('GL', '10-Q', '0000320335-18-000033') num of sentences: 363 -> 20\n",
      "('GL', '10-Q', '0000320335-18-000016') num of sentences: 362 -> 18\n",
      "('GL', '10-Q', '0000320335-17-000044') num of sentences: 359 -> 16\n",
      "('GL', '10-Q', '0000320335-17-000029') num of sentences: 372 -> 15\n",
      "('GL', '10-Q', '0000320335-17-000018') num of sentences: 368 -> 10\n",
      "('GL', '10-Q', '0000320335-16-000098') num of sentences: 388 -> 17\n",
      "('GL', '10-Q', '0000320335-16-000092') num of sentences: 386 -> 17\n",
      "('GL', '10-Q', '0000320335-16-000078') num of sentences: 363 -> 17\n",
      "('GL', '10-Q', '0000320335-15-000045') num of sentences: 427 -> 21\n",
      "('GL', '10-Q', '0000320335-15-000035') num of sentences: 407 -> 19\n",
      "('GL', '10-Q', '0000320335-15-000013') num of sentences: 387 -> 18\n",
      "('GL', '10-Q', '0001193125-14-402773') num of sentences: 387 -> 26\n",
      "('GL', '10-Q', '0001193125-14-191468') num of sentences: 374 -> 22\n",
      "('GL', '10-Q', '0001193125-13-434167') num of sentences: 419 -> 27\n",
      "('GL', '10-Q', '0001193125-13-326079') num of sentences: 419 -> 19\n",
      "('GL', '10-Q', '0001193125-13-210593') num of sentences: 402 -> 18\n",
      "('GL', '10-Q', '0001193125-12-460061') num of sentences: 421 -> 27\n",
      "('GL', '10-Q', '0001193125-12-342840') num of sentences: 404 -> 24\n",
      "('GL', '10-Q', '0001193125-12-221919') num of sentences: 381 -> 25\n",
      "('GL', '10-Q', '0001193125-11-301448') num of sentences: 413 -> 23\n",
      "('GL', '10-Q', '0001193125-11-131793') num of sentences: 358 -> 15\n",
      "('GL', '10-Q', '0001193125-10-251848') num of sentences: 400 -> 18\n",
      "('GL', '10-Q', '0001193125-10-181240') num of sentences: 422 -> 26\n",
      "('GL', '10-Q', '0001193125-10-112180') num of sentences: 422 -> 24\n",
      "('GL', '10-Q', '0001193125-09-227080') num of sentences: 450 -> 27\n",
      "('GL', '10-Q', '0001193125-09-168413') num of sentences: 438 -> 23\n",
      "('GL', '10-Q', '0001193125-09-105258') num of sentences: 404 -> 23\n",
      "('GL', '10-Q', '0001193125-08-229885') num of sentences: 360 -> 14\n",
      "('GL', '10-Q', '0001193125-08-171953') num of sentences: 326 -> 12\n",
      "('GL', '10-Q', '0001193125-08-110923') num of sentences: 328 -> 16\n",
      "('GL', '10-Q', '0001193125-07-239575') num of sentences: 368 -> 27\n",
      "('GL', '10-Q', '0001193125-07-175075') num of sentences: 359 -> 24\n",
      "('GL', '10-Q', '0001193125-07-107532') num of sentences: 336 -> 21\n",
      "('GL', '10-Q', '0001193125-06-227873') num of sentences: 347 -> 14\n",
      "('GL', '10-Q', '0001193125-06-165709') num of sentences: 336 -> 12\n",
      "('GL', '10-Q', '0001193125-06-102126') num of sentences: 322 -> 13\n",
      "('GL', '10-Q', '0001193125-05-219580') num of sentences: 307 -> 19\n",
      "('GL', '10-Q', '0001193125-05-158726') num of sentences: 318 -> 22\n",
      "('GL', '10-Q', '0001193125-05-100284') num of sentences: 313 -> 20\n",
      "('GL', '10-Q', '0001193125-04-190456') num of sentences: 291 -> 23\n",
      "('GL', '10-Q', '0001193125-04-134156') num of sentences: 259 -> 12\n",
      "('GL', '10-Q', '0001193125-04-082033') num of sentences: 301 -> 16\n",
      "('GL', '10-Q', '0001193125-03-078307') num of sentences: 290 -> 18\n",
      "('GL', '10-Q', '0001193125-03-034329') num of sentences: 256 -> 19\n",
      "('GL', '10-Q', '0000931763-03-001581') num of sentences: 232 -> 11\n",
      "('GL', '10-Q', '0000931763-02-003414') num of sentences: 185 -> 5\n",
      "('GL', '10-Q', '0000931763-02-002736') num of sentences: 180 -> 7\n",
      "('GL', '10-Q', '0000931763-02-001770') num of sentences: 113 -> 7\n",
      "('GL', '10-Q', '0000931763-01-502108') num of sentences: 135 -> 5\n",
      "('GL', '10-Q', '0000931763-01-501466') num of sentences: 107 -> 4\n",
      "('GL', '10-Q', '0000931763-01-500605') num of sentences: 102 -> 2\n",
      "('IEX', '10-K', '0000832101-21-000017') num of sentences: 218 -> 34\n",
      "('IEX', '10-K', '0000832101-20-000007') num of sentences: 207 -> 33\n",
      "('IEX', '10-K', '0000832101-19-000005') num of sentences: 251 -> 51\n",
      "('IEX', '10-K', '0000832101-18-000019') num of sentences: 270 -> 52\n",
      "('IEX', '10-K', '0000832101-17-000016') num of sentences: 254 -> 53\n",
      "('IEX', '10-K', '0000832101-16-000057') num of sentences: 258 -> 57\n",
      "('IEX', '10-K', '0000832101-15-000009') num of sentences: 278 -> 50\n",
      "('IEX', '10-K', '0001445305-14-000435') num of sentences: 297 -> 53\n",
      "('IEX', '10-K', '0001193125-13-069436') num of sentences: 280 -> 46\n",
      "('IEX', '10-K', '0000950123-11-018609') num of sentences: 178 -> 26\n",
      "('IEX', '10-K', '0000950137-05-002422') num of sentences: 2 -> 0\n",
      "('IEX', '10-K', '0000950137-04-001504') num of sentences: 2 -> 0\n",
      "('IEX', '10-K', '0000950137-03-001231') num of sentences: 2 -> 0\n",
      "('IEX', '10-Q', '0000832101-21-000060') num of sentences: 201 -> 37\n",
      "('IEX', '10-Q', '0000832101-21-000053') num of sentences: 263 -> 60\n",
      "('IEX', '10-Q', '0000832101-21-000029') num of sentences: 214 -> 36\n",
      "('IEX', '10-Q', '0000832101-20-000039') num of sentences: 270 -> 58\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('IEX', '10-Q', '0000832101-20-000027') num of sentences: 262 -> 60\n",
      "('IEX', '10-Q', '0000832101-20-000014') num of sentences: 181 -> 34\n",
      "('IEX', '10-Q', '0000832101-19-000031') num of sentences: 238 -> 59\n",
      "('IEX', '10-Q', '0000832101-19-000024') num of sentences: 232 -> 55\n",
      "('IEX', '10-Q', '0000832101-19-000010') num of sentences: 162 -> 33\n",
      "('IEX', '10-Q', '0000832101-18-000045') num of sentences: 228 -> 52\n",
      "('IEX', '10-Q', '0000832101-18-000037') num of sentences: 226 -> 53\n",
      "('IEX', '10-Q', '0000832101-18-000027') num of sentences: 160 -> 34\n",
      "('IEX', '10-Q', '0000832101-17-000051') num of sentences: 225 -> 55\n",
      "('IEX', '10-Q', '0000832101-17-000037') num of sentences: 223 -> 56\n",
      "('IEX', '10-Q', '0000832101-17-000027') num of sentences: 161 -> 34\n",
      "('IEX', '10-Q', '0000832101-16-000093') num of sentences: 220 -> 52\n",
      "('IEX', '10-Q', '0000832101-16-000085') num of sentences: 215 -> 56\n",
      "('IEX', '10-Q', '0000832101-16-000067') num of sentences: 129 -> 24\n",
      "('IEX', '10-Q', '0000832101-15-000039') num of sentences: 210 -> 52\n",
      "('IEX', '10-Q', '0000832101-15-000031') num of sentences: 185 -> 52\n",
      "('IEX', '10-Q', '0000832101-15-000021') num of sentences: 128 -> 28\n",
      "('IEX', '10-Q', '0000832101-14-000009') num of sentences: 178 -> 51\n",
      "('IEX', '10-Q', '0001445305-14-001514') num of sentences: 121 -> 27\n",
      "('IEX', '10-Q', '0001445305-13-002609') num of sentences: 206 -> 50\n",
      "('IEX', '10-Q', '0001193125-13-318966') num of sentences: 192 -> 44\n",
      "('IEX', '10-Q', '0001193125-13-199528') num of sentences: 146 -> 24\n",
      "('IEX', '10-Q', '0001193125-12-449176') num of sentences: 208 -> 46\n",
      "('IEX', '10-Q', '0001193125-12-328998') num of sentences: 210 -> 46\n",
      "('IEX', '10-Q', '0001193125-12-218054') num of sentences: 149 -> 30\n",
      "('IEX', '10-Q', '0001193125-11-288786') num of sentences: 176 -> 30\n",
      "('IEX', '10-Q', '0000950123-11-074497') num of sentences: 119 -> 28\n",
      "('IEX', '10-Q', '0000950123-11-043713') num of sentences: 86 -> 15\n",
      "('IEX', '10-Q', '0000950123-10-100265') num of sentences: 100 -> 11\n",
      "('IEX', '10-Q', '0000950123-10-074296') num of sentences: 101 -> 14\n",
      "('IEX', '10-Q', '0000950123-10-044480') num of sentences: 65 -> 9\n",
      "('IEX', '10-Q', '0000950123-09-057549') num of sentences: 103 -> 13\n",
      "('IEX', '10-Q', '0000950123-09-031231') num of sentences: 92 -> 13\n",
      "('IEX', '10-Q', '0000950152-09-004927') num of sentences: 67 -> 8\n",
      "('IEX', '10-Q', '0000950137-08-013606') num of sentences: 126 -> 18\n",
      "('IEX', '10-Q', '0000950137-08-010399') num of sentences: 106 -> 21\n",
      "('IEX', '10-Q', '0000950137-08-007035') num of sentences: 74 -> 9\n",
      "('IEX', '10-Q', '0000950137-07-016840') num of sentences: 129 -> 19\n",
      "('IEX', '10-Q', '0000950137-07-011592') num of sentences: 123 -> 18\n",
      "('IEX', '10-Q', '0000950137-07-006915') num of sentences: 99 -> 10\n",
      "('IEX', '10-Q', '0000950137-06-012075') num of sentences: 136 -> 20\n",
      "('IEX', '10-Q', '0000950137-06-008859') num of sentences: 128 -> 21\n",
      "('IEX', '10-Q', '0000950137-06-005193') num of sentences: 84 -> 10\n",
      "('IEX', '10-Q', '0000950137-05-013577') num of sentences: 134 -> 17\n",
      "('IEX', '10-Q', '0000950137-05-009810') num of sentences: 132 -> 19\n",
      "('IEX', '10-Q', '0000950137-05-005525') num of sentences: 103 -> 13\n",
      "('IEX', '10-Q', '0000950137-04-009371') num of sentences: 132 -> 16\n",
      "('IEX', '10-Q', '0000950137-04-006194') num of sentences: 134 -> 12\n",
      "('IEX', '10-Q', '0000950137-04-003547') num of sentences: 112 -> 12\n",
      "('IEX', '10-Q', '0000950137-03-005789') num of sentences: 149 -> 15\n",
      "('IEX', '10-Q', '0000950137-03-004194') num of sentences: 144 -> 12\n",
      "('IEX', '10-Q', '0000950137-03-002868') num of sentences: 113 -> 8\n",
      "('IEX', '10-Q', '0000950137-02-006277') num of sentences: 202 -> 20\n",
      "('IEX', '10-Q', '0000950137-02-004406') num of sentences: 171 -> 18\n",
      "('IEX', '10-Q', '0000950137-02-002747') num of sentences: 133 -> 12\n",
      "('IEX', '10-Q', '0000950137-01-504443') num of sentences: 171 -> 27\n",
      "('IEX', '10-Q', '0000950137-01-502819') num of sentences: 162 -> 24\n",
      "('IEX', '10-Q', '0000950137-01-501409') num of sentences: 109 -> 16\n",
      "('IEX', '10-Q', '0000950137-00-004539') num of sentences: 136 -> 22\n",
      "('IEX', '10-Q', '0000950137-00-003567') num of sentences: 131 -> 20\n",
      "('GOOG', '10-K', '0001652044-21-000010') num of sentences: 370 -> 48\n",
      "('GOOG', '10-K', '0001652044-20-000008') num of sentences: 324 -> 45\n",
      "('GOOG', '10-K', '0001652044-19-000004') num of sentences: 332 -> 48\n",
      "('GOOG', '10-K', '0001652044-18-000007') num of sentences: 352 -> 52\n",
      "('GOOG', '10-K', '0001652044-17-000008') num of sentences: 322 -> 49\n",
      "('GOOG', '10-K', '0001652044-16-000012') num of sentences: 379 -> 48\n",
      "('GOOG', '10-Q', '0001652044-21-000057') num of sentences: 257 -> 47\n",
      "('GOOG', '10-Q', '0001652044-21-000047') num of sentences: 249 -> 49\n",
      "('GOOG', '10-Q', '0001652044-21-000020') num of sentences: 223 -> 37\n",
      "('GOOG', '10-Q', '0001652044-20-000050') num of sentences: 267 -> 47\n",
      "('GOOG', '10-Q', '0001652044-20-000032') num of sentences: 258 -> 46\n",
      "('GOOG', '10-Q', '0001652044-20-000021') num of sentences: 225 -> 36\n",
      "('GOOG', '10-Q', '0001652044-19-000032') num of sentences: 203 -> 34\n",
      "('GOOG', '10-Q', '0001652044-19-000023') num of sentences: 203 -> 37\n",
      "('GOOG', '10-Q', '0001652044-19-000015') num of sentences: 182 -> 29\n",
      "('GOOG', '10-Q', '0001652044-18-000035') num of sentences: 255 -> 34\n",
      "('GOOG', '10-Q', '0001652044-18-000027') num of sentences: 253 -> 34\n",
      "('GOOG', '10-Q', '0001652044-18-000016') num of sentences: 205 -> 22\n",
      "('GOOG', '10-Q', '0001652044-17-000042') num of sentences: 222 -> 30\n",
      "('GOOG', '10-Q', '0001652044-17-000026') num of sentences: 214 -> 29\n",
      "('GOOG', '10-Q', '0001652044-17-000014') num of sentences: 189 -> 25\n",
      "('GOOG', '10-Q', '0001652044-16-000038') num of sentences: 214 -> 28\n",
      "('GOOG', '10-Q', '0001652044-16-000032') num of sentences: 220 -> 32\n",
      "('GOOG', '10-Q', '0001652044-16-000021') num of sentences: 198 -> 22\n",
      "('GOOG', '10-Q', '0001652044-15-000005') num of sentences: 184 -> 21\n",
      "('SIVB', '10-K', '0000719739-21-000023') num of sentences: 733 -> 43\n",
      "('SIVB', '10-K', '0000719739-20-000016') num of sentences: 708 -> 41\n",
      "('SIVB', '10-K', '0000719739-19-000018') num of sentences: 658 -> 24\n",
      "('SIVB', '10-K', '0000719739-18-000011') num of sentences: 678 -> 35\n",
      "('SIVB', '10-K', '0000719739-17-000012') num of sentences: 699 -> 40\n",
      "('SIVB', '10-K', '0000719739-16-000073') num of sentences: 668 -> 46\n",
      "('SIVB', '10-K', '0000719739-15-000022') num of sentences: 639 -> 46\n",
      "('SIVB', '10-K', '0000719739-14-000012') num of sentences: 684 -> 34\n",
      "('SIVB', '10-K', '0000719739-13-000009') num of sentences: 675 -> 41\n",
      "('SIVB', '10-K', '0001193125-12-085818') num of sentences: 654 -> 43\n",
      "('SIVB', '10-K', '0001193125-11-047635') num of sentences: 771 -> 57\n",
      "('SIVB', '10-K', '0001193125-10-044799') num of sentences: 811 -> 47\n",
      "('SIVB', '10-K', '0001193125-09-042756') num of sentences: 741 -> 49\n",
      "('SIVB', '10-K', '0001193125-08-043869') num of sentences: 744 -> 47\n",
      "('SIVB', '10-K', '0001104659-06-019224') num of sentences: 421 -> 5\n",
      "('SIVB', '10-K', '0001104659-05-011395') num of sentences: 566 -> 19\n",
      "('SIVB', '10-K', '0001104659-04-007053') num of sentences: 620 -> 32\n",
      "('SIVB', '10-K', '0001047469-03-007766') num of sentences: 2 -> 0\n",
      "('SIVB', '10-Q', '0000719739-21-000071') num of sentences: 706 -> 44\n",
      "('SIVB', '10-Q', '0000719739-21-000060') num of sentences: 658 -> 42\n",
      "('SIVB', '10-Q', '0000719739-21-000036') num of sentences: 594 -> 41\n",
      "('SIVB', '10-Q', '0000719739-20-000074') num of sentences: 750 -> 46\n",
      "('SIVB', '10-Q', '0000719739-20-000055') num of sentences: 750 -> 44\n",
      "('SIVB', '10-Q', '0000719739-20-000036') num of sentences: 654 -> 35\n",
      "('SIVB', '10-Q', '0000719739-19-000075') num of sentences: 543 -> 38\n",
      "('SIVB', '10-Q', '0000719739-19-000052') num of sentences: 543 -> 38\n",
      "('SIVB', '10-Q', '0000719739-19-000034') num of sentences: 492 -> 35\n",
      "('SIVB', '10-Q', '0000719739-18-000049') num of sentences: 534 -> 32\n",
      "('SIVB', '10-Q', '0000719739-18-000038') num of sentences: 539 -> 32\n",
      "('SIVB', '10-Q', '0000719739-18-000024') num of sentences: 489 -> 34\n",
      "('SIVB', '10-Q', '0000719739-17-000062') num of sentences: 542 -> 39\n",
      "('SIVB', '10-Q', '0000719739-17-000049') num of sentences: 542 -> 33\n",
      "('SIVB', '10-Q', '0000719739-17-000021') num of sentences: 502 -> 28\n",
      "('SIVB', '10-Q', '0000719739-16-000114') num of sentences: 542 -> 33\n",
      "('SIVB', '10-Q', '0000719739-16-000095') num of sentences: 544 -> 32\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('SIVB', '10-Q', '0000719739-16-000085') num of sentences: 435 -> 25\n",
      "('SIVB', '10-Q', '0000719739-15-000059') num of sentences: 625 -> 43\n",
      "('SIVB', '10-Q', '0000719739-15-000048') num of sentences: 630 -> 45\n",
      "('SIVB', '10-Q', '0000719739-15-000034') num of sentences: 520 -> 32\n",
      "('SIVB', '10-Q', '0000719739-14-000044') num of sentences: 563 -> 39\n",
      "('SIVB', '10-Q', '0000719739-14-000034') num of sentences: 563 -> 42\n",
      "('SIVB', '10-Q', '0000719739-14-000021') num of sentences: 473 -> 25\n",
      "('SIVB', '10-Q', '0000719739-13-000054') num of sentences: 511 -> 30\n",
      "('SIVB', '10-Q', '0000719739-13-000040') num of sentences: 512 -> 28\n",
      "('SIVB', '10-Q', '0000719739-13-000019') num of sentences: 412 -> 20\n",
      "('SIVB', '10-Q', '0000719739-12-000011') num of sentences: 498 -> 34\n",
      "('SIVB', '10-Q', '0001193125-12-344003') num of sentences: 460 -> 28\n",
      "('SIVB', '10-Q', '0001193125-12-225234') num of sentences: 389 -> 24\n",
      "('SIVB', '10-Q', '0001193125-11-297377') num of sentences: 464 -> 44\n",
      "('SIVB', '10-Q', '0001193125-11-212416') num of sentences: 478 -> 45\n",
      "('SIVB', '10-Q', '0001193125-11-130721') num of sentences: 411 -> 33\n",
      "('SIVB', '10-Q', '0001193125-10-250157') num of sentences: 549 -> 46\n",
      "('SIVB', '10-Q', '0001193125-10-181548') num of sentences: 524 -> 42\n",
      "('SIVB', '10-Q', '0001193125-10-112861') num of sentences: 426 -> 33\n",
      "('SIVB', '10-Q', '0001193125-09-227746') num of sentences: 539 -> 42\n",
      "('SIVB', '10-Q', '0001193125-09-169253') num of sentences: 506 -> 38\n",
      "('SIVB', '10-Q', '0001193125-09-105436') num of sentences: 415 -> 29\n",
      "('SIVB', '10-Q', '0001193125-08-231745') num of sentences: 529 -> 32\n",
      "('SIVB', '10-Q', '0001193125-08-170171') num of sentences: 516 -> 35\n",
      "('SIVB', '10-Q', '0001193125-08-109999') num of sentences: 418 -> 25\n",
      "('SIVB', '10-Q', '0001193125-07-242426') num of sentences: 426 -> 35\n",
      "('SIVB', '10-Q', '0001193125-07-177464') num of sentences: 417 -> 27\n",
      "('SIVB', '10-Q', '0001104659-07-038279') num of sentences: 127 -> 2\n",
      "('SIVB', '10-Q', '0001104659-06-073678') num of sentences: 399 -> 19\n",
      "('SIVB', '10-Q', '0001104659-06-053227') num of sentences: 378 -> 13\n",
      "('SIVB', '10-Q', '0001104659-06-033375') num of sentences: 168 -> 5\n",
      "('SIVB', '10-Q', '0001104659-05-063168') num of sentences: 180 -> 11\n",
      "('SIVB', '10-Q', '0001104659-05-063169') num of sentences: 165 -> 10\n",
      "('SIVB', '10-Q', '0001104659-05-022061') num of sentences: 87 -> 3\n",
      "('SIVB', '10-Q', '0001047469-04-025818') num of sentences: 647 -> 28\n",
      "('SIVB', '10-Q', '0001104659-04-013238') num of sentences: 226 -> 9\n",
      "('SIVB', '10-Q', '0001104659-03-026710') num of sentences: 29 -> 0\n",
      "('SIVB', '10-Q', '0001104659-03-018768') num of sentences: 28 -> 1\n",
      "('SIVB', '10-Q', '0001104659-03-009338') num of sentences: 41 -> 0\n",
      "('YUM', '10-K', '0001564590-21-009460') num of sentences: 360 -> 22\n",
      "('YUM', '10-K', '0001041061-21-000012') num of sentences: 384 -> 21\n",
      "('YUM', '10-K', '0001564590-20-007403') num of sentences: 345 -> 24\n",
      "('YUM', '10-K', '0001041061-20-000015') num of sentences: 290 -> 10\n",
      "('YUM', '10-K', '0001564590-19-004944') num of sentences: 421 -> 27\n",
      "('YUM', '10-K', '0001041061-19-000010') num of sentences: 334 -> 21\n",
      "('YUM', '10-K', '0001564590-18-003524') num of sentences: 432 -> 30\n",
      "('YUM', '10-K', '0001041061-18-000013') num of sentences: 338 -> 27\n",
      "('YUM', '10-K', '0001564590-17-003681') num of sentences: 350 -> 31\n",
      "('YUM', '10-K', '0001041061-17-000016') num of sentences: 337 -> 26\n",
      "('YUM', '10-K', '0001041061-16-000056') num of sentences: 280 -> 33\n",
      "('YUM', '10-K', '0001041061-15-000007') num of sentences: 319 -> 42\n",
      "('YUM', '10-K', '0001041061-13-000007') num of sentences: 376 -> 46\n",
      "('YUM', '10-K', '0001041061-12-000005') num of sentences: 333 -> 37\n",
      "('YUM', '10-K', '0001041061-11-000009') num of sentences: 250 -> 24\n",
      "('YUM', '10-K', '0001041061-10-000011') num of sentences: 392 -> 26\n",
      "('YUM', '10-K', '0001041061-09-000077') num of sentences: 394 -> 24\n",
      "('YUM', '10-K', '0001041061-08-000092') num of sentences: 340 -> 28\n",
      "('YUM', '10-K', '0001041061-07-000140') num of sentences: 567 -> 49\n",
      "('YUM', '10-K', '0001041061-06-000109') num of sentences: 440 -> 54\n",
      "('YUM', '10-K', '0001041061-05-000102') num of sentences: 364 -> 48\n",
      "('YUM', '10-K', '0001041061-04-000122') num of sentences: 421 -> 39\n",
      "('YUM', '10-K', '0001041061-03-000003') num of sentences: 631 -> 42\n",
      "('YUM', '10-K', '0001041061-02-000003') num of sentences: 362 -> 26\n",
      "('YUM', '10-K', '0001041061-01-500003') num of sentences: 376 -> 37\n",
      "('YUM', '10-Q', '0001564590-21-055031') num of sentences: 228 -> 19\n",
      "('YUM', '10-Q', '0001041061-21-000056') num of sentences: 229 -> 26\n",
      "('YUM', '10-Q', '0001564590-21-041869') num of sentences: 215 -> 12\n",
      "('YUM', '10-Q', '0001041061-21-000042') num of sentences: 212 -> 23\n",
      "('YUM', '10-Q', '0001564590-21-024421') num of sentences: 189 -> 8\n",
      "('YUM', '10-Q', '0001041061-21-000022') num of sentences: 177 -> 20\n",
      "('YUM', '10-Q', '0001564590-20-051640') num of sentences: 229 -> 19\n",
      "('YUM', '10-Q', '0001041061-20-000064') num of sentences: 242 -> 28\n",
      "('YUM', '10-Q', '0001564590-20-037176') num of sentences: 198 -> 14\n",
      "('YUM', '10-Q', '0001041061-20-000053') num of sentences: 224 -> 19\n",
      "('YUM', '10-Q', '0001564590-20-023189') num of sentences: 178 -> 5\n",
      "('YUM', '10-Q', '0001041061-20-000034') num of sentences: 196 -> 15\n",
      "('YUM', '10-Q', '0001564590-19-041988') num of sentences: 182 -> 10\n",
      "('YUM', '10-Q', '0001041061-19-000048') num of sentences: 163 -> 11\n",
      "('YUM', '10-Q', '0001041061-19-000033') num of sentences: 163 -> 9\n",
      "('YUM', '10-Q', '0001564590-19-028492') num of sentences: 173 -> 8\n",
      "('YUM', '10-Q', '0001564590-19-018249') num of sentences: 169 -> 5\n",
      "('YUM', '10-Q', '0001041061-19-000018') num of sentences: 140 -> 4\n",
      "('YUM', '10-Q', '0001564590-18-028240') num of sentences: 203 -> 13\n",
      "('YUM', '10-Q', '0001041061-18-000052') num of sentences: 195 -> 15\n",
      "('YUM', '10-Q', '0001564590-18-020158') num of sentences: 199 -> 11\n",
      "('YUM', '10-Q', '0001041061-18-000040') num of sentences: 179 -> 13\n",
      "('YUM', '10-Q', '0001041061-18-000026') num of sentences: 168 -> 10\n",
      "('YUM', '10-Q', '0001564590-18-010822') num of sentences: 178 -> 6\n",
      "('YUM', '10-Q', '0001041061-17-000065') num of sentences: 223 -> 20\n",
      "('YUM', '10-Q', '0001564590-17-019306') num of sentences: 211 -> 18\n",
      "('YUM', '10-Q', '0001041061-17-000057') num of sentences: 201 -> 12\n",
      "('YUM', '10-Q', '0001564590-17-013258') num of sentences: 205 -> 14\n",
      "('YUM', '10-Q', '0001041061-17-000038') num of sentences: 186 -> 8\n",
      "('YUM', '10-Q', '0001564590-17-006178') num of sentences: 199 -> 10\n",
      "('YUM', '10-Q', '0001564590-16-029416') num of sentences: 134 -> 10\n",
      "('YUM', '10-Q', '0001041061-16-000095') num of sentences: 254 -> 24\n",
      "('YUM', '10-Q', '0001041061-16-000084') num of sentences: 217 -> 20\n",
      "('YUM', '10-Q', '0001041061-16-000066') num of sentences: 184 -> 8\n",
      "('YUM', '10-Q', '0001041061-15-000033') num of sentences: 164 -> 23\n",
      "('YUM', '10-Q', '0001041061-15-000023') num of sentences: 165 -> 20\n",
      "('YUM', '10-Q', '0001041061-15-000015') num of sentences: 130 -> 15\n",
      "('YUM', '10-Q', '0001041061-14-000031') num of sentences: 184 -> 41\n",
      "('YUM', '10-Q', '0001041061-14-000023') num of sentences: 155 -> 23\n",
      "('YUM', '10-Q', '0001041061-14-000014') num of sentences: 140 -> 17\n",
      "('YUM', '10-Q', '0001041061-13-000044') num of sentences: 240 -> 37\n",
      "('YUM', '10-Q', '0001041061-13-000035') num of sentences: 216 -> 34\n",
      "('YUM', '10-Q', '0001041061-13-000020') num of sentences: 174 -> 25\n",
      "('YUM', '10-Q', '0001041061-12-000042') num of sentences: 208 -> 28\n",
      "('YUM', '10-Q', '0001041061-12-000035') num of sentences: 213 -> 22\n",
      "('YUM', '10-Q', '0001041061-12-000013') num of sentences: 183 -> 20\n",
      "('YUM', '10-Q', '0001041061-11-000052') num of sentences: 216 -> 25\n",
      "('YUM', '10-Q', '0001041061-11-000040') num of sentences: 192 -> 21\n",
      "('YUM', '10-Q', '0001041061-11-000017') num of sentences: 120 -> 13\n",
      "('YUM', '10-Q', '0001041061-10-000047') num of sentences: 146 -> 12\n",
      "('YUM', '10-Q', '0001041061-10-000035') num of sentences: 132 -> 8\n",
      "('YUM', '10-Q', '0001041061-10-000023') num of sentences: 114 -> 9\n",
      "('YUM', '10-Q', '0001041061-09-000240') num of sentences: 125 -> 16\n",
      "('YUM', '10-Q', '0001041061-09-000192') num of sentences: 125 -> 18\n",
      "('YUM', '10-Q', '0001041061-09-000143') num of sentences: 99 -> 6\n",
      "('YUM', '10-Q', '0001041061-08-000224') num of sentences: 132 -> 33\n",
      "('YUM', '10-Q', '0001041061-08-000197') num of sentences: 117 -> 30\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('YUM', '10-Q', '0001041061-08-000156') num of sentences: 87 -> 18\n",
      "('YUM', '10-Q', '0001041061-07-000282') num of sentences: 308 -> 48\n",
      "('YUM', '10-Q', '0001041061-07-000233') num of sentences: 290 -> 40\n",
      "('YUM', '10-Q', '0001041061-07-000186') num of sentences: 219 -> 32\n",
      "('YUM', '10-Q', '0001041061-06-000207') num of sentences: 213 -> 36\n",
      "('YUM', '10-Q', '0001041061-06-000176') num of sentences: 172 -> 39\n",
      "('YUM', '10-Q', '0001041061-06-000137') num of sentences: 145 -> 28\n",
      "('YUM', '10-Q', '0001041061-05-000297') num of sentences: 225 -> 44\n",
      "('YUM', '10-Q', '0001041061-05-000255') num of sentences: 214 -> 42\n",
      "('YUM', '10-Q', '0001041061-05-000154') num of sentences: 173 -> 22\n",
      "('YUM', '10-Q', '0001041061-04-000318') num of sentences: 218 -> 34\n",
      "('YUM', '10-Q', '0001041061-04-000246') num of sentences: 209 -> 34\n",
      "('YUM', '10-Q', '0001041061-04-000154') num of sentences: 172 -> 27\n",
      "('YUM', '10-Q', '0001041061-03-000137') num of sentences: 185 -> 16\n",
      "('YUM', '10-Q', '0001041061-03-000064') num of sentences: 171 -> 21\n",
      "('YUM', '10-Q', '0001041061-03-000005') num of sentences: 126 -> 15\n",
      "('YUM', '10-Q', '0001041061-02-000019') num of sentences: 261 -> 44\n",
      "('YUM', '10-Q', '0001157523-02-000674') num of sentences: 227 -> 37\n",
      "('YUM', '10-Q', '0001041061-02-000006') num of sentences: 164 -> 22\n",
      "('YUM', '10-Q', '0001041061-01-500017') num of sentences: 237 -> 17\n",
      "('YUM', '10-Q', '0001041061-01-500010') num of sentences: 237 -> 18\n",
      "('GOOG_1288776', '10-K', '0001193125-05-065298') num of sentences: 950 -> 50\n",
      "('GOOG_1288776', '10-K', '0001193125-06-056598') num of sentences: 504 -> 37\n",
      "('GOOG_1288776', '10-K', '0001193125-07-044494') num of sentences: 444 -> 29\n",
      "('GOOG_1288776', '10-K', '0001193125-10-030774') num of sentences: 355 -> 36\n",
      "('GOOG_1288776', '10-K', '0001193125-11-032930') num of sentences: 322 -> 31\n",
      "('GOOG_1288776', '10-K', '0001193125-12-025336') num of sentences: 331 -> 35\n",
      "('GOOG_1288776', '10-K', '0001193125-13-028362') num of sentences: 296 -> 32\n",
      "('GOOG_1288776', '10-K', '0001288776-14-000020') num of sentences: 324 -> 38\n",
      "('GOOG_1288776', '10-K', '0001288776-15-000008') num of sentences: 295 -> 41\n",
      "('GOOG_1288776', '10-K', '0001652044-16-000012') num of sentences: 379 -> 48\n",
      "('GOOG_1288776', '10-Q', '0001193125-04-141838') num of sentences: 815 -> 45\n",
      "('GOOG_1288776', '10-Q', '0001193125-04-197540') num of sentences: 835 -> 49\n",
      "('GOOG_1288776', '10-Q', '0001193125-05-108755') num of sentences: 826 -> 32\n",
      "('GOOG_1288776', '10-Q', '0001193125-05-168339') num of sentences: 868 -> 35\n",
      "('GOOG_1288776', '10-Q', '0001193125-05-225524') num of sentences: 874 -> 40\n",
      "('GOOG_1288776', '10-Q', '0001193125-06-107734') num of sentences: 326 -> 20\n",
      "('GOOG_1288776', '10-Q', '0001193125-06-167945') num of sentences: 369 -> 23\n",
      "('GOOG_1288776', '10-Q', '0001193125-06-228163') num of sentences: 369 -> 26\n",
      "('GOOG_1288776', '10-Q', '0001193125-07-108436') num of sentences: 306 -> 26\n",
      "('GOOG_1288776', '10-Q', '0001193125-07-175880') num of sentences: 333 -> 29\n",
      "('GOOG_1288776', '10-Q', '0001193125-07-238468') num of sentences: 328 -> 29\n",
      "('GOOG_1288776', '10-Q', '0001193125-08-111739') num of sentences: 310 -> 28\n",
      "('GOOG_1288776', '10-Q', '0001193125-08-170309') num of sentences: 330 -> 37\n",
      "('GOOG_1288776', '10-Q', '0001193125-08-230197') num of sentences: 354 -> 39\n",
      "('GOOG_1288776', '10-Q', '0001193125-09-101727') num of sentences: 319 -> 28\n",
      "('GOOG_1288776', '10-Q', '0001193125-09-163845') num of sentences: 307 -> 30\n",
      "('GOOG_1288776', '10-Q', '0001193125-09-222384') num of sentences: 307 -> 26\n",
      "('GOOG_1288776', '10-Q', '0001193125-10-108704') num of sentences: 266 -> 18\n",
      "('GOOG_1288776', '10-Q', '0001193125-10-172387') num of sentences: 279 -> 27\n",
      "('GOOG_1288776', '10-Q', '0001193125-10-241317') num of sentences: 264 -> 26\n",
      "('GOOG_1288776', '10-Q', '0001193125-11-134428') num of sentences: 258 -> 19\n",
      "('GOOG_1288776', '10-Q', '0001193125-11-199078') num of sentences: 291 -> 29\n",
      "('GOOG_1288776', '10-Q', '0001193125-12-182401') num of sentences: 258 -> 18\n",
      "('GOOG_1288776', '10-Q', '0001193125-12-312575') num of sentences: 294 -> 29\n",
      "('GOOG_1288776', '10-Q', '0001193125-12-440217') num of sentences: 303 -> 30\n",
      "('GOOG_1288776', '10-Q', '0001288776-13-000030') num of sentences: 232 -> 21\n",
      "('GOOG_1288776', '10-Q', '0001288776-13-000055') num of sentences: 256 -> 27\n",
      "('GOOG_1288776', '10-Q', '0001288776-13-000068') num of sentences: 273 -> 27\n",
      "('GOOG_1288776', '10-Q', '0001288776-14-000040') num of sentences: 251 -> 19\n",
      "('GOOG_1288776', '10-Q', '0001288776-14-000065') num of sentences: 272 -> 25\n",
      "('GOOG_1288776', '10-Q', '0001288776-14-000075') num of sentences: 274 -> 28\n",
      "('GOOG_1288776', '10-Q', '0001288776-15-000023') num of sentences: 155 -> 19\n",
      "('GOOG_1288776', '10-Q', '0001288776-15-000035') num of sentences: 161 -> 18\n",
      "('GOOG_1288776', '10-Q', '0001288776-15-000046') num of sentences: 184 -> 21\n",
      "17136\n"
     ]
    }
   ],
   "source": [
    "# Process MD&A sections\n",
    "\n",
    "### read raw text  \n",
    "### filter for sentences containing topics of interest and causality\n",
    "### save selected sentences in df_sentences\n",
    "\n",
    "### create sentences nodes and save in neo4j database \n",
    "\n",
    "import util\n",
    "\n",
    "#import importlib\n",
    "#importlib.reload(util)\n",
    "\n",
    "# test\n",
    "df_sent = pd.DataFrame()\n",
    "df_doc = df_samples[:]\n",
    "path_root = data_root+\"Samples\\\\\"\n",
    "\n",
    "df_sent = util.transfer_sentences(df_sent, df_doc, path_root, save=True)\n",
    "\n",
    "df_sent.to_pickle(data_root + 'df_sent.pkl')\n",
    "print(len(df_sent)) #17136"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "3b293efe",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sentence</th>\n",
       "      <th>ticker</th>\n",
       "      <th>file</th>\n",
       "      <th>topic</th>\n",
       "      <th>causal</th>\n",
       "      <th>e_raw</th>\n",
       "      <th>c_raw</th>\n",
       "      <th>c_model</th>\n",
       "      <th>c_noun</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>Operating expenses in the second quarter and first six months of 2021 were higher primarily due to the effect of lower promotional and selling costs incurred in the second quarter and first six months of 2020 attributable to the COVID-19 pandemic as well as incremental costs associated with establishing Organon as a standalone company</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[costs, costs]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [15, 17]], ['attributable to', 'JJ', [36, 38]]]}</td>\n",
       "      <td>[Operating expenses in the second quarter and first six months of 2021 were higher primarily, the effect of lower promotional and selling costs incurred in the second quarter and first six months of 2020]</td>\n",
       "      <td>[the effect of lower promotional and selling costs incurred in the second quarter and first six months of 2020, the COVID-19 pandemic as well as incremental costs associated with establishing Organon as a standalone]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'effect'}, {'link': 'of lower promotional and'}, {'noun': 'selling cost'}, {'link': 'incurred in the second'}, {'noun': 'quarter'}, {'link': 'and first six'}, {'noun': 'month'}, {'link': 'of 2020'}], [{'link': ' the COVID-19'}, {'noun': 'pandemic'}, {'link': 'as well as incremental'}, {'noun': 'cost'}, {'link': 'associated with establishing'}, {'noun': 'Organon'}, {'link': 'as a standalone'}]]</td>\n",
       "      <td>[[effect, selling cost, quarter, month], [pandemic, cost, Organon]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>The increase is primarily due to higher sales of women’s health products, including Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection, as well as higher sales of biosimilar products resulting from the continued uptake of Renflexis (infliximab-abda) in the United States and the uptake of Aybintio (bevacizumab) in the European Union (\"EU\")</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales, sales]</td>\n",
       "      <td>{'CvE': [['resulting', 'VBG', [40, 41]]], 'nonverbs': [['due to', 'JJ', [4, 6]]]}</td>\n",
       "      <td>[from the continued uptake of Renflexis (infliximab-abda) in the United States and the uptake of Aybintio (bevacizumab) in the European Union (\"EU\", The increase is primarily]</td>\n",
       "      <td>[higher sales of women’s health products, including Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection, as well as higher sales of biosimilar products, higher sales of women’s health products, including Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection, as well as higher sales of biosimilar products]</td>\n",
       "      <td>[[{'link': ' higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'woman'}, {'link': '’s'}, {'noun': 'health product'}, {'link': ', including'}, {'noun': 'Nexplanon'}, {'link': '/'}, {'noun': 'Implanon NXT'}, {'link': ','}, {'noun': 'Follistim AQ'}, {'link': '('}, {'noun': 'follitropin beta injection'}, {'link': ') and'}, {'noun': 'Ganirelix Acetate Injection'}, {'link': ', as well as higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar product'}], [{'link': ' higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'woman'}, {'link': '’s'}, {'noun': 'health product'}, {'link': ', including'}, {'noun': 'Nexplanon'}, {'link': '/'}, {'noun': 'Implanon NXT'}, {'link': ','}, {'noun': 'Follistim AQ'}, {'link': '('}, {'noun': 'follitropin beta injection'}, {'link': ') and'}, {'noun': 'Ganirelix Acetate Injection'}, {'link': ', as well as higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar product'}]]</td>\n",
       "      <td>[[sale, woman, health product, Nexplanon, Implanon NXT, Follistim AQ, follitropin beta injection, Ganirelix Acetate Injection, sale, biosimilar product], [sale, woman, health product, Nexplanon, Implanon NXT, Follistim AQ, follitropin beta injection, Ganirelix Acetate Injection, sale, biosimilar product]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>The sales increase was partially offset by ongoing generic competition for cardiovascular products Zetia and Vytorin (ezetimibe and simvastatin) mainly in Japan, decline in sales due to the volume-based procurement program (the \"VBP\") in China, an expiration of distribution agreement in Korea for Rosuzet in December 2020, and decreased demand for Cozaar/Hyzaar</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales, sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [28, 30]]]}</td>\n",
       "      <td>[The sales increase was partially offset by ongoing generic competition for cardiovascular products Zetia and Vytorin (ezetimibe and simvastatin) mainly in Japan, decline in sales]</td>\n",
       "      <td>[the volume-based procurement program (the \"VBP\") in China, an expiration of distribution agreement in Korea for Rosuzet in December 2020, and decreased demand for Cozaar/]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'volume'}, {'link': '- based'}, {'noun': 'procurement program'}, {'link': '( the \"'}, {'noun': 'VBP'}, {'link': '\" ) in'}, {'noun': 'China'}, {'link': ', an'}, {'noun': 'expiration'}, {'link': 'of'}, {'noun': 'distribution agreement'}, {'link': 'in'}, {'noun': 'Korea'}, {'link': 'for'}, {'noun': 'Rosuzet'}, {'link': 'in'}, {'noun': 'December'}, {'link': '2020 , and decreased'}, {'noun': 'demand'}, {'link': 'for'}, {'noun': 'Cozaar/'}]]</td>\n",
       "      <td>[[volume, procurement program, VBP, China, expiration, distribution agreement, Korea, Rosuzet, December, demand, Cozaar/]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>The sales decline was offset by higher sales of women's health products Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection due to higher demand, and higher sales of biosimilars resulting from the continued uptake of Renflexis mainly in the United States and Aybintio in the EU</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales, sales, sales]</td>\n",
       "      <td>{'CvE': [['resulting', 'VBG', [39, 40]]], 'nonverbs': [['due to', 'IN', [29, 31]]]}</td>\n",
       "      <td>[from the continued uptake of Renflexis mainly in the United States and Aybintio in the, The sales decline was offset by higher sales of women's health products Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection]</td>\n",
       "      <td>[higher demand, and higher sales of biosimilars, higher demand, and higher sales of biosimilars]</td>\n",
       "      <td>[[{'link': ' higher'}, {'noun': 'demand'}, {'link': ', and higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar'}], [{'link': ' higher'}, {'noun': 'demand'}, {'link': ', and higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar'}]]</td>\n",
       "      <td>[[demand, sale, biosimilar], [demand, sale, biosimilar]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>Additionally, the VBP in China continues to unfavorably affect a number of our products with an impact to sales of approximately $40 million for the second quarter of 2021 compared to the second quarter of 2020 and approximately $90 million for the first six months of 2021 compared to the same period in 2020</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'CvE': [['affect', 'VB', [9, 10]]]}</td>\n",
       "      <td>[a number of our products with an impact to sales of approximately $40 million for the second quarter of 2021 compared to the second quarter of 2020 and approximately $90 million for the first six months of 2021 compared to the same period in]</td>\n",
       "      <td>[Additionally, the VBP in China continues to unfavorably]</td>\n",
       "      <td>[[{'link': ' Additionally , the'}, {'noun': 'VBP'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'continues to unfavorably'}]]</td>\n",
       "      <td>[[VBP, China]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>The COVID-19 pandemic continued to negatively affect sales in the second quarter of 2021 across several markets</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'CvE': [['affect', 'VB', [6, 7]]]}</td>\n",
       "      <td>[sales in the second quarter of 2021 across several]</td>\n",
       "      <td>[The COVID-19 pandemic continued to negatively]</td>\n",
       "      <td>[[{'link': ' The COVID-19'}, {'noun': 'pandemic'}, {'link': 'continued to negatively'}]]</td>\n",
       "      <td>[[pandemic]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Women’s Health Contraception Worldwide sales of  Nexplanon/Implanon NXT , a single-rod subdermal contraceptive implant, increased 40% and 13% in the second quarter and first six months of 2021, respectively, primarily reflecting recovery from the COVID-19 pandemic in the United States, Europe and Canada, favorable impact from pricing, and phasing of tenders in Latin America during the second quarter of 2021</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'EvC': [['reflecting', 'VBG', [41, 42]]]}</td>\n",
       "      <td>[Women’s Health Contraception Worldwide sales of  Nexplanon/Implanon NXT , a single-rod subdermal contraceptive implant, increased 40% and 13% in the second quarter and first six months of 2021, respectively, primarily]</td>\n",
       "      <td>[recovery from the COVID-19 pandemic in the United States, Europe and Canada, favorable impact from pricing, and phasing of tenders in Latin America during the second quarter of]</td>\n",
       "      <td>[[{'noun': ' recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ','}, {'noun': 'Europe'}, {'link': 'and'}, {'noun': 'Canada'}, {'link': ', favorable'}, {'noun': 'impact'}, {'link': 'from'}, {'noun': 'pricing'}, {'link': ', and phasing of'}, {'noun': 'tender'}, {'link': 'in'}, {'noun': 'Latin America'}, {'link': 'during the second'}, {'noun': 'quarter'}, {'link': 'of'}]]</td>\n",
       "      <td>[[ recovery, pandemic, United States, Europe, Canada, impact, pricing, tender, Latin America, quarter]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Worldwide sales of  NuvaRing , a vaginal contraceptive product, declined 16% and 22% in the second quarter and first six months of 2021 primarily due to ongoing generic competition in the United States and the EU</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [28, 30]]]}</td>\n",
       "      <td>[Worldwide sales of  NuvaRing , a vaginal contraceptive product, declined 16% and 22% in the second quarter and first six months of 2021 primarily]</td>\n",
       "      <td>[ongoing generic competition in the United States and the]</td>\n",
       "      <td>[[{'link': ' ongoing generic'}, {'noun': 'competition'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'and the'}]]</td>\n",
       "      <td>[[competition, United States]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Revenues for the second quarter of 2021 and the first six months of 2021 primarily reflect our share of the profits</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Revenues, profits]</td>\n",
       "      <td>{'EvC': [['reflect', 'VBP', [15, 16]]]}</td>\n",
       "      <td>[Revenues for the second quarter of 2021 and the first six months of 2021 primarily]</td>\n",
       "      <td>[our share of the]</td>\n",
       "      <td>[[{'link': ' our'}, {'noun': 'share'}, {'link': 'of the'}]]</td>\n",
       "      <td>[[share]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>Revenues for the second quarter and the first six months of 2020 reflect supply sales of the generic product to the manufacturer</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Revenues, sales]</td>\n",
       "      <td>{'EvC': [['reflect', 'VBP', [12, 13]]]}</td>\n",
       "      <td>[Revenues for the second quarter and the first six months of 2020]</td>\n",
       "      <td>[supply sales of the generic product to the]</td>\n",
       "      <td>[[{'noun': ' supply sale'}, {'link': 'of the generic'}, {'noun': 'product'}, {'link': 'to the'}]]</td>\n",
       "      <td>[[ supply sale, product]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>The decline in revenue for the second quarter and first six months of 2021 is due to the entry of a new market participant</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[revenue]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [15, 17]]]}</td>\n",
       "      <td>[The decline in revenue for the second quarter and first six months of 2021 is]</td>\n",
       "      <td>[the entry of a new market]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'entry'}, {'link': 'of a new'}, {'noun': 'market'}]]</td>\n",
       "      <td>[[entry, market]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Fertility Worldwide sales of Follistim AQ (marketed in most countries outside the United States as Puregon), a fertility treatment, increased 48% and 37% in the second quarter and the first six months of 2021, respectively, primarily due to volume growth in the United States as well as recovery from the COVID-19 pandemic in the United States Europe, Canada and China, partially offset by overall unfavorable discount rates in the U.S</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [44, 46]]]}</td>\n",
       "      <td>[Fertility Worldwide sales of Follistim AQ (marketed in most countries outside the United States as Puregon), a fertility treatment, increased 48% and 37% in the second quarter and the first six months of 2021, respectively, primarily]</td>\n",
       "      <td>[volume growth in the United States as well as recovery from the COVID-19 pandemic in the United States Europe, Canada and China, partially offset by overall unfavorable discount rates in the]</td>\n",
       "      <td>[[{'noun': ' volume growth'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'as well as'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in the'}, {'noun': 'United States Europe'}, {'link': ','}, {'noun': 'Canada'}, {'link': 'and'}, {'noun': 'China'}, {'link': ', partially offset by overall unfavorable'}, {'noun': 'discount rate'}, {'link': 'in the'}]]</td>\n",
       "      <td>[[ volume growth, United States, recovery, pandemic, United States Europe, Canada, China, discount rate]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Worldwide sales of Ganirelix Acetate Injection (marketed in certain countries outside the United States as Orgalutran), a fertility treatment, increased 117% in the second quarter of 2021, primarily due to the recovery from the COVID-19 pandemic in Europe, Canada and China</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [34, 36]]]}</td>\n",
       "      <td>[Worldwide sales of Ganirelix Acetate Injection (marketed in certain countries outside the United States as Orgalutran), a fertility treatment, increased 117% in the second quarter of 2021, primarily]</td>\n",
       "      <td>[the recovery from the COVID-19 pandemic in Europe, Canada and]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in'}, {'noun': 'Europe'}, {'link': ','}, {'noun': 'Canada'}, {'link': 'and'}]]</td>\n",
       "      <td>[[recovery, pandemic, Europe, Canada]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>For the first six months of 2021, sales increased 101% primarily due to increased demand in the United States as well as recovery from the COVID-19 pandemic in the United States, Europe, Canada and China</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [13, 15]]]}</td>\n",
       "      <td>[For the first six months of 2021, sales increased 101% primarily]</td>\n",
       "      <td>[increased demand in the United States as well as recovery from the COVID-19 pandemic in the United States, Europe, Canada and]</td>\n",
       "      <td>[[{'link': ' increased'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'as well as'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ','}, {'noun': 'Europe'}, {'link': ','}, {'noun': 'Canada'}, {'link': 'and'}]]</td>\n",
       "      <td>[[demand, United States, recovery, pandemic, United States, Europe, Canada]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>Sales growth in the second quarter and first six months of 2021 was driven primarily by continued demand growth in the United States since launch in 2017, partially offset by higher discount rates</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales]</td>\n",
       "      <td>{'CvE': [['driven', 'VBN', [13, 14]]], 'nonverbs': [['since', 'IN', [23, 24]]]}</td>\n",
       "      <td>[Sales growth in the second quarter and first six months of 2021 was, primarily by continued demand growth in the United States]</td>\n",
       "      <td>[primarily by continued demand growth in the United States, launch in 2017, partially offset by higher discount]</td>\n",
       "      <td>[[{'link': ' primarily by continued'}, {'noun': 'demand growth'}, {'link': 'in the'}, {'noun': 'United States'}], [{'link': ' launch in 2017 , partially offset by higher'}, {'noun': 'discount'}]]</td>\n",
       "      <td>[[demand growth, United States], [discount]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>For the second quarter and first six months of 2021, sales reflect uptake since the July 2020 launch in the United States, partially offset by a decrease in the EU reflecting increasing competitive pressures and price erosion</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'EvC': [['reflect', 'VBP', [12, 13]], ['reflecting', 'VBG', [32, 33]]], 'nonverbs': [['since', 'IN', [14, 15]]]}</td>\n",
       "      <td>[For the second quarter and first six months of 2021, sales, the July 2020 launch in the United States, partially offset by a decrease in the EU, uptake]</td>\n",
       "      <td>[uptake, increasing competitive pressures and price, the July 2020 launch in the United States, partially offset by a decrease in the EU]</td>\n",
       "      <td>[[{'noun': ' uptake'}], [{'link': ' increasing competitive'}, {'noun': 'pressure'}, {'link': 'and'}, {'noun': 'price'}], [{'link': ' the'}, {'noun': 'July'}, {'link': '2020'}, {'noun': 'launch'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ', partially offset by a'}, {'noun': 'decrease'}, {'link': 'in the'}, {'noun': 'EU'}]]</td>\n",
       "      <td>[[ uptake], [pressure, price], [July, launch, United States, decrease, EU]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>Sales in the second quarter and first six months of 2021 decreased 2% and 27%, respectively, primarily due to timing of shipments to Brazil related to government orders</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [21, 23]]]}</td>\n",
       "      <td>[Sales in the second quarter and first six months of 2021 decreased 2% and 27%, respectively, primarily]</td>\n",
       "      <td>[timing of shipments to Brazil related to government]</td>\n",
       "      <td>[[{'noun': ' timing'}, {'link': 'of'}, {'noun': 'shipment'}, {'link': 'to'}, {'noun': 'Brazil'}, {'link': 'related to'}, {'noun': 'government'}]]</td>\n",
       "      <td>[[ timing, shipment, Brazil, government]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>We recorded sales of $8 million and $16 million during the second quarter and first six months of 2021, respectively, with no comparable sales during the second quarter and first six months of 2020 due to the approval of  Aybintio  in the EU in August 2020 and its launch in September 2020</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales, sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [38, 40]]]}</td>\n",
       "      <td>[We recorded sales of $8 million and $16 million during the second quarter and first six months of 2021, respectively, with no comparable sales during the second quarter and first six months of 2020]</td>\n",
       "      <td>[the approval of  Aybintio  in the EU in August 2020 and its launch in September]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'approval'}, {'link': 'of  '}, {'noun': 'Aybintio'}, {'link': '  in the'}, {'noun': 'EU'}, {'link': 'in'}, {'noun': 'August'}, {'link': '2020 and its'}, {'noun': 'launch'}, {'link': 'in'}, {'noun': 'September'}]]</td>\n",
       "      <td>[[approval, Aybintio, EU, August, launch, September]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>Sales decreased 26% in the first six months of 2021 primarily driven by lower sales of  Ezetrol  in Japan, lower demand in the United States due to generic competition, as well as lower sales of  Ezetrol  and  Inegy  in the EU</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales, sales, sales]</td>\n",
       "      <td>{'CvE': [['driven', 'VBN', [12, 13]]], 'nonverbs': [['due to', 'JJ', [29, 31]]]}</td>\n",
       "      <td>[Sales decreased 26% in the first six months of 2021 primarily, by lower sales of  Ezetrol  in Japan, lower demand in the United States]</td>\n",
       "      <td>[by lower sales of  Ezetrol  in Japan, lower demand in the United States, generic competition, as well as lower sales of  Ezetrol  and  Inegy  in the]</td>\n",
       "      <td>[[{'link': ' by lower'}, {'noun': 'sale'}, {'link': 'of  '}, {'noun': 'Ezetrol'}, {'link': '  in'}, {'noun': 'Japan'}, {'link': ', lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'United States'}], [{'link': ' generic'}, {'noun': 'competition'}, {'link': ', as well as lower'}, {'noun': 'sale'}, {'link': 'of  '}, {'noun': 'Ezetrol'}, {'link': '  and  '}, {'noun': 'Inegy'}, {'link': '  in the'}]]</td>\n",
       "      <td>[[sale, Ezetrol, Japan, demand, United States], [competition, sale, Ezetrol, Inegy]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>Sales of  Atozet  (ezetimibe and atorvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, increased 5% in the second quarter of 2021 primarily due to volume growth in France and a slight increase in sales in various markets, partially offset by lower demand in Germany due to competition</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales, sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [37, 39]], ['due to', 'JJ', [60, 62]]]}</td>\n",
       "      <td>[Sales of  Atozet  (ezetimibe and atorvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, increased 5% in the second quarter of 2021 primarily, volume growth in France and a slight increase in sales in various markets, partially offset by lower demand in Germany]</td>\n",
       "      <td>[volume growth in France and a slight increase in sales in various markets, partially offset by lower demand in Germany, ]</td>\n",
       "      <td>[[{'noun': ' volume growth'}, {'link': 'in'}, {'noun': 'France'}, {'link': 'and a slight'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'sale'}, {'link': 'in various'}, {'noun': 'market'}, {'link': ', partially offset by lower'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'Germany'}], None]</td>\n",
       "      <td>[[ volume growth, France, increase, sale, market, demand, Germany]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>Sales of  Atozet  declined 2% in the first six months of 2021 due to lower demand in the EU, primarily in Germany and Spain due to competition, coupled with unfavorable pricing, partially offset by a volume increase in France and higher demand in the Asia Pacific region</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [15, 17]], ['due to', 'IN', [28, 30]]]}</td>\n",
       "      <td>[Sales of  Atozet  declined 2% in the first six months of 2021, lower demand in the EU, primarily in Germany and Spain]</td>\n",
       "      <td>[lower demand in the EU, primarily in Germany and Spain, competition, coupled with unfavorable pricing, partially offset by a volume increase in France and higher demand in the Asia Pacific]</td>\n",
       "      <td>[[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'EU'}, {'link': ', primarily in'}, {'noun': 'Germany'}, {'link': 'and'}, {'noun': 'Spain'}], [{'noun': ' competition'}, {'link': ', coupled with unfavorable'}, {'noun': 'pricing'}, {'link': ', partially offset by a'}, {'noun': 'volume increase'}, {'link': 'in'}, {'noun': 'France'}, {'link': 'and higher'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'Asia Pacific'}]]</td>\n",
       "      <td>[[demand, EU, Germany, Spain], [ competition, pricing, volume increase, France, demand, Asia Pacific]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>Sales of  Rosuzet  (ezetimibe and rosuvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, declined 42% and 47% in the second quarter and first six months of 2021, respectively, due to the expiration of a distribution agreement in Korea in December 2020</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [46, 48]]]}</td>\n",
       "      <td>[Sales of  Rosuzet  (ezetimibe and rosuvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, declined 42% and 47% in the second quarter and first six months of 2021, respectively,]</td>\n",
       "      <td>[the expiration of a distribution agreement in Korea in December]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'expiration'}, {'link': 'of a'}, {'noun': 'distribution agreement'}, {'link': 'in'}, {'noun': 'Korea'}, {'link': 'in'}, {'noun': 'December'}]]</td>\n",
       "      <td>[[expiration, distribution agreement, Korea, December]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>The sales decrease in the first six months of 2021 reflects lower demand in the United States, lower demand due to generic competition in Japan and the Asia Pacific region, the effect of the shift in product mix and lower demand in China, and lower sales in Canada as sales in the second quarter of 2020 was higher due to competitor supply shortages</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales, sales, sales]</td>\n",
       "      <td>{'EvC': [['reflects', 'VBZ', [10, 11]]], 'nonverbs': [['due to', 'IN', [20, 22]], ['due to', 'IN', [61, 63]]]}</td>\n",
       "      <td>[The sales decrease in the first six months of 2021, lower demand in the United States, lower demand, generic competition in Japan and the Asia Pacific region, the effect of the shift in product mix and lower demand in China, and lower sales in Canada as sales in the second quarter of 2020 was higher]</td>\n",
       "      <td>[lower demand in the United States, lower demand, generic competition in Japan and the Asia Pacific region, the effect of the shift in product mix and lower demand in China, and lower sales in Canada as sales in the second quarter of 2020 was higher, competitor supply]</td>\n",
       "      <td>[[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ', lower'}, {'noun': 'demand'}], [{'link': ' generic'}, {'noun': 'competition'}, {'link': 'in'}, {'noun': 'Japan'}, {'link': 'and the'}, {'noun': 'Asia Pacific region'}, {'link': ', the'}, {'noun': 'effect'}, {'link': 'of the'}, {'noun': 'shift'}, {'link': 'in'}, {'noun': 'product mix'}, {'link': 'and lower'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'China'}, {'link': ', and lower'}, {'noun': 'sale'}, {'link': 'in'}, {'noun': 'Canada'}, {'link': 'as'}, {'noun': 'sale'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of 2020 was higher'}], [{'noun': ' competitor supply'}]]</td>\n",
       "      <td>[[demand, United States, demand], [competition, Japan, Asia Pacific region, effect, shift, product mix, demand, China, sale, Canada, sale, quarter], [ competitor supply]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>Sales of  Zocor  decreased 21% in the first six months of 2021, primarily due to lower volumes in China due to the VBP impact</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [17, 19]], ['due to', 'IN', [23, 25]]]}</td>\n",
       "      <td>[Sales of  Zocor  decreased 21% in the first six months of 2021, primarily, lower volumes in China]</td>\n",
       "      <td>[lower volumes in China, the VBP]</td>\n",
       "      <td>[[{'link': ' lower'}, {'noun': 'volume'}, {'link': 'in'}, {'noun': 'China'}], [{'link': ' the'}, {'noun': 'VBP'}]]</td>\n",
       "      <td>[[volume, China], [VBP]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>Respiratory Worldwide sales of  Singulair , a once-a-day oral medicine for the chronic treatment of asthma and for the relief of symptoms of allergic rhinitis, declined 8% in the second quarter of 2021 primarily due to the lower performance in Japan attributable to generic competition as well as timing of shipments in Japan in the second quarter of 2020, VBP impact in China partially offset by the recovery from the COVID-19 pandemic</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [41, 43]], ['attributable to', 'JJ', [48, 50]]]}</td>\n",
       "      <td>[Respiratory Worldwide sales of  Singulair , a once-a-day oral medicine for the chronic treatment of asthma and for the relief of symptoms of allergic rhinitis, declined 8% in the second quarter of 2021 primarily, the lower performance in Japan]</td>\n",
       "      <td>[the lower performance in Japan, generic competition as well as timing of shipments in Japan in the second quarter of 2020, VBP impact in China partially offset by the recovery from the COVID-19]</td>\n",
       "      <td>[[{'link': ' the lower'}, {'noun': 'performance'}, {'link': 'in'}, {'noun': 'Japan'}], [{'link': ' generic'}, {'noun': 'competition'}, {'link': 'as well as'}, {'noun': 'timing'}, {'link': 'of'}, {'noun': 'shipment'}, {'link': 'in'}, {'noun': 'Japan'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of 2020 ,'}, {'noun': 'VBP impact'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'partially offset by the'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}]]</td>\n",
       "      <td>[[performance, Japan], [competition, timing, shipment, Japan, quarter, VBP impact, China, recovery]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>Sales for the first six months of 2021  -37- also reflect lower demand in Europe and Canada in the beginning of 2021 due to the COVID-19 pandemic</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales]</td>\n",
       "      <td>{'EvC': [['reflect', 'VBP', [11, 12]]], 'nonverbs': [['due to', 'IN', [23, 25]]]}</td>\n",
       "      <td>[Sales for the first six months of 2021  -37- also, lower demand in Europe and Canada in the beginning of 2021]</td>\n",
       "      <td>[lower demand in Europe and Canada in the beginning of 2021, the COVID-19]</td>\n",
       "      <td>[[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'Europe'}, {'link': 'and'}, {'noun': 'Canada'}, {'link': 'in the'}, {'noun': 'beginning'}, {'link': 'of 2021'}], [{'link': ' the'}, {'noun': 'COVID-19'}]]</td>\n",
       "      <td>[[demand, Europe, Canada, beginning], [COVID-19]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>Global sales of  Nasonex , an inhaled nasal corticosteroid for the treatment of nasal allergy symptoms, increased 6% in the second quarter of 2021 primarily due to higher demand in China and favorable performance in Russia, partially offset by lower sales in the United States due to the impact of COVID-19 pandemic and generic competition in Japan</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales, sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [28, 30]], ['due to', 'IN', [49, 51]]]}</td>\n",
       "      <td>[Global sales of  Nasonex , an inhaled nasal corticosteroid for the treatment of nasal allergy symptoms, increased 6% in the second quarter of 2021 primarily, higher demand in China and favorable performance in Russia, partially offset by lower sales in the United States]</td>\n",
       "      <td>[higher demand in China and favorable performance in Russia, partially offset by lower sales in the United States, the impact of COVID-19 pandemic and generic competition in]</td>\n",
       "      <td>[[{'link': ' higher'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'and favorable'}, {'noun': 'performance'}, {'link': 'in'}, {'noun': 'Russia'}, {'link': ', partially offset by lower'}, {'noun': 'sale'}, {'link': 'in the'}, {'noun': 'United States'}], [{'link': ' the'}, {'noun': 'impact'}, {'link': 'of COVID-19'}, {'noun': 'pandemic'}, {'link': 'and generic'}, {'noun': 'competition'}, {'link': 'in'}]]</td>\n",
       "      <td>[[demand, China, performance, Russia, sale, United States], [impact, pandemic, competition]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>Global sales of  Nasonex  decreased 21% in the first six months of 2021 primarily driven by lower demand impacted by the COVID-19 pandemic across several markets in the United States, Europe, and Latin America, and generic competition in Japan, partially offset by higher demand in China</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'CvE': [['driven', 'VBN', [17, 18]], ['impacted', 'VBN', [21, 22]]]}</td>\n",
       "      <td>[Global sales of  Nasonex  decreased 21% in the first six months of 2021 primarily, by lower demand]</td>\n",
       "      <td>[by lower demand, by the COVID-19 pandemic across several markets in the United States, Europe, and Latin America, and generic competition in Japan, partially offset by higher demand in]</td>\n",
       "      <td>[[{'link': ' by lower'}, {'noun': 'demand'}], [{'link': ' by the COVID-19'}, {'noun': 'pandemic'}, {'link': 'across several'}, {'noun': 'market'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ','}, {'noun': 'Europe'}, {'link': ', and'}, {'noun': 'Latin America'}, {'link': ', and generic'}, {'noun': 'competition'}, {'link': 'in'}, {'noun': 'Japan'}, {'link': ', partially offset by higher'}, {'noun': 'demand'}, {'link': 'in'}]]</td>\n",
       "      <td>[[demand], [pandemic, market, United States, Europe, Latin America, competition, Japan, demand]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>Global sales of  Dulera , a combination medicine for the treatment of asthma, increased 34% in the second quarter of 2021 primarily due to favorable discount rates in the United States</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [25, 27]]]}</td>\n",
       "      <td>[Global sales of  Dulera , a combination medicine for the treatment of asthma, increased 34% in the second quarter of 2021 primarily]</td>\n",
       "      <td>[favorable discount rates in the United]</td>\n",
       "      <td>[[{'link': ' favorable'}, {'noun': 'discount rate'}, {'link': 'in the'}, {'noun': 'United'}]]</td>\n",
       "      <td>[[discount rate, United]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>For the first six months of 2021, global sales of  Dulera  decreased 26% largely due to significant buy-in in the six months of 2020 related to the COVID-19 pandemic, partially offset by the favorable discount rates in the United States in the second quarter of 2021</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [18, 20]]]}</td>\n",
       "      <td>[For the first six months of 2021, global sales of  Dulera  decreased 26% largely]</td>\n",
       "      <td>[significant buy-in in the six months of 2020 related to the COVID-19 pandemic, partially offset by the favorable discount rates in the United States in the second quarter of]</td>\n",
       "      <td>[[{'link': ' significant'}, {'noun': 'buy'}, {'link': '-'}, {'noun': 'in'}, {'link': 'in the six'}, {'noun': 'month'}, {'link': 'of 2020 related to the COVID-19'}, {'noun': 'pandemic'}, {'link': ', partially offset by the favorable'}, {'noun': 'discount rate'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of'}]]</td>\n",
       "      <td>[[buy, in, month, pandemic, discount rate, United States, quarter]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>Sales of  Arcoxia  for the first six months of 2021 decreased 12% primarily due to the impact of VBP in China and lower demand in the Asia Pacific region attributable to the COVID-19 pandemic</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Sales]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [16, 18]], ['attributable to', 'JJ', [32, 34]]]}</td>\n",
       "      <td>[Sales of  Arcoxia  for the first six months of 2021 decreased 12% primarily, the impact of VBP in China and lower demand in the Asia Pacific region]</td>\n",
       "      <td>[the impact of VBP in China and lower demand in the Asia Pacific region, the COVID-19]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'impact'}, {'link': 'of'}, {'noun': 'VBP'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'and lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'Asia Pacific region'}], [{'link': ' the'}, {'noun': 'COVID-19'}]]</td>\n",
       "      <td>[[impact, VBP, China, demand, Asia Pacific region], [COVID-19]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>The sales decline was also attributable to lower demand in certain markets in the Middle East and Russia that occurred during the first quarter of 2021</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'nonverbs': [['attributable to', 'JJ', [5, 7]]]}</td>\n",
       "      <td>[The sales decline was also]</td>\n",
       "      <td>[lower demand in certain markets in the Middle East and Russia that occurred during the first quarter of]</td>\n",
       "      <td>[[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in certain'}, {'noun': 'market'}, {'link': 'in the'}, {'noun': 'Middle East'}, {'link': 'and'}, {'noun': 'Russia'}, {'link': 'that occurred during the first'}, {'noun': 'quarter'}, {'link': 'of'}]]</td>\n",
       "      <td>[[demand, market, Middle East, Russia, quarter]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>Other Worldwide sales of  Proscar , for the treatment of symptomatic benign prostate enlargement, declined 38% and 32% in the second quarter and first six months of 2021 primarily due to lower performance reflecting the impact of VBP in China</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[sales]</td>\n",
       "      <td>{'EvC': [['reflecting', 'VBG', [37, 38]]], 'nonverbs': [['due to', 'IN', [33, 35]]]}</td>\n",
       "      <td>[lower performance, Other Worldwide sales of  Proscar , for the treatment of symptomatic benign prostate enlargement, declined 38% and 32% in the second quarter and first six months of 2021 primarily]</td>\n",
       "      <td>[the impact of VBP in, lower performance]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'impact'}, {'link': 'of'}, {'noun': 'VBP'}, {'link': 'in'}], [{'link': ' lower'}, {'noun': 'performance'}]]</td>\n",
       "      <td>[[impact, VBP], [performance]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>The increase in cost of sales for the second quarter is primarily due to increases in manufacturing costs and certain costs related to tolling arrangements with Merck which were not in place in the second quarter of 2020</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[cost, sales, costs, costs]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [12, 14]]]}</td>\n",
       "      <td>[The increase in cost of sales for the second quarter is primarily]</td>\n",
       "      <td>[increases in manufacturing costs and certain costs related to tolling arrangements with Merck which were not in place in the second quarter of]</td>\n",
       "      <td>[[{'noun': ' increase'}, {'link': 'in'}, {'noun': 'manufacturing cost'}, {'link': 'and certain'}, {'noun': 'cost'}, {'link': 'related to'}, {'noun': 'tolling arrangement'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': 'which were not in'}, {'noun': 'place'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of'}]]</td>\n",
       "      <td>[[ increase, manufacturing cost, cost, tolling arrangement, Merck, place, quarter]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>The increase during the period reflects increases in manufacturing costs absorbed by Organon, increase in stand up costs, and cost related to tolling arrangements with Merck, which were not in place during the comparable prior year period</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[costs, costs, cost]</td>\n",
       "      <td>{'EvC': [['reflects', 'VBZ', [5, 6]]]}</td>\n",
       "      <td>[The increase during the period]</td>\n",
       "      <td>[increases in manufacturing costs absorbed by Organon, increase in stand up costs, and cost related to tolling arrangements with Merck, which were not in place during the comparable prior year]</td>\n",
       "      <td>[[{'noun': ' increase'}, {'link': 'in'}, {'noun': 'manufacturing cost'}, {'link': 'absorbed by'}, {'noun': 'Organon'}, {'link': ', increase in'}, {'noun': 'stand'}, {'link': 'up'}, {'noun': 'cost'}, {'link': ', and'}, {'noun': 'cost'}, {'link': 'related to'}, {'noun': 'tolling arrangement'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': ', which were not in'}, {'noun': 'place'}, {'link': 'during the comparable prior'}, {'noun': 'year'}]]</td>\n",
       "      <td>[[ increase, manufacturing cost, Organon, stand, cost, cost, tolling arrangement, Merck, place, year]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>The increase also reflects increases in direct corporate Organon costs</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[costs]</td>\n",
       "      <td>{'EvC': [['reflects', 'VBZ', [3, 4]]]}</td>\n",
       "      <td>[The increase also]</td>\n",
       "      <td>[increases in direct corporate Organon]</td>\n",
       "      <td>[[{'noun': ' increase'}, {'link': 'in direct corporate'}, {'noun': 'Organon'}]]</td>\n",
       "      <td>[[ increase, Organon]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>The gross margin declines reflect an increase in stand up costs, as well as certain costs related to tolling arrangements with Merck, which have lower gross margin percentages compared to product sales</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[margin, costs, costs, margin, sales]</td>\n",
       "      <td>{'EvC': [['reflect', 'VBP', [4, 5]]]}</td>\n",
       "      <td>[The gross margin declines]</td>\n",
       "      <td>[an increase in stand up costs, as well as certain costs related to tolling arrangements with Merck, which have lower gross margin percentages compared to product]</td>\n",
       "      <td>[[{'link': ' an'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'stand'}, {'link': 'up'}, {'noun': 'cost'}, {'link': ', as well as certain'}, {'noun': 'cost'}, {'link': 'related to'}, {'noun': 'tolling arrangement'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': ', which have lower gross'}, {'noun': 'margin percentage'}, {'link': 'compared to'}, {'noun': 'product'}]]</td>\n",
       "      <td>[[increase, stand, cost, cost, tolling arrangement, Merck, margin percentage, product]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>Selling, General and Administrative Selling, general and administrative expenses increased 46% and 33% in the second quarter of 2021 and the first six months of 2021, respectively, due to costs incurred to establish Organon as a standalone entity, higher employee related costs, and higher selling and promotional costs</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[costs, costs, costs]</td>\n",
       "      <td>{'nonverbs': [['due to', 'IN', [33, 35]]]}</td>\n",
       "      <td>[Selling, General and Administrative Selling, general and administrative expenses increased 46% and 33% in the second quarter of 2021 and the first six months of 2021, respectively,]</td>\n",
       "      <td>[costs incurred to establish Organon as a standalone entity, higher employee related costs, and higher selling and promotional]</td>\n",
       "      <td>[[{'noun': ' cost'}, {'link': 'incurred to establish'}, {'noun': 'Organon'}, {'link': 'as a standalone'}, {'noun': 'entity'}, {'link': ', higher'}, {'noun': 'employee'}, {'link': 'related'}, {'noun': 'cost'}, {'link': ', and higher'}, {'noun': 'selling'}, {'link': 'and promotional'}]]</td>\n",
       "      <td>[[ cost, Organon, entity, employee, cost, selling]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>Research and Development Research and development expenses increased 49% in the second quarter of 2021 and 49% for the first six months of 2021 primarily reflecting higher employee related costs incurred to establish Organon as a standalone entity</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[costs]</td>\n",
       "      <td>{'EvC': [['reflecting', 'VBG', [27, 28]]]}</td>\n",
       "      <td>[Research and Development Research and development expenses increased 49% in the second quarter of 2021 and 49% for the first six months of 2021 primarily]</td>\n",
       "      <td>[higher employee related costs incurred to establish Organon as a standalone]</td>\n",
       "      <td>[[{'link': ' higher'}, {'noun': 'employee'}, {'link': 'related'}, {'noun': 'cost'}, {'link': 'incurred to establish'}, {'noun': 'Organon'}, {'link': 'as a standalone'}]]</td>\n",
       "      <td>[[employee, cost, Organon]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>Restructuring Costs Certain of our operations have been affected by restructuring plans initiated by Merck</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[Costs]</td>\n",
       "      <td>{'CvE': [['affected', 'VBN', [8, 9]]]}</td>\n",
       "      <td>[Restructuring Costs Certain of our operations have been]</td>\n",
       "      <td>[by restructuring plans initiated by]</td>\n",
       "      <td>[[{'link': ' by restructuring'}, {'noun': 'plan'}, {'link': 'initiated by'}]]</td>\n",
       "      <td>[[plan]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>The decline in restructuring costs is due to lower allocated costs from Merck during the second quarter and the first six months of 2021 compared to the comparable periods of 2020</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[costs, costs]</td>\n",
       "      <td>{'nonverbs': [['due to', 'JJ', [6, 8]]]}</td>\n",
       "      <td>[The decline in restructuring costs is]</td>\n",
       "      <td>[lower allocated costs from Merck during the second quarter and the first six months of 2021 compared to the comparable periods of]</td>\n",
       "      <td>[[{'link': ' lower allocated'}, {'noun': 'cost'}, {'link': 'from'}, {'noun': 'Merck'}, {'link': 'during the second'}, {'noun': 'quarter'}, {'link': 'and the first six'}, {'noun': 'month'}, {'link': 'of 2021 compared to the comparable'}, {'noun': 'period'}, {'link': 'of'}]]</td>\n",
       "      <td>[[cost, Merck, quarter, month, period]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>The decrease in net income for both periods reflects an increase in costs and expenses incurred to establish Organon as a standalone entity, partially offset by higher sales due to higher demand for certain of our products across several markets in the second quarter of 2021</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[income, costs, sales]</td>\n",
       "      <td>{'EvC': [['reflects', 'VBZ', [8, 9]]], 'nonverbs': [['due to', 'IN', [29, 31]]]}</td>\n",
       "      <td>[The decrease in net income for both periods, an increase in costs and expenses incurred to establish Organon as a standalone entity, partially offset by higher sales]</td>\n",
       "      <td>[an increase in costs and expenses incurred to establish Organon as a standalone entity, partially offset by higher sales, higher demand for certain of our products across several markets in the second quarter of]</td>\n",
       "      <td>[[{'link': ' an'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'cost'}, {'link': 'and'}, {'noun': 'expense'}, {'link': 'incurred to establish'}, {'noun': 'Organon'}, {'link': 'as a standalone'}, {'noun': 'entity'}, {'link': ', partially offset by higher'}, {'noun': 'sale'}], [{'link': ' higher'}, {'noun': 'demand'}, {'link': 'for certain of our'}, {'noun': 'product'}, {'link': 'across several'}, {'noun': 'market'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of'}]]</td>\n",
       "      <td>[[increase, cost, expense, Organon, entity, sale], [demand, product, market, quarter]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>Cash provided by operating activities was favorably impacted by an increase in accounts payable, including amounts due to Merck, partially offset by a decline in net income</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[income]</td>\n",
       "      <td>{'CvE': [['impacted', 'VBN', [7, 8]]], 'nonverbs': [['due to', 'JJ', [17, 19]]]}</td>\n",
       "      <td>[Cash provided by operating activities was favorably, by an increase in accounts payable, including amounts]</td>\n",
       "      <td>[by an increase in accounts payable, including amounts, Merck, partially offset by a decline in net]</td>\n",
       "      <td>[[{'link': ' by an'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'account'}, {'link': 'payable , including'}, {'noun': 'amount'}], [{'noun': ' Merck'}, {'link': ', partially offset by a'}, {'noun': 'decline'}, {'link': 'in'}, {'noun': 'net'}]]</td>\n",
       "      <td>[[increase, account, amount], [ Merck, decline, net]]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>The change in cash used in financing activities reflects the proceeds from the issuance of long term debt, the payment of related debt issuance costs and the settlement of  the transactions with Merck in connection with the Separation (see Note 17 to our Condensed Consolidated Financial Statements)</td>\n",
       "      <td>OGN</td>\n",
       "      <td>0001821825-21-000009</td>\n",
       "      <td>[costs]</td>\n",
       "      <td>{'EvC': [['reflects', 'VBZ', [8, 9]]]}</td>\n",
       "      <td>[The change in cash used in financing activities]</td>\n",
       "      <td>[the proceeds from the issuance of long term debt, the payment of related debt issuance costs and the settlement of  the transactions with Merck in connection with the Separation (see Note 17 to our Condensed Consolidated Financial Statements]</td>\n",
       "      <td>[[{'link': ' the'}, {'noun': 'proceed'}, {'link': 'from the'}, {'noun': 'issuance'}, {'link': 'of long'}, {'noun': 'term debt'}, {'link': ', the'}, {'noun': 'payment'}, {'link': 'of related'}, {'noun': 'debt issuance cost'}, {'link': 'and the'}, {'noun': 'settlement'}, {'link': 'of   the'}, {'noun': 'transaction'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': 'in'}, {'noun': 'connection'}, {'link': 'with the'}, {'noun': 'separation'}, {'link': '( see Note 17 to our'}, {'noun': 'Condensed Consolidated Financial statement'}]]</td>\n",
       "      <td>[[proceed, issuance, term debt, payment, debt issuance cost, settlement, transaction, Merck, connection, separation, Condensed Consolidated Financial statement]]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                 sentence  \\\n",
       "64                                                                                                       Operating expenses in the second quarter and first six months of 2021 were higher primarily due to the effect of lower promotional and selling costs incurred in the second quarter and first six months of 2020 attributable to the COVID-19 pandemic as well as incremental costs associated with establishing Organon as a standalone company   \n",
       "68                                                    The increase is primarily due to higher sales of women’s health products, including Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection, as well as higher sales of biosimilar products resulting from the continued uptake of Renflexis (infliximab-abda) in the United States and the uptake of Aybintio (bevacizumab) in the European Union (\"EU\")   \n",
       "69                                                                             The sales increase was partially offset by ongoing generic competition for cardiovascular products Zetia and Vytorin (ezetimibe and simvastatin) mainly in Japan, decline in sales due to the volume-based procurement program (the \"VBP\") in China, an expiration of distribution agreement in Korea for Rosuzet in December 2020, and decreased demand for Cozaar/Hyzaar   \n",
       "72                                                                                                                    The sales decline was offset by higher sales of women's health products Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection due to higher demand, and higher sales of biosimilars resulting from the continued uptake of Renflexis mainly in the United States and Aybintio in the EU   \n",
       "74                                                                                                                                  Additionally, the VBP in China continues to unfavorably affect a number of our products with an impact to sales of approximately $40 million for the second quarter of 2021 compared to the second quarter of 2020 and approximately $90 million for the first six months of 2021 compared to the same period in 2020   \n",
       "75                                                                                                                                                                                                                                                                                                                                        The COVID-19 pandemic continued to negatively affect sales in the second quarter of 2021 across several markets   \n",
       "80                             Women’s Health Contraception Worldwide sales of  Nexplanon/Implanon NXT , a single-rod subdermal contraceptive implant, increased 40% and 13% in the second quarter and first six months of 2021, respectively, primarily reflecting recovery from the COVID-19 pandemic in the United States, Europe and Canada, favorable impact from pricing, and phasing of tenders in Latin America during the second quarter of 2021   \n",
       "81                                                                                                                                                                                                                                   Worldwide sales of  NuvaRing , a vaginal contraceptive product, declined 16% and 22% in the second quarter and first six months of 2021 primarily due to ongoing generic competition in the United States and the EU   \n",
       "87                                                                                                                                                                                                                                                                                                                                    Revenues for the second quarter of 2021 and the first six months of 2021 primarily reflect our share of the profits   \n",
       "88                                                                                                                                                                                                                                                                                                                       Revenues for the second quarter and the first six months of 2020 reflect supply sales of the generic product to the manufacturer   \n",
       "89                                                                                                                                                                                                                                                                                                                             The decline in revenue for the second quarter and first six months of 2021 is due to the entry of a new market participant   \n",
       "91    Fertility Worldwide sales of Follistim AQ (marketed in most countries outside the United States as Puregon), a fertility treatment, increased 48% and 37% in the second quarter and the first six months of 2021, respectively, primarily due to volume growth in the United States as well as recovery from the COVID-19 pandemic in the United States Europe, Canada and China, partially offset by overall unfavorable discount rates in the U.S   \n",
       "93                                                                                                                                                                      Worldwide sales of Ganirelix Acetate Injection (marketed in certain countries outside the United States as Orgalutran), a fertility treatment, increased 117% in the second quarter of 2021, primarily due to the recovery from the COVID-19 pandemic in Europe, Canada and China   \n",
       "94                                                                                                                                                                                                                                            For the first six months of 2021, sales increased 101% primarily due to increased demand in the United States as well as recovery from the COVID-19 pandemic in the United States, Europe, Canada and China   \n",
       "99                                                                                                                                                                                                                                                   Sales growth in the second quarter and first six months of 2021 was driven primarily by continued demand growth in the United States since launch in 2017, partially offset by higher discount rates   \n",
       "102                                                                                                                                                                                                                     For the second quarter and first six months of 2021, sales reflect uptake since the July 2020 launch in the United States, partially offset by a decrease in the EU reflecting increasing competitive pressures and price erosion   \n",
       "105                                                                                                                                                                                                                                                                              Sales in the second quarter and first six months of 2021 decreased 2% and 27%, respectively, primarily due to timing of shipments to Brazil related to government orders   \n",
       "108                                                                                                                                                     We recorded sales of $8 million and $16 million during the second quarter and first six months of 2021, respectively, with no comparable sales during the second quarter and first six months of 2020 due to the approval of  Aybintio  in the EU in August 2020 and its launch in September 2020   \n",
       "119                                                                                                                                                                                                                    Sales decreased 26% in the first six months of 2021 primarily driven by lower sales of  Ezetrol  in Japan, lower demand in the United States due to generic competition, as well as lower sales of  Ezetrol  and  Inegy  in the EU   \n",
       "124                                                                                                        Sales of  Atozet  (ezetimibe and atorvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, increased 5% in the second quarter of 2021 primarily due to volume growth in France and a slight increase in sales in various markets, partially offset by lower demand in Germany due to competition   \n",
       "125                                                                                                                                                                        Sales of  Atozet  declined 2% in the first six months of 2021 due to lower demand in the EU, primarily in Germany and Spain due to competition, coupled with unfavorable pricing, partially offset by a volume increase in France and higher demand in the Asia Pacific region   \n",
       "126                                                                                                                                          Sales of  Rosuzet  (ezetimibe and rosuvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, declined 42% and 47% in the second quarter and first six months of 2021, respectively, due to the expiration of a distribution agreement in Korea in December 2020   \n",
       "130                                                                                         The sales decrease in the first six months of 2021 reflects lower demand in the United States, lower demand due to generic competition in Japan and the Asia Pacific region, the effect of the shift in product mix and lower demand in China, and lower sales in Canada as sales in the second quarter of 2020 was higher due to competitor supply shortages   \n",
       "132                                                                                                                                                                                                                                                                                                                         Sales of  Zocor  decreased 21% in the first six months of 2021, primarily due to lower volumes in China due to the VBP impact   \n",
       "133  Respiratory Worldwide sales of  Singulair , a once-a-day oral medicine for the chronic treatment of asthma and for the relief of symptoms of allergic rhinitis, declined 8% in the second quarter of 2021 primarily due to the lower performance in Japan attributable to generic competition as well as timing of shipments in Japan in the second quarter of 2020, VBP impact in China partially offset by the recovery from the COVID-19 pandemic   \n",
       "135                                                                                                                                                                                                                                                                                                     Sales for the first six months of 2021  -37- also reflect lower demand in Europe and Canada in the beginning of 2021 due to the COVID-19 pandemic   \n",
       "137                                                                                          Global sales of  Nasonex , an inhaled nasal corticosteroid for the treatment of nasal allergy symptoms, increased 6% in the second quarter of 2021 primarily due to higher demand in China and favorable performance in Russia, partially offset by lower sales in the United States due to the impact of COVID-19 pandemic and generic competition in Japan   \n",
       "138                                                                                                                                                       Global sales of  Nasonex  decreased 21% in the first six months of 2021 primarily driven by lower demand impacted by the COVID-19 pandemic across several markets in the United States, Europe, and Latin America, and generic competition in Japan, partially offset by higher demand in China   \n",
       "139                                                                                                                                                                                                                                                              Global sales of  Dulera , a combination medicine for the treatment of asthma, increased 34% in the second quarter of 2021 primarily due to favorable discount rates in the United States   \n",
       "140                                                                                                                                                                            For the first six months of 2021, global sales of  Dulera  decreased 26% largely due to significant buy-in in the six months of 2020 related to the COVID-19 pandemic, partially offset by the favorable discount rates in the United States in the second quarter of 2021   \n",
       "142                                                                                                                                                                                                                                                       Sales of  Arcoxia  for the first six months of 2021 decreased 12% primarily due to the impact of VBP in China and lower demand in the Asia Pacific region attributable to the COVID-19 pandemic   \n",
       "143                                                                                                                                                                                                                                                                                               The sales decline was also attributable to lower demand in certain markets in the Middle East and Russia that occurred during the first quarter of 2021   \n",
       "144                                                                                                                                                                                                    Other Worldwide sales of  Proscar , for the treatment of symptomatic benign prostate enlargement, declined 38% and 32% in the second quarter and first six months of 2021 primarily due to lower performance reflecting the impact of VBP in China   \n",
       "147                                                                                                                                                                                                                          The increase in cost of sales for the second quarter is primarily due to increases in manufacturing costs and certain costs related to tolling arrangements with Merck which were not in place in the second quarter of 2020   \n",
       "149                                                                                                                                                                                                        The increase during the period reflects increases in manufacturing costs absorbed by Organon, increase in stand up costs, and cost related to tolling arrangements with Merck, which were not in place during the comparable prior year period   \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                The increase also reflects increases in direct corporate Organon costs   \n",
       "153                                                                                                                                                                                                                                             The gross margin declines reflect an increase in stand up costs, as well as certain costs related to tolling arrangements with Merck, which have lower gross margin percentages compared to product sales   \n",
       "154                                                                                                                       Selling, General and Administrative Selling, general and administrative expenses increased 46% and 33% in the second quarter of 2021 and the first six months of 2021, respectively, due to costs incurred to establish Organon as a standalone entity, higher employee related costs, and higher selling and promotional costs   \n",
       "155                                                                                                                                                                                               Research and Development Research and development expenses increased 49% in the second quarter of 2021 and 49% for the first six months of 2021 primarily reflecting higher employee related costs incurred to establish Organon as a standalone entity   \n",
       "156                                                                                                                                                                                                                                                                                                                                            Restructuring Costs Certain of our operations have been affected by restructuring plans initiated by Merck   \n",
       "157                                                                                                                                                                                                                                                                   The decline in restructuring costs is due to lower allocated costs from Merck during the second quarter and the first six months of 2021 compared to the comparable periods of 2020   \n",
       "177                                                                                                                                                                   The decrease in net income for both periods reflects an increase in costs and expenses incurred to establish Organon as a standalone entity, partially offset by higher sales due to higher demand for certain of our products across several markets in the second quarter of 2021   \n",
       "194                                                                                                                                                                                                                                                                          Cash provided by operating activities was favorably impacted by an increase in accounts payable, including amounts due to Merck, partially offset by a decline in net income   \n",
       "197                                                                                                                                           The change in cash used in financing activities reflects the proceeds from the issuance of long term debt, the payment of related debt issuance costs and the settlement of  the transactions with Merck in connection with the Separation (see Note 17 to our Condensed Consolidated Financial Statements)   \n",
       "\n",
       "    ticker                  file                                  topic  \\\n",
       "64     OGN  0001821825-21-000009                         [costs, costs]   \n",
       "68     OGN  0001821825-21-000009                         [sales, sales]   \n",
       "69     OGN  0001821825-21-000009                         [sales, sales]   \n",
       "72     OGN  0001821825-21-000009                  [sales, sales, sales]   \n",
       "74     OGN  0001821825-21-000009                                [sales]   \n",
       "75     OGN  0001821825-21-000009                                [sales]   \n",
       "80     OGN  0001821825-21-000009                                [sales]   \n",
       "81     OGN  0001821825-21-000009                                [sales]   \n",
       "87     OGN  0001821825-21-000009                    [Revenues, profits]   \n",
       "88     OGN  0001821825-21-000009                      [Revenues, sales]   \n",
       "89     OGN  0001821825-21-000009                              [revenue]   \n",
       "91     OGN  0001821825-21-000009                                [sales]   \n",
       "93     OGN  0001821825-21-000009                                [sales]   \n",
       "94     OGN  0001821825-21-000009                                [sales]   \n",
       "99     OGN  0001821825-21-000009                                [Sales]   \n",
       "102    OGN  0001821825-21-000009                                [sales]   \n",
       "105    OGN  0001821825-21-000009                                [Sales]   \n",
       "108    OGN  0001821825-21-000009                         [sales, sales]   \n",
       "119    OGN  0001821825-21-000009                  [Sales, sales, sales]   \n",
       "124    OGN  0001821825-21-000009                         [Sales, sales]   \n",
       "125    OGN  0001821825-21-000009                                [Sales]   \n",
       "126    OGN  0001821825-21-000009                                [Sales]   \n",
       "130    OGN  0001821825-21-000009                  [sales, sales, sales]   \n",
       "132    OGN  0001821825-21-000009                                [Sales]   \n",
       "133    OGN  0001821825-21-000009                                [sales]   \n",
       "135    OGN  0001821825-21-000009                                [Sales]   \n",
       "137    OGN  0001821825-21-000009                         [sales, sales]   \n",
       "138    OGN  0001821825-21-000009                                [sales]   \n",
       "139    OGN  0001821825-21-000009                                [sales]   \n",
       "140    OGN  0001821825-21-000009                                [sales]   \n",
       "142    OGN  0001821825-21-000009                                [Sales]   \n",
       "143    OGN  0001821825-21-000009                                [sales]   \n",
       "144    OGN  0001821825-21-000009                                [sales]   \n",
       "147    OGN  0001821825-21-000009            [cost, sales, costs, costs]   \n",
       "149    OGN  0001821825-21-000009                   [costs, costs, cost]   \n",
       "150    OGN  0001821825-21-000009                                [costs]   \n",
       "153    OGN  0001821825-21-000009  [margin, costs, costs, margin, sales]   \n",
       "154    OGN  0001821825-21-000009                  [costs, costs, costs]   \n",
       "155    OGN  0001821825-21-000009                                [costs]   \n",
       "156    OGN  0001821825-21-000009                                [Costs]   \n",
       "157    OGN  0001821825-21-000009                         [costs, costs]   \n",
       "177    OGN  0001821825-21-000009                 [income, costs, sales]   \n",
       "194    OGN  0001821825-21-000009                               [income]   \n",
       "197    OGN  0001821825-21-000009                                [costs]   \n",
       "\n",
       "                                                                                                                causal  \\\n",
       "64                                     {'nonverbs': [['due to', 'JJ', [15, 17]], ['attributable to', 'JJ', [36, 38]]]}   \n",
       "68                                   {'CvE': [['resulting', 'VBG', [40, 41]]], 'nonverbs': [['due to', 'JJ', [4, 6]]]}   \n",
       "69                                                                          {'nonverbs': [['due to', 'IN', [28, 30]]]}   \n",
       "72                                 {'CvE': [['resulting', 'VBG', [39, 40]]], 'nonverbs': [['due to', 'IN', [29, 31]]]}   \n",
       "74                                                                                {'CvE': [['affect', 'VB', [9, 10]]]}   \n",
       "75                                                                                 {'CvE': [['affect', 'VB', [6, 7]]]}   \n",
       "80                                                                          {'EvC': [['reflecting', 'VBG', [41, 42]]]}   \n",
       "81                                                                          {'nonverbs': [['due to', 'JJ', [28, 30]]]}   \n",
       "87                                                                             {'EvC': [['reflect', 'VBP', [15, 16]]]}   \n",
       "88                                                                             {'EvC': [['reflect', 'VBP', [12, 13]]]}   \n",
       "89                                                                          {'nonverbs': [['due to', 'JJ', [15, 17]]]}   \n",
       "91                                                                          {'nonverbs': [['due to', 'JJ', [44, 46]]]}   \n",
       "93                                                                          {'nonverbs': [['due to', 'IN', [34, 36]]]}   \n",
       "94                                                                          {'nonverbs': [['due to', 'JJ', [13, 15]]]}   \n",
       "99                                     {'CvE': [['driven', 'VBN', [13, 14]]], 'nonverbs': [['since', 'IN', [23, 24]]]}   \n",
       "102  {'EvC': [['reflect', 'VBP', [12, 13]], ['reflecting', 'VBG', [32, 33]]], 'nonverbs': [['since', 'IN', [14, 15]]]}   \n",
       "105                                                                         {'nonverbs': [['due to', 'JJ', [21, 23]]]}   \n",
       "108                                                                         {'nonverbs': [['due to', 'IN', [38, 40]]]}   \n",
       "119                                   {'CvE': [['driven', 'VBN', [12, 13]]], 'nonverbs': [['due to', 'JJ', [29, 31]]]}   \n",
       "124                                             {'nonverbs': [['due to', 'JJ', [37, 39]], ['due to', 'JJ', [60, 62]]]}   \n",
       "125                                             {'nonverbs': [['due to', 'IN', [15, 17]], ['due to', 'IN', [28, 30]]]}   \n",
       "126                                                                         {'nonverbs': [['due to', 'IN', [46, 48]]]}   \n",
       "130     {'EvC': [['reflects', 'VBZ', [10, 11]]], 'nonverbs': [['due to', 'IN', [20, 22]], ['due to', 'IN', [61, 63]]]}   \n",
       "132                                             {'nonverbs': [['due to', 'IN', [17, 19]], ['due to', 'IN', [23, 25]]]}   \n",
       "133                                    {'nonverbs': [['due to', 'JJ', [41, 43]], ['attributable to', 'JJ', [48, 50]]]}   \n",
       "135                                  {'EvC': [['reflect', 'VBP', [11, 12]]], 'nonverbs': [['due to', 'IN', [23, 25]]]}   \n",
       "137                                             {'nonverbs': [['due to', 'IN', [28, 30]], ['due to', 'IN', [49, 51]]]}   \n",
       "138                                              {'CvE': [['driven', 'VBN', [17, 18]], ['impacted', 'VBN', [21, 22]]]}   \n",
       "139                                                                         {'nonverbs': [['due to', 'JJ', [25, 27]]]}   \n",
       "140                                                                         {'nonverbs': [['due to', 'JJ', [18, 20]]]}   \n",
       "142                                    {'nonverbs': [['due to', 'IN', [16, 18]], ['attributable to', 'JJ', [32, 34]]]}   \n",
       "143                                                                  {'nonverbs': [['attributable to', 'JJ', [5, 7]]]}   \n",
       "144                               {'EvC': [['reflecting', 'VBG', [37, 38]]], 'nonverbs': [['due to', 'IN', [33, 35]]]}   \n",
       "147                                                                         {'nonverbs': [['due to', 'JJ', [12, 14]]]}   \n",
       "149                                                                             {'EvC': [['reflects', 'VBZ', [5, 6]]]}   \n",
       "150                                                                             {'EvC': [['reflects', 'VBZ', [3, 4]]]}   \n",
       "153                                                                              {'EvC': [['reflect', 'VBP', [4, 5]]]}   \n",
       "154                                                                         {'nonverbs': [['due to', 'IN', [33, 35]]]}   \n",
       "155                                                                         {'EvC': [['reflecting', 'VBG', [27, 28]]]}   \n",
       "156                                                                             {'CvE': [['affected', 'VBN', [8, 9]]]}   \n",
       "157                                                                           {'nonverbs': [['due to', 'JJ', [6, 8]]]}   \n",
       "177                                   {'EvC': [['reflects', 'VBZ', [8, 9]]], 'nonverbs': [['due to', 'IN', [29, 31]]]}   \n",
       "194                                   {'CvE': [['impacted', 'VBN', [7, 8]]], 'nonverbs': [['due to', 'JJ', [17, 19]]]}   \n",
       "197                                                                             {'EvC': [['reflects', 'VBZ', [8, 9]]]}   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                       e_raw  \\\n",
       "64                                                                                                              [Operating expenses in the second quarter and first six months of 2021 were higher primarily, the effect of lower promotional and selling costs incurred in the second quarter and first six months of 2020]   \n",
       "68                                                                                                                                           [from the continued uptake of Renflexis (infliximab-abda) in the United States and the uptake of Aybintio (bevacizumab) in the European Union (\"EU\", The increase is primarily]   \n",
       "69                                                                                                                                      [The sales increase was partially offset by ongoing generic competition for cardiovascular products Zetia and Vytorin (ezetimibe and simvastatin) mainly in Japan, decline in sales]   \n",
       "72                                                       [from the continued uptake of Renflexis mainly in the United States and Aybintio in the, The sales decline was offset by higher sales of women's health products Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection]   \n",
       "74                                                                       [a number of our products with an impact to sales of approximately $40 million for the second quarter of 2021 compared to the second quarter of 2020 and approximately $90 million for the first six months of 2021 compared to the same period in]   \n",
       "75                                                                                                                                                                                                                                                                      [sales in the second quarter of 2021 across several]   \n",
       "80                                                                                               [Women’s Health Contraception Worldwide sales of  Nexplanon/Implanon NXT , a single-rod subdermal contraceptive implant, increased 40% and 13% in the second quarter and first six months of 2021, respectively, primarily]   \n",
       "81                                                                                                                                                                       [Worldwide sales of  NuvaRing , a vaginal contraceptive product, declined 16% and 22% in the second quarter and first six months of 2021 primarily]   \n",
       "87                                                                                                                                                                                                                                      [Revenues for the second quarter of 2021 and the first six months of 2021 primarily]   \n",
       "88                                                                                                                                                                                                                                                        [Revenues for the second quarter and the first six months of 2020]   \n",
       "89                                                                                                                                                                                                                                           [The decline in revenue for the second quarter and first six months of 2021 is]   \n",
       "91                                                                               [Fertility Worldwide sales of Follistim AQ (marketed in most countries outside the United States as Puregon), a fertility treatment, increased 48% and 37% in the second quarter and the first six months of 2021, respectively, primarily]   \n",
       "93                                                                                                                  [Worldwide sales of Ganirelix Acetate Injection (marketed in certain countries outside the United States as Orgalutran), a fertility treatment, increased 117% in the second quarter of 2021, primarily]   \n",
       "94                                                                                                                                                                                                                                                        [For the first six months of 2021, sales increased 101% primarily]   \n",
       "99                                                                                                                                                                                          [Sales growth in the second quarter and first six months of 2021 was, primarily by continued demand growth in the United States]   \n",
       "102                                                                                                                                                                [For the second quarter and first six months of 2021, sales, the July 2020 launch in the United States, partially offset by a decrease in the EU, uptake]   \n",
       "105                                                                                                                                                                                                                 [Sales in the second quarter and first six months of 2021 decreased 2% and 27%, respectively, primarily]   \n",
       "108                                                                                                                  [We recorded sales of $8 million and $16 million during the second quarter and first six months of 2021, respectively, with no comparable sales during the second quarter and first six months of 2020]   \n",
       "119                                                                                                                                                                                 [Sales decreased 26% in the first six months of 2021 primarily, by lower sales of  Ezetrol  in Japan, lower demand in the United States]   \n",
       "124  [Sales of  Atozet  (ezetimibe and atorvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, increased 5% in the second quarter of 2021 primarily, volume growth in France and a slight increase in sales in various markets, partially offset by lower demand in Germany]   \n",
       "125                                                                                                                                                                                                  [Sales of  Atozet  declined 2% in the first six months of 2021, lower demand in the EU, primarily in Germany and Spain]   \n",
       "126                                                                                       [Sales of  Rosuzet  (ezetimibe and rosuvastatin calcium) (marketed outside of the United States), a medicine for lowering LDL cholesterol, declined 42% and 47% in the second quarter and first six months of 2021, respectively,]   \n",
       "130           [The sales decrease in the first six months of 2021, lower demand in the United States, lower demand, generic competition in Japan and the Asia Pacific region, the effect of the shift in product mix and lower demand in China, and lower sales in Canada as sales in the second quarter of 2020 was higher]   \n",
       "132                                                                                                                                                                                                                      [Sales of  Zocor  decreased 21% in the first six months of 2021, primarily, lower volumes in China]   \n",
       "133                                                                    [Respiratory Worldwide sales of  Singulair , a once-a-day oral medicine for the chronic treatment of asthma and for the relief of symptoms of allergic rhinitis, declined 8% in the second quarter of 2021 primarily, the lower performance in Japan]   \n",
       "135                                                                                                                                                                                                          [Sales for the first six months of 2021  -37- also, lower demand in Europe and Canada in the beginning of 2021]   \n",
       "137                                         [Global sales of  Nasonex , an inhaled nasal corticosteroid for the treatment of nasal allergy symptoms, increased 6% in the second quarter of 2021 primarily, higher demand in China and favorable performance in Russia, partially offset by lower sales in the United States]   \n",
       "138                                                                                                                                                                                                                     [Global sales of  Nasonex  decreased 21% in the first six months of 2021 primarily, by lower demand]   \n",
       "139                                                                                                                                                                                    [Global sales of  Dulera , a combination medicine for the treatment of asthma, increased 34% in the second quarter of 2021 primarily]   \n",
       "140                                                                                                                                                                                                                                       [For the first six months of 2021, global sales of  Dulera  decreased 26% largely]   \n",
       "142                                                                                                                                                                    [Sales of  Arcoxia  for the first six months of 2021 decreased 12% primarily, the impact of VBP in China and lower demand in the Asia Pacific region]   \n",
       "143                                                                                                                                                                                                                                                                                             [The sales decline was also]   \n",
       "144                                                                                                                 [lower performance, Other Worldwide sales of  Proscar , for the treatment of symptomatic benign prostate enlargement, declined 38% and 32% in the second quarter and first six months of 2021 primarily]   \n",
       "147                                                                                                                                                                                                                                                      [The increase in cost of sales for the second quarter is primarily]   \n",
       "149                                                                                                                                                                                                                                                                                         [The increase during the period]   \n",
       "150                                                                                                                                                                                                                                                                                                      [The increase also]   \n",
       "153                                                                                                                                                                                                                                                                                              [The gross margin declines]   \n",
       "154                                                                                                                                   [Selling, General and Administrative Selling, general and administrative expenses increased 46% and 33% in the second quarter of 2021 and the first six months of 2021, respectively,]   \n",
       "155                                                                                                                                                              [Research and Development Research and development expenses increased 49% in the second quarter of 2021 and 49% for the first six months of 2021 primarily]   \n",
       "156                                                                                                                                                                                                                                                                [Restructuring Costs Certain of our operations have been]   \n",
       "157                                                                                                                                                                                                                                                                                  [The decline in restructuring costs is]   \n",
       "177                                                                                                                                                  [The decrease in net income for both periods, an increase in costs and expenses incurred to establish Organon as a standalone entity, partially offset by higher sales]   \n",
       "194                                                                                                                                                                                                             [Cash provided by operating activities was favorably, by an increase in accounts payable, including amounts]   \n",
       "197                                                                                                                                                                                                                                                                        [The change in cash used in financing activities]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                            c_raw  \\\n",
       "64                                                                                                                                                                                       [the effect of lower promotional and selling costs incurred in the second quarter and first six months of 2020, the COVID-19 pandemic as well as incremental costs associated with establishing Organon as a standalone]   \n",
       "68   [higher sales of women’s health products, including Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection, as well as higher sales of biosimilar products, higher sales of women’s health products, including Nexplanon/Implanon NXT, Follistim AQ (follitropin beta injection) and Ganirelix Acetate Injection, as well as higher sales of biosimilar products]   \n",
       "69                                                                                                                                                                                                                                   [the volume-based procurement program (the \"VBP\") in China, an expiration of distribution agreement in Korea for Rosuzet in December 2020, and decreased demand for Cozaar/]   \n",
       "72                                                                                                                                                                                                                                                                                                               [higher demand, and higher sales of biosimilars, higher demand, and higher sales of biosimilars]   \n",
       "74                                                                                                                                                                                                                                                                                                                                                      [Additionally, the VBP in China continues to unfavorably]   \n",
       "75                                                                                                                                                                                                                                                                                                                                                                [The COVID-19 pandemic continued to negatively]   \n",
       "80                                                                                                                                                                                                                             [recovery from the COVID-19 pandemic in the United States, Europe and Canada, favorable impact from pricing, and phasing of tenders in Latin America during the second quarter of]   \n",
       "81                                                                                                                                                                                                                                                                                                                                                     [ongoing generic competition in the United States and the]   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                             [our share of the]   \n",
       "88                                                                                                                                                                                                                                                                                                                                                                   [supply sales of the generic product to the]   \n",
       "89                                                                                                                                                                                                                                                                                                                                                                                    [the entry of a new market]   \n",
       "91                                                                                                                                                                                                               [volume growth in the United States as well as recovery from the COVID-19 pandemic in the United States Europe, Canada and China, partially offset by overall unfavorable discount rates in the]   \n",
       "93                                                                                                                                                                                                                                                                                                                                                [the recovery from the COVID-19 pandemic in Europe, Canada and]   \n",
       "94                                                                                                                                                                                                                                                                                [increased demand in the United States as well as recovery from the COVID-19 pandemic in the United States, Europe, Canada and]   \n",
       "99                                                                                                                                                                                                                                                                                               [primarily by continued demand growth in the United States, launch in 2017, partially offset by higher discount]   \n",
       "102                                                                                                                                                                                                                                                                     [uptake, increasing competitive pressures and price, the July 2020 launch in the United States, partially offset by a decrease in the EU]   \n",
       "105                                                                                                                                                                                                                                                                                                                                                         [timing of shipments to Brazil related to government]   \n",
       "108                                                                                                                                                                                                                                                                                                                             [the approval of  Aybintio  in the EU in August 2020 and its launch in September]   \n",
       "119                                                                                                                                                                                                                                                        [by lower sales of  Ezetrol  in Japan, lower demand in the United States, generic competition, as well as lower sales of  Ezetrol  and  Inegy  in the]   \n",
       "124                                                                                                                                                                                                                                                                                    [volume growth in France and a slight increase in sales in various markets, partially offset by lower demand in Germany, ]   \n",
       "125                                                                                                                                                                                                                [lower demand in the EU, primarily in Germany and Spain, competition, coupled with unfavorable pricing, partially offset by a volume increase in France and higher demand in the Asia Pacific]   \n",
       "126                                                                                                                                                                                                                                                                                                                                             [the expiration of a distribution agreement in Korea in December]   \n",
       "130                                                                                                                                 [lower demand in the United States, lower demand, generic competition in Japan and the Asia Pacific region, the effect of the shift in product mix and lower demand in China, and lower sales in Canada as sales in the second quarter of 2020 was higher, competitor supply]   \n",
       "132                                                                                                                                                                                                                                                                                                                                                                             [lower volumes in China, the VBP]   \n",
       "133                                                                                                                                                                                                           [the lower performance in Japan, generic competition as well as timing of shipments in Japan in the second quarter of 2020, VBP impact in China partially offset by the recovery from the COVID-19]   \n",
       "135                                                                                                                                                                                                                                                                                                                                    [lower demand in Europe and Canada in the beginning of 2021, the COVID-19]   \n",
       "137                                                                                                                                                                                                                                [higher demand in China and favorable performance in Russia, partially offset by lower sales in the United States, the impact of COVID-19 pandemic and generic competition in]   \n",
       "138                                                                                                                                                                                                                    [by lower demand, by the COVID-19 pandemic across several markets in the United States, Europe, and Latin America, and generic competition in Japan, partially offset by higher demand in]   \n",
       "139                                                                                                                                                                                                                                                                                                                                                                      [favorable discount rates in the United]   \n",
       "140                                                                                                                                                                                                                               [significant buy-in in the six months of 2020 related to the COVID-19 pandemic, partially offset by the favorable discount rates in the United States in the second quarter of]   \n",
       "142                                                                                                                                                                                                                                                                                                                        [the impact of VBP in China and lower demand in the Asia Pacific region, the COVID-19]   \n",
       "143                                                                                                                                                                                                                                                                                                     [lower demand in certain markets in the Middle East and Russia that occurred during the first quarter of]   \n",
       "144                                                                                                                                                                                                                                                                                                                                                                     [the impact of VBP in, lower performance]   \n",
       "147                                                                                                                                                                                                                                                              [increases in manufacturing costs and certain costs related to tolling arrangements with Merck which were not in place in the second quarter of]   \n",
       "149                                                                                                                                                                                                             [increases in manufacturing costs absorbed by Organon, increase in stand up costs, and cost related to tolling arrangements with Merck, which were not in place during the comparable prior year]   \n",
       "150                                                                                                                                                                                                                                                                                                                                                                       [increases in direct corporate Organon]   \n",
       "153                                                                                                                                                                                                                                           [an increase in stand up costs, as well as certain costs related to tolling arrangements with Merck, which have lower gross margin percentages compared to product]   \n",
       "154                                                                                                                                                                                                                                                                               [costs incurred to establish Organon as a standalone entity, higher employee related costs, and higher selling and promotional]   \n",
       "155                                                                                                                                                                                                                                                                                                                                 [higher employee related costs incurred to establish Organon as a standalone]   \n",
       "156                                                                                                                                                                                                                                                                                                                                                                         [by restructuring plans initiated by]   \n",
       "157                                                                                                                                                                                                                                                                           [lower allocated costs from Merck during the second quarter and the first six months of 2021 compared to the comparable periods of]   \n",
       "177                                                                                                                                                                                         [an increase in costs and expenses incurred to establish Organon as a standalone entity, partially offset by higher sales, higher demand for certain of our products across several markets in the second quarter of]   \n",
       "194                                                                                                                                                                                                                                                                                                          [by an increase in accounts payable, including amounts, Merck, partially offset by a decline in net]   \n",
       "197                                                                                                                                                           [the proceeds from the issuance of long term debt, the payment of related debt issuance costs and the settlement of  the transactions with Merck in connection with the Separation (see Note 17 to our Condensed Consolidated Financial Statements]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              c_model  \\\n",
       "64                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          [[{'link': ' the'}, {'noun': 'effect'}, {'link': 'of lower promotional and'}, {'noun': 'selling cost'}, {'link': 'incurred in the second'}, {'noun': 'quarter'}, {'link': 'and first six'}, {'noun': 'month'}, {'link': 'of 2020'}], [{'link': ' the COVID-19'}, {'noun': 'pandemic'}, {'link': 'as well as incremental'}, {'noun': 'cost'}, {'link': 'associated with establishing'}, {'noun': 'Organon'}, {'link': 'as a standalone'}]]   \n",
       "68   [[{'link': ' higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'woman'}, {'link': '’s'}, {'noun': 'health product'}, {'link': ', including'}, {'noun': 'Nexplanon'}, {'link': '/'}, {'noun': 'Implanon NXT'}, {'link': ','}, {'noun': 'Follistim AQ'}, {'link': '('}, {'noun': 'follitropin beta injection'}, {'link': ') and'}, {'noun': 'Ganirelix Acetate Injection'}, {'link': ', as well as higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar product'}], [{'link': ' higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'woman'}, {'link': '’s'}, {'noun': 'health product'}, {'link': ', including'}, {'noun': 'Nexplanon'}, {'link': '/'}, {'noun': 'Implanon NXT'}, {'link': ','}, {'noun': 'Follistim AQ'}, {'link': '('}, {'noun': 'follitropin beta injection'}, {'link': ') and'}, {'noun': 'Ganirelix Acetate Injection'}, {'link': ', as well as higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar product'}]]   \n",
       "69                                                                                                                                                                                                                                                                                                                                                                                                                                                                               [[{'link': ' the'}, {'noun': 'volume'}, {'link': '- based'}, {'noun': 'procurement program'}, {'link': '( the \"'}, {'noun': 'VBP'}, {'link': '\" ) in'}, {'noun': 'China'}, {'link': ', an'}, {'noun': 'expiration'}, {'link': 'of'}, {'noun': 'distribution agreement'}, {'link': 'in'}, {'noun': 'Korea'}, {'link': 'for'}, {'noun': 'Rosuzet'}, {'link': 'in'}, {'noun': 'December'}, {'link': '2020 , and decreased'}, {'noun': 'demand'}, {'link': 'for'}, {'noun': 'Cozaar/'}]]   \n",
       "72                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [[{'link': ' higher'}, {'noun': 'demand'}, {'link': ', and higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar'}], [{'link': ' higher'}, {'noun': 'demand'}, {'link': ', and higher'}, {'noun': 'sale'}, {'link': 'of'}, {'noun': 'biosimilar'}]]   \n",
       "74                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      [[{'link': ' Additionally , the'}, {'noun': 'VBP'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'continues to unfavorably'}]]   \n",
       "75                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           [[{'link': ' The COVID-19'}, {'noun': 'pandemic'}, {'link': 'continued to negatively'}]]   \n",
       "80                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         [[{'noun': ' recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ','}, {'noun': 'Europe'}, {'link': 'and'}, {'noun': 'Canada'}, {'link': ', favorable'}, {'noun': 'impact'}, {'link': 'from'}, {'noun': 'pricing'}, {'link': ', and phasing of'}, {'noun': 'tender'}, {'link': 'in'}, {'noun': 'Latin America'}, {'link': 'during the second'}, {'noun': 'quarter'}, {'link': 'of'}]]   \n",
       "81                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      [[{'link': ' ongoing generic'}, {'noun': 'competition'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'and the'}]]   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        [[{'link': ' our'}, {'noun': 'share'}, {'link': 'of the'}]]   \n",
       "88                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  [[{'noun': ' supply sale'}, {'link': 'of the generic'}, {'noun': 'product'}, {'link': 'to the'}]]   \n",
       "89                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  [[{'link': ' the'}, {'noun': 'entry'}, {'link': 'of a new'}, {'noun': 'market'}]]   \n",
       "91                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                [[{'noun': ' volume growth'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'as well as'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in the'}, {'noun': 'United States Europe'}, {'link': ','}, {'noun': 'Canada'}, {'link': 'and'}, {'noun': 'China'}, {'link': ', partially offset by overall unfavorable'}, {'noun': 'discount rate'}, {'link': 'in the'}]]   \n",
       "93                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            [[{'link': ' the'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in'}, {'noun': 'Europe'}, {'link': ','}, {'noun': 'Canada'}, {'link': 'and'}]]   \n",
       "94                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             [[{'link': ' increased'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'as well as'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}, {'noun': 'pandemic'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ','}, {'noun': 'Europe'}, {'link': ','}, {'noun': 'Canada'}, {'link': 'and'}]]   \n",
       "99                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                [[{'link': ' primarily by continued'}, {'noun': 'demand growth'}, {'link': 'in the'}, {'noun': 'United States'}], [{'link': ' launch in 2017 , partially offset by higher'}, {'noun': 'discount'}]]   \n",
       "102                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                [[{'noun': ' uptake'}], [{'link': ' increasing competitive'}, {'noun': 'pressure'}, {'link': 'and'}, {'noun': 'price'}], [{'link': ' the'}, {'noun': 'July'}, {'link': '2020'}, {'noun': 'launch'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ', partially offset by a'}, {'noun': 'decrease'}, {'link': 'in the'}, {'noun': 'EU'}]]   \n",
       "105                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 [[{'noun': ' timing'}, {'link': 'of'}, {'noun': 'shipment'}, {'link': 'to'}, {'noun': 'Brazil'}, {'link': 'related to'}, {'noun': 'government'}]]   \n",
       "108                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 [[{'link': ' the'}, {'noun': 'approval'}, {'link': 'of  '}, {'noun': 'Aybintio'}, {'link': '  in the'}, {'noun': 'EU'}, {'link': 'in'}, {'noun': 'August'}, {'link': '2020 and its'}, {'noun': 'launch'}, {'link': 'in'}, {'noun': 'September'}]]   \n",
       "119                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           [[{'link': ' by lower'}, {'noun': 'sale'}, {'link': 'of  '}, {'noun': 'Ezetrol'}, {'link': '  in'}, {'noun': 'Japan'}, {'link': ', lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'United States'}], [{'link': ' generic'}, {'noun': 'competition'}, {'link': ', as well as lower'}, {'noun': 'sale'}, {'link': 'of  '}, {'noun': 'Ezetrol'}, {'link': '  and  '}, {'noun': 'Inegy'}, {'link': '  in the'}]]   \n",
       "124                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          [[{'noun': ' volume growth'}, {'link': 'in'}, {'noun': 'France'}, {'link': 'and a slight'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'sale'}, {'link': 'in various'}, {'noun': 'market'}, {'link': ', partially offset by lower'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'Germany'}], None]   \n",
       "125                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      [[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'EU'}, {'link': ', primarily in'}, {'noun': 'Germany'}, {'link': 'and'}, {'noun': 'Spain'}], [{'noun': ' competition'}, {'link': ', coupled with unfavorable'}, {'noun': 'pricing'}, {'link': ', partially offset by a'}, {'noun': 'volume increase'}, {'link': 'in'}, {'noun': 'France'}, {'link': 'and higher'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'Asia Pacific'}]]   \n",
       "126                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       [[{'link': ' the'}, {'noun': 'expiration'}, {'link': 'of a'}, {'noun': 'distribution agreement'}, {'link': 'in'}, {'noun': 'Korea'}, {'link': 'in'}, {'noun': 'December'}]]   \n",
       "130                                                                                                                                                                                                                                              [[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ', lower'}, {'noun': 'demand'}], [{'link': ' generic'}, {'noun': 'competition'}, {'link': 'in'}, {'noun': 'Japan'}, {'link': 'and the'}, {'noun': 'Asia Pacific region'}, {'link': ', the'}, {'noun': 'effect'}, {'link': 'of the'}, {'noun': 'shift'}, {'link': 'in'}, {'noun': 'product mix'}, {'link': 'and lower'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'China'}, {'link': ', and lower'}, {'noun': 'sale'}, {'link': 'in'}, {'noun': 'Canada'}, {'link': 'as'}, {'noun': 'sale'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of 2020 was higher'}], [{'noun': ' competitor supply'}]]   \n",
       "132                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                [[{'link': ' lower'}, {'noun': 'volume'}, {'link': 'in'}, {'noun': 'China'}], [{'link': ' the'}, {'noun': 'VBP'}]]   \n",
       "133                                                                                                                                                                                                                                                                                                                                                                                                                                                                          [[{'link': ' the lower'}, {'noun': 'performance'}, {'link': 'in'}, {'noun': 'Japan'}], [{'link': ' generic'}, {'noun': 'competition'}, {'link': 'as well as'}, {'noun': 'timing'}, {'link': 'of'}, {'noun': 'shipment'}, {'link': 'in'}, {'noun': 'Japan'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of 2020 ,'}, {'noun': 'VBP impact'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'partially offset by the'}, {'noun': 'recovery'}, {'link': 'from the COVID-19'}]]   \n",
       "135                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'Europe'}, {'link': 'and'}, {'noun': 'Canada'}, {'link': 'in the'}, {'noun': 'beginning'}, {'link': 'of 2021'}], [{'link': ' the'}, {'noun': 'COVID-19'}]]   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         [[{'link': ' higher'}, {'noun': 'demand'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'and favorable'}, {'noun': 'performance'}, {'link': 'in'}, {'noun': 'Russia'}, {'link': ', partially offset by lower'}, {'noun': 'sale'}, {'link': 'in the'}, {'noun': 'United States'}], [{'link': ' the'}, {'noun': 'impact'}, {'link': 'of COVID-19'}, {'noun': 'pandemic'}, {'link': 'and generic'}, {'noun': 'competition'}, {'link': 'in'}]]   \n",
       "138                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          [[{'link': ' by lower'}, {'noun': 'demand'}], [{'link': ' by the COVID-19'}, {'noun': 'pandemic'}, {'link': 'across several'}, {'noun': 'market'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': ','}, {'noun': 'Europe'}, {'link': ', and'}, {'noun': 'Latin America'}, {'link': ', and generic'}, {'noun': 'competition'}, {'link': 'in'}, {'noun': 'Japan'}, {'link': ', partially offset by higher'}, {'noun': 'demand'}, {'link': 'in'}]]   \n",
       "139                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [[{'link': ' favorable'}, {'noun': 'discount rate'}, {'link': 'in the'}, {'noun': 'United'}]]   \n",
       "140                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             [[{'link': ' significant'}, {'noun': 'buy'}, {'link': '-'}, {'noun': 'in'}, {'link': 'in the six'}, {'noun': 'month'}, {'link': 'of 2020 related to the COVID-19'}, {'noun': 'pandemic'}, {'link': ', partially offset by the favorable'}, {'noun': 'discount rate'}, {'link': 'in the'}, {'noun': 'United States'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of'}]]   \n",
       "142                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            [[{'link': ' the'}, {'noun': 'impact'}, {'link': 'of'}, {'noun': 'VBP'}, {'link': 'in'}, {'noun': 'China'}, {'link': 'and lower'}, {'noun': 'demand'}, {'link': 'in the'}, {'noun': 'Asia Pacific region'}], [{'link': ' the'}, {'noun': 'COVID-19'}]]   \n",
       "143                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         [[{'link': ' lower'}, {'noun': 'demand'}, {'link': 'in certain'}, {'noun': 'market'}, {'link': 'in the'}, {'noun': 'Middle East'}, {'link': 'and'}, {'noun': 'Russia'}, {'link': 'that occurred during the first'}, {'noun': 'quarter'}, {'link': 'of'}]]   \n",
       "144                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          [[{'link': ' the'}, {'noun': 'impact'}, {'link': 'of'}, {'noun': 'VBP'}, {'link': 'in'}], [{'link': ' lower'}, {'noun': 'performance'}]]   \n",
       "147                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              [[{'noun': ' increase'}, {'link': 'in'}, {'noun': 'manufacturing cost'}, {'link': 'and certain'}, {'noun': 'cost'}, {'link': 'related to'}, {'noun': 'tolling arrangement'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': 'which were not in'}, {'noun': 'place'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of'}]]   \n",
       "149                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         [[{'noun': ' increase'}, {'link': 'in'}, {'noun': 'manufacturing cost'}, {'link': 'absorbed by'}, {'noun': 'Organon'}, {'link': ', increase in'}, {'noun': 'stand'}, {'link': 'up'}, {'noun': 'cost'}, {'link': ', and'}, {'noun': 'cost'}, {'link': 'related to'}, {'noun': 'tolling arrangement'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': ', which were not in'}, {'noun': 'place'}, {'link': 'during the comparable prior'}, {'noun': 'year'}]]   \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   [[{'noun': ' increase'}, {'link': 'in direct corporate'}, {'noun': 'Organon'}]]   \n",
       "153                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               [[{'link': ' an'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'stand'}, {'link': 'up'}, {'noun': 'cost'}, {'link': ', as well as certain'}, {'noun': 'cost'}, {'link': 'related to'}, {'noun': 'tolling arrangement'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': ', which have lower gross'}, {'noun': 'margin percentage'}, {'link': 'compared to'}, {'noun': 'product'}]]   \n",
       "154                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [[{'noun': ' cost'}, {'link': 'incurred to establish'}, {'noun': 'Organon'}, {'link': 'as a standalone'}, {'noun': 'entity'}, {'link': ', higher'}, {'noun': 'employee'}, {'link': 'related'}, {'noun': 'cost'}, {'link': ', and higher'}, {'noun': 'selling'}, {'link': 'and promotional'}]]   \n",
       "155                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         [[{'link': ' higher'}, {'noun': 'employee'}, {'link': 'related'}, {'noun': 'cost'}, {'link': 'incurred to establish'}, {'noun': 'Organon'}, {'link': 'as a standalone'}]]   \n",
       "156                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [[{'link': ' by restructuring'}, {'noun': 'plan'}, {'link': 'initiated by'}]]   \n",
       "157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 [[{'link': ' lower allocated'}, {'noun': 'cost'}, {'link': 'from'}, {'noun': 'Merck'}, {'link': 'during the second'}, {'noun': 'quarter'}, {'link': 'and the first six'}, {'noun': 'month'}, {'link': 'of 2021 compared to the comparable'}, {'noun': 'period'}, {'link': 'of'}]]   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                            [[{'link': ' an'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'cost'}, {'link': 'and'}, {'noun': 'expense'}, {'link': 'incurred to establish'}, {'noun': 'Organon'}, {'link': 'as a standalone'}, {'noun': 'entity'}, {'link': ', partially offset by higher'}, {'noun': 'sale'}], [{'link': ' higher'}, {'noun': 'demand'}, {'link': 'for certain of our'}, {'noun': 'product'}, {'link': 'across several'}, {'noun': 'market'}, {'link': 'in the second'}, {'noun': 'quarter'}, {'link': 'of'}]]   \n",
       "194                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           [[{'link': ' by an'}, {'noun': 'increase'}, {'link': 'in'}, {'noun': 'account'}, {'link': 'payable , including'}, {'noun': 'amount'}], [{'noun': ' Merck'}, {'link': ', partially offset by a'}, {'noun': 'decline'}, {'link': 'in'}, {'noun': 'net'}]]   \n",
       "197                                                                                                                                                                                                                                                                                                                                                                                                                [[{'link': ' the'}, {'noun': 'proceed'}, {'link': 'from the'}, {'noun': 'issuance'}, {'link': 'of long'}, {'noun': 'term debt'}, {'link': ', the'}, {'noun': 'payment'}, {'link': 'of related'}, {'noun': 'debt issuance cost'}, {'link': 'and the'}, {'noun': 'settlement'}, {'link': 'of   the'}, {'noun': 'transaction'}, {'link': 'with'}, {'noun': 'Merck'}, {'link': 'in'}, {'noun': 'connection'}, {'link': 'with the'}, {'noun': 'separation'}, {'link': '( see Note 17 to our'}, {'noun': 'Condensed Consolidated Financial statement'}]]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                 c_noun  \n",
       "64                                                                                                                                                                                                                                                  [[effect, selling cost, quarter, month], [pandemic, cost, Organon]]  \n",
       "68   [[sale, woman, health product, Nexplanon, Implanon NXT, Follistim AQ, follitropin beta injection, Ganirelix Acetate Injection, sale, biosimilar product], [sale, woman, health product, Nexplanon, Implanon NXT, Follistim AQ, follitropin beta injection, Ganirelix Acetate Injection, sale, biosimilar product]]  \n",
       "69                                                                                                                                                                                           [[volume, procurement program, VBP, China, expiration, distribution agreement, Korea, Rosuzet, December, demand, Cozaar/]]  \n",
       "72                                                                                                                                                                                                                                                             [[demand, sale, biosimilar], [demand, sale, biosimilar]]  \n",
       "74                                                                                                                                                                                                                                                                                                       [[VBP, China]]  \n",
       "75                                                                                                                                                                                                                                                                                                         [[pandemic]]  \n",
       "80                                                                                                                                                                                                              [[ recovery, pandemic, United States, Europe, Canada, impact, pricing, tender, Latin America, quarter]]  \n",
       "81                                                                                                                                                                                                                                                                                       [[competition, United States]]  \n",
       "87                                                                                                                                                                                                                                                                                                            [[share]]  \n",
       "88                                                                                                                                                                                                                                                                                            [[ supply sale, product]]  \n",
       "89                                                                                                                                                                                                                                                                                                    [[entry, market]]  \n",
       "91                                                                                                                                                                                                            [[ volume growth, United States, recovery, pandemic, United States Europe, Canada, China, discount rate]]  \n",
       "93                                                                                                                                                                                                                                                                               [[recovery, pandemic, Europe, Canada]]  \n",
       "94                                                                                                                                                                                                                                         [[demand, United States, recovery, pandemic, United States, Europe, Canada]]  \n",
       "99                                                                                                                                                                                                                                                                         [[demand growth, United States], [discount]]  \n",
       "102                                                                                                                                                                                                                                         [[ uptake], [pressure, price], [July, launch, United States, decrease, EU]]  \n",
       "105                                                                                                                                                                                                                                                                           [[ timing, shipment, Brazil, government]]  \n",
       "108                                                                                                                                                                                                                                                               [[approval, Aybintio, EU, August, launch, September]]  \n",
       "119                                                                                                                                                                                                                                [[sale, Ezetrol, Japan, demand, United States], [competition, sale, Ezetrol, Inegy]]  \n",
       "124                                                                                                                                                                                                                                                 [[ volume growth, France, increase, sale, market, demand, Germany]]  \n",
       "125                                                                                                                                                                                                              [[demand, EU, Germany, Spain], [ competition, pricing, volume increase, France, demand, Asia Pacific]]  \n",
       "126                                                                                                                                                                                                                                                             [[expiration, distribution agreement, Korea, December]]  \n",
       "130                                                                                                                                          [[demand, United States, demand], [competition, Japan, Asia Pacific region, effect, shift, product mix, demand, China, sale, Canada, sale, quarter], [ competitor supply]]  \n",
       "132                                                                                                                                                                                                                                                                                            [[volume, China], [VBP]]  \n",
       "133                                                                                                                                                                                                                [[performance, Japan], [competition, timing, shipment, Japan, quarter, VBP impact, China, recovery]]  \n",
       "135                                                                                                                                                                                                                                                                   [[demand, Europe, Canada, beginning], [COVID-19]]  \n",
       "137                                                                                                                                                                                                                        [[demand, China, performance, Russia, sale, United States], [impact, pandemic, competition]]  \n",
       "138                                                                                                                                                                                                                    [[demand], [pandemic, market, United States, Europe, Latin America, competition, Japan, demand]]  \n",
       "139                                                                                                                                                                                                                                                                                           [[discount rate, United]]  \n",
       "140                                                                                                                                                                                                                                                 [[buy, in, month, pandemic, discount rate, United States, quarter]]  \n",
       "142                                                                                                                                                                                                                                                     [[impact, VBP, China, demand, Asia Pacific region], [COVID-19]]  \n",
       "143                                                                                                                                                                                                                                                                    [[demand, market, Middle East, Russia, quarter]]  \n",
       "144                                                                                                                                                                                                                                                                                      [[impact, VBP], [performance]]  \n",
       "147                                                                                                                                                                                                                                 [[ increase, manufacturing cost, cost, tolling arrangement, Merck, place, quarter]]  \n",
       "149                                                                                                                                                                                                              [[ increase, manufacturing cost, Organon, stand, cost, cost, tolling arrangement, Merck, place, year]]  \n",
       "150                                                                                                                                                                                                                                                                                              [[ increase, Organon]]  \n",
       "153                                                                                                                                                                                                                             [[increase, stand, cost, cost, tolling arrangement, Merck, margin percentage, product]]  \n",
       "154                                                                                                                                                                                                                                                                 [[ cost, Organon, entity, employee, cost, selling]]  \n",
       "155                                                                                                                                                                                                                                                                                         [[employee, cost, Organon]]  \n",
       "156                                                                                                                                                                                                                                                                                                            [[plan]]  \n",
       "157                                                                                                                                                                                                                                                                             [[cost, Merck, quarter, month, period]]  \n",
       "177                                                                                                                                                                                                                              [[increase, cost, expense, Organon, entity, sale], [demand, product, market, quarter]]  \n",
       "194                                                                                                                                                                                                                                                               [[increase, account, amount], [ Merck, decline, net]]  \n",
       "197                                                                                                                                                   [[proceed, issuance, term debt, payment, debt issuance cost, settlement, transaction, Merck, connection, separation, Condensed Consolidated Financial statement]]  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Example of extracted causal sentences from one MDA discussion\n",
    "df_sent = pd.read_json('C:/Users/clair/Desktop/Thesis/masterThesis2022/Data/Samples/OGN/10-Q/0001821825-21-000009/causal_sent.json')\n",
    "\n",
    "df_sent"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "0253eaeb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "17136"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_root = \"C:/Users/clair/Desktop/Thesis/masterThesis2022/Data/\"\n",
    "\n",
    "df_sent = pd.read_pickle(data_root + 'df_sent.pkl')\n",
    "\n",
    "len(df_sent)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "346871de",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BEFORE: Number of sentence nodes created: ['count(s)'] [[9830]]\n",
      "BEFORE: Number of noun nodes created: ['count(n)'] [[4924]]\n",
      "AFTER: Number of sentence nodes created: ['count(s)'] [[13983]]\n",
      "AFTER: Number of noun nodes created: ['count(n)'] [[5973]]\n"
     ]
    }
   ],
   "source": [
    "# Create sentence and noun nodes\n",
    "### It is best to run in batches (c. 5000 sentences takes 1 min)\n",
    "\n",
    "with driver.session() as session:\n",
    "    \n",
    "    #session.run(\"MATCH (s:CausalSentence) DETACH DELETE (s) \")\n",
    "    #session.run(\"MATCH (n:Noun) DETACH DELETE (n) \")\n",
    "    \n",
    "    result = session.run(\"MATCH (s:CausalSentence) RETURN count(s) \")\n",
    "    print('BEFORE: Number of sentence nodes created:', result.keys(), result.values())\n",
    "        \n",
    "    result = session.run(\"MATCH (n:Noun) RETURN count(n) \")\n",
    "    print('BEFORE: Number of noun nodes created:', result.keys(), result.values())\n",
    "\n",
    "    \n",
    "    for index, row in df_sent[12000:].iterrows():\n",
    "\n",
    "        session.run(\"MERGE (s:CausalSentence {text: $text}) \"\n",
    "                    \"ON CREATE SET s.file = $file, s.topic = $topic, s.effect_raw = $effect_raw, s.cause_raw = $cause_raw \"\n",
    "                    \"WITH s MATCH (s:CausalSentence {file: $file}), (d:Document {file: $file}) \"\n",
    "                    \"MERGE (d)-[r:HAS]->(s) \",\n",
    "                    text=row['sentence'],file=row['file'],topic=row['topic'],effect_raw=row['e_raw'],cause_raw=row['c_raw'])\n",
    "        \n",
    "        if row['c_noun']:\n",
    "            nouns = sum([x for x in row['c_noun'] if x], [])\n",
    "            \n",
    "            for i, np in enumerate(nouns):\n",
    "                session.run(\"MERGE (n:Noun {text:$noun}) \",noun=np)\n",
    "                session.run(\"MATCH (s:CausalSentence), (n:Noun) WHERE s.text = $text AND n.text = $noun MERGE (s)-[r:HAS {order:$i}]->(n) \",\n",
    "                            i=i, noun=np, text=row['sentence'])\n",
    "        \n",
    "    result = session.run(\"MATCH (s:CausalSentence) RETURN count(s) \")\n",
    "\n",
    "    print('AFTER: Number of sentence nodes created:', result.keys(), result.values())\n",
    "\n",
    "    result = session.run(\"MATCH (n:Noun) RETURN count(n) \")\n",
    "\n",
    "    print('AFTER: Number of noun nodes created:', result.keys(), result.values())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4358002d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1e8d1e88",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4afee7e4",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "76e96cd7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "38f536dc",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cd5e5953",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "49adb106",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0a4a8c63",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
